id	sid	tid	token	lemma	pos
dpc-1817	1	1	dermatology	dermatology	NOUN
dpc-1817	1	2	:	:	PUNCT
dpc-1817	1	3	practical	practical	ADJ
dpc-1817	1	4	and	and	CCONJ
dpc-1817	1	5	conceptual	conceptual	ADJ
dpc-1817	1	6	original	original	ADJ
dpc-1817	1	7	article	article	NOUN
dpc-1817	1	8	|	|	ADV
dpc-1817	1	9	dermatol	dermatol	ADJ
dpc-1817	1	10	pract	pract	NOUN
dpc-1817	1	11	concept	concept	NOUN
dpc-1817	1	12	.	.	PUNCT
dpc-1817	2	1	2022;12(1):e2022036	2022;12(1):e2022036	NUM
dpc-1817	2	2	1	1	NUM
dpc-1817	2	3	isotretinoin	isotretinoin	NOUN
dpc-1817	2	4	treatment	treatment	NOUN
dpc-1817	2	5	practices	practice	NOUN
dpc-1817	2	6	and	and	CCONJ
dpc-1817	2	7	outcomes	outcome	NOUN
dpc-1817	2	8	in	in	ADP
dpc-1817	2	9	acne	acne	NOUN
dpc-1817	2	10	patients	patient	NOUN
dpc-1817	2	11	during	during	ADP
dpc-1817	2	12	the	the	DET
dpc-1817	2	13	covid-19	covid-19	PROPN
dpc-1817	2	14	pandemic	pandemic	NOUN
dpc-1817	2	15	:	:	PUNCT
dpc-1817	2	16	a	a	DET
dpc-1817	2	17	single	single	ADJ
dpc-1817	2	18	center	center	NOUN
dpc-1817	2	19	,	,	PUNCT
dpc-1817	2	20	retrospective	retrospective	ADJ
dpc-1817	2	21	,	,	PUNCT
dpc-1817	2	22	comparative	comparative	ADJ
dpc-1817	2	23	study	study	NOUN
dpc-1817	2	24	mehmet	mehmet	PROPN
dpc-1817	2	25	fatih	fatih	PROPN
dpc-1817	2	26	atak1,2	atak1,2	PROPN
dpc-1817	2	27	,	,	PUNCT
dpc-1817	2	28	banu	banu	PROPN
dpc-1817	2	29	ismail	ismail	PROPN
dpc-1817	2	30	mendi2	mendi2	PROPN
dpc-1817	2	31	,	,	PUNCT
dpc-1817	2	32	incilay	incilay	ADJ
dpc-1817	2	33	kalay	kalay	NOUN
dpc-1817	2	34	yildizhan2	yildizhan2	PROPN
dpc-1817	2	35	,	,	PUNCT
dpc-1817	2	36	hatice	hatice	PROPN
dpc-1817	2	37	sanli2	sanli2	PROPN
dpc-1817	2	38	,	,	PUNCT
dpc-1817	2	39	banu	banu	PROPN
dpc-1817	2	40	farabi3	farabi3	PROPN
dpc-1817	2	41	1	1	NUM
dpc-1817	2	42	dermatology	dermatology	NOUN
dpc-1817	2	43	department	department	NOUN
dpc-1817	2	44	,	,	PUNCT
dpc-1817	2	45	tokat	tokat	NOUN
dpc-1817	2	46	state	state	NOUN
dpc-1817	2	47	hospital	hospital	NOUN
dpc-1817	2	48	,	,	PUNCT
dpc-1817	2	49	tokat	tokat	NOUN
dpc-1817	2	50	,	,	PUNCT
dpc-1817	2	51	turkey	turkey	NOUN
dpc-1817	2	52	2	2	NUM
dpc-1817	2	53	dermatology	dermatology	NOUN
dpc-1817	2	54	department	department	NOUN
dpc-1817	2	55	,	,	PUNCT
dpc-1817	2	56	ankara	ankara	PROPN
dpc-1817	2	57	university	university	PROPN
dpc-1817	2	58	,	,	PUNCT
dpc-1817	2	59	ankara	ankara	PROPN
dpc-1817	2	60	,	,	PUNCT
dpc-1817	2	61	turkey	turkey	PROPN
dpc-1817	2	62	3	3	NUM
dpc-1817	2	63	department	department	NOUN
dpc-1817	2	64	of	of	ADP
dpc-1817	2	65	internal	internal	ADJ
dpc-1817	2	66	medicine	medicine	NOUN
dpc-1817	2	67	,	,	PUNCT
dpc-1817	2	68	saint	saint	PROPN
dpc-1817	2	69	peter	peter	PROPN
dpc-1817	2	70	’s	’s	PART
dpc-1817	2	71	university	university	PROPN
dpc-1817	2	72	hospital	hospital	NOUN
dpc-1817	2	73	,	,	PUNCT
dpc-1817	2	74	new	new	PROPN
dpc-1817	2	75	brunswick	brunswick	PROPN
dpc-1817	2	76	,	,	PUNCT
dpc-1817	2	77	nj	nj	PROPN
dpc-1817	2	78	,	,	PUNCT
dpc-1817	2	79	usa	usa	PROPN
dpc-1817	2	80	key	key	PROPN
dpc-1817	2	81	words	word	NOUN
dpc-1817	2	82	:	:	PUNCT
dpc-1817	2	83	isotretinoin	isotretinoin	PROPN
dpc-1817	2	84	,	,	PUNCT
dpc-1817	2	85	treatment	treatment	NOUN
dpc-1817	2	86	,	,	PUNCT
dpc-1817	2	87	acne	acne	NOUN
dpc-1817	2	88	,	,	PUNCT
dpc-1817	2	89	covid-19	covid-19	PROPN
dpc-1817	2	90	,	,	PUNCT
dpc-1817	2	91	pandemic	pandemic	ADJ
dpc-1817	2	92	citation	citation	NOUN
dpc-1817	2	93	:	:	PUNCT
dpc-1817	2	94	atak	atak	PROPN
dpc-1817	2	95	mf	mf	VERB
dpc-1817	2	96	,	,	PUNCT
dpc-1817	2	97	ismail	ismail	PROPN
dpc-1817	2	98	mendi	mendi	PROPN
dpc-1817	2	99	b	b	PROPN
dpc-1817	2	100	,	,	PUNCT
dpc-1817	2	101	kalay	kalay	VERB
dpc-1817	2	102	yildizhan	yildizhan	PROPN
dpc-1817	2	103	i	i	PROPN
dpc-1817	2	104	,	,	PUNCT
dpc-1817	2	105	sanli	sanli	PROPN
dpc-1817	2	106	h	h	PROPN
dpc-1817	2	107	,	,	PUNCT
dpc-1817	2	108	farabi	farabi	PROPN
dpc-1817	2	109	b.	b.	PROPN
dpc-1817	2	110	isotretinoin	isotretinoin	PROPN
dpc-1817	2	111	treatment	treatment	NOUN
dpc-1817	2	112	practices	practice	NOUN
dpc-1817	2	113	and	and	CCONJ
dpc-1817	2	114	outcomes	outcome	NOUN
dpc-1817	2	115	in	in	ADP
dpc-1817	2	116	acne	acne	NOUN
dpc-1817	2	117	patients	patient	NOUN
dpc-1817	2	118	during	during	ADP
dpc-1817	2	119	the	the	DET
dpc-1817	2	120	covid-19	covid-19	PROPN
dpc-1817	2	121	pandemic	pandemic	NOUN
dpc-1817	2	122	:	:	PUNCT
dpc-1817	2	123	a	a	DET
dpc-1817	2	124	single	single	ADJ
dpc-1817	2	125	center	center	NOUN
dpc-1817	2	126	,	,	PUNCT
dpc-1817	2	127	retrospective	retrospective	ADJ
dpc-1817	2	128	,	,	PUNCT
dpc-1817	2	129	comparative	comparative	ADJ
dpc-1817	2	130	study	study	NOUN
dpc-1817	2	131	.	.	PUNCT
dpc-1817	3	1	dermatol	dermatol	NOUN
dpc-1817	3	2	pract	pract	PROPN
dpc-1817	3	3	concept	concept	NOUN
dpc-1817	3	4	.	.	PUNCT
dpc-1817	4	1	2022;12(1):e2022036	2022;12(1):e2022036	X
dpc-1817	4	2	.	.	PUNCT
dpc-1817	5	1	doi	doi	PROPN
dpc-1817	5	2	:	:	PUNCT
dpc-1817	5	3	https://doi.org/10.5826/dpc.1201a36	https://doi.org/10.5826/dpc.1201a36	NOUN
dpc-1817	5	4	accepted	accept	VERB
dpc-1817	5	5	:	:	PUNCT
dpc-1817	5	6	august	august	PROPN
dpc-1817	5	7	30	30	NUM
dpc-1817	5	8	,	,	PUNCT
dpc-1817	5	9	2021	2021	NUM
dpc-1817	5	10	;	;	PUNCT
dpc-1817	5	11	published	publish	VERB
dpc-1817	5	12	:	:	PUNCT
dpc-1817	5	13	january	january	PROPN
dpc-1817	5	14	2022	2022	NUM
dpc-1817	6	1	copyright	copyright	NOUN
dpc-1817	6	2	:	:	PUNCT
dpc-1817	6	3	©	©	PROPN
dpc-1817	6	4	2022	2022	NUM
dpc-1817	6	5	atak	atak	PROPN
dpc-1817	6	6	et	et	PROPN
dpc-1817	6	7	al	al	PROPN
dpc-1817	6	8	.	.	PUNCT
dpc-1817	7	1	this	this	PRON
dpc-1817	7	2	is	be	AUX
dpc-1817	7	3	an	an	DET
dpc-1817	7	4	open	open	ADJ
dpc-1817	7	5	-	-	PUNCT
dpc-1817	7	6	access	access	NOUN
dpc-1817	7	7	article	article	NOUN
dpc-1817	7	8	distributed	distribute	VERB
dpc-1817	7	9	under	under	ADP
dpc-1817	7	10	the	the	DET
dpc-1817	7	11	terms	term	NOUN
dpc-1817	7	12	of	of	ADP
dpc-1817	7	13	the	the	DET
dpc-1817	7	14	creative	creative	ADJ
dpc-1817	7	15	commons	common	NOUN
dpc-1817	7	16	attribution	attribution	NOUN
dpc-1817	7	17	-	-	PUNCT
dpc-1817	7	18	noncommercial	noncommercial	ADJ
dpc-1817	7	19	license	license	NOUN
dpc-1817	7	20	(	(	PUNCT
dpc-1817	7	21	by	by	ADP
dpc-1817	7	22	-	-	PUNCT
dpc-1817	7	23	nc-4.0	nc-4.0	NOUN
dpc-1817	7	24	)	)	PUNCT
dpc-1817	7	25	,	,	PUNCT
dpc-1817	7	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1817	7	27	,	,	PUNCT
dpc-1817	7	28	which	which	PRON
dpc-1817	7	29	permits	permit	VERB
dpc-1817	7	30	unrestricted	unrestricted	ADJ
dpc-1817	7	31	noncommercial	noncommercial	ADJ
dpc-1817	7	32	use	use	NOUN
dpc-1817	7	33	,	,	PUNCT
dpc-1817	7	34	distribution	distribution	NOUN
dpc-1817	7	35	,	,	PUNCT
dpc-1817	7	36	and	and	CCONJ
dpc-1817	7	37	reproduction	reproduction	NOUN
dpc-1817	7	38	in	in	ADP
dpc-1817	7	39	any	any	DET
dpc-1817	7	40	medium	medium	NOUN
dpc-1817	7	41	,	,	PUNCT
dpc-1817	7	42	provided	provide	VERB
dpc-1817	7	43	the	the	DET
dpc-1817	7	44	original	original	ADJ
dpc-1817	7	45	authors	author	NOUN
dpc-1817	7	46	and	and	CCONJ
dpc-1817	7	47	source	source	NOUN
dpc-1817	7	48	are	be	AUX
dpc-1817	7	49	credited	credit	VERB
dpc-1817	7	50	.	.	PUNCT
dpc-1817	8	1	funding	funding	NOUN
dpc-1817	8	2	:	:	PUNCT
dpc-1817	8	3	none	none	NOUN
dpc-1817	8	4	.	.	PUNCT
dpc-1817	9	1	competing	compete	VERB
dpc-1817	9	2	interests	interest	NOUN
dpc-1817	9	3	:	:	PUNCT
dpc-1817	9	4	none	none	NOUN
dpc-1817	9	5	.	.	PUNCT
dpc-1817	10	1	authorship	authorship	NOUN
dpc-1817	10	2	:	:	PUNCT
dpc-1817	10	3	all	all	DET
dpc-1817	10	4	authors	author	NOUN
dpc-1817	10	5	have	have	AUX
dpc-1817	10	6	contributed	contribute	VERB
dpc-1817	10	7	significantly	significantly	ADV
dpc-1817	10	8	to	to	ADP
dpc-1817	10	9	this	this	DET
dpc-1817	10	10	publication	publication	NOUN
dpc-1817	10	11	.	.	PUNCT
dpc-1817	11	1	mfa	mfa	PROPN
dpc-1817	11	2	:	:	PUNCT
dpc-1817	11	3	conceptualization	conceptualization	NOUN
dpc-1817	11	4	,	,	PUNCT
dpc-1817	11	5	data	data	NOUN
dpc-1817	11	6	curation	curation	NOUN
dpc-1817	11	7	,	,	PUNCT
dpc-1817	11	8	formal	formal	ADJ
dpc-1817	11	9	analysis	analysis	NOUN
dpc-1817	11	10	,	,	PUNCT
dpc-1817	11	11	methodology	methodology	NOUN
dpc-1817	11	12	,	,	PUNCT
dpc-1817	11	13	resources	resource	NOUN
dpc-1817	11	14	,	,	PUNCT
dpc-1817	11	15	validation	validation	NOUN
dpc-1817	11	16	,	,	PUNCT
dpc-1817	11	17	writing	writing	NOUN
dpc-1817	11	18	-	-	PUNCT
dpc-1817	11	19	original	original	ADJ
dpc-1817	11	20	draft	draft	NOUN
dpc-1817	11	21	,	,	PUNCT
dpc-1817	11	22	writing	write	VERB
dpc-1817	11	23	review	review	NOUN
dpc-1817	11	24	&	&	CCONJ
dpc-1817	11	25	editing	editing	PROPN
dpc-1817	11	26	;	;	PUNCT
dpc-1817	11	27	bf	bf	NUM
dpc-1817	11	28	:	:	PUNCT
dpc-1817	11	29	methodology	methodology	NOUN
dpc-1817	11	30	,	,	PUNCT
dpc-1817	11	31	resources	resource	NOUN
dpc-1817	11	32	,	,	PUNCT
dpc-1817	11	33	supervision	supervision	NOUN
dpc-1817	11	34	,	,	PUNCT
dpc-1817	11	35	validation	validation	NOUN
dpc-1817	11	36	,	,	PUNCT
dpc-1817	11	37	writing	writing	NOUN
dpc-1817	11	38	-	-	PUNCT
dpc-1817	11	39	original	original	ADJ
dpc-1817	11	40	draft	draft	NOUN
dpc-1817	11	41	,	,	PUNCT
dpc-1817	11	42	writing	write	VERB
dpc-1817	11	43	review	review	NOUN
dpc-1817	11	44	&	&	CCONJ
dpc-1817	11	45	editing	editing	PROPN
dpc-1817	11	46	;	;	PUNCT
dpc-1817	11	47	bi	bi	NOUN
dpc-1817	11	48	:	:	PUNCT
dpc-1817	11	49	data	data	NOUN
dpc-1817	11	50	curation	curation	NOUN
dpc-1817	11	51	,	,	PUNCT
dpc-1817	11	52	resources	resource	NOUN
dpc-1817	11	53	;	;	PUNCT
dpc-1817	12	1	iky	iky	PROPN
dpc-1817	12	2	:	:	PUNCT
dpc-1817	12	3	writing	writing	NOUN
dpc-1817	12	4	-	-	PUNCT
dpc-1817	12	5	review	review	NOUN
dpc-1817	12	6	&	&	CCONJ
dpc-1817	12	7	editing	editing	NOUN
dpc-1817	12	8	;	;	PUNCT
dpc-1817	12	9	hs	hs	NUM
dpc-1817	12	10	:	:	PUNCT
dpc-1817	12	11	revision	revision	NOUN
dpc-1817	12	12	of	of	ADP
dpc-1817	12	13	the	the	DET
dpc-1817	12	14	content	content	NOUN
dpc-1817	12	15	corresponding	correspond	VERB
dpc-1817	12	16	author	author	NOUN
dpc-1817	12	17	:	:	PUNCT
dpc-1817	12	18	banu	banu	PROPN
dpc-1817	12	19	farabi	farabi	PROPN
dpc-1817	12	20	,	,	PUNCT
dpc-1817	12	21	department	department	NOUN
dpc-1817	12	22	of	of	ADP
dpc-1817	12	23	internal	internal	ADJ
dpc-1817	12	24	medicine	medicine	NOUN
dpc-1817	12	25	,	,	PUNCT
dpc-1817	12	26	saint	saint	PROPN
dpc-1817	12	27	peter	peter	PROPN
dpc-1817	12	28	’s	’s	PART
dpc-1817	12	29	university	university	PROPN
dpc-1817	12	30	hospital	hospital	NOUN
dpc-1817	12	31	,	,	PUNCT
dpc-1817	12	32	new	new	PROPN
dpc-1817	12	33	brunswick	brunswick	PROPN
dpc-1817	12	34	,	,	PUNCT
dpc-1817	12	35	nj	nj	PROPN
dpc-1817	12	36	,	,	PUNCT
dpc-1817	12	37	usa	usa	PROPN
dpc-1817	12	38	.	.	PROPN
dpc-1817	12	39	e	e	X
dpc-1817	12	40	-	-	NOUN
dpc-1817	12	41	mail	mail	NOUN
dpc-1817	12	42	:	:	PUNCT
dpc-1817	12	43	banufarabi91@gmail.com	banufarabi91@gmail.com	X
dpc-1817	12	44	introduction	introduction	NOUN
dpc-1817	12	45	:	:	PUNCT
dpc-1817	12	46	the	the	DET
dpc-1817	12	47	covid-19	covid-19	PROPN
dpc-1817	12	48	pandemic	pandemic	NOUN
dpc-1817	12	49	drastically	drastically	ADV
dpc-1817	12	50	changed	change	VERB
dpc-1817	12	51	the	the	DET
dpc-1817	12	52	priorities	priority	NOUN
dpc-1817	12	53	in	in	ADP
dpc-1817	12	54	healthcare	healthcare	PROPN
dpc-1817	12	55	services	service	NOUN
dpc-1817	12	56	;	;	PUNCT
dpc-1817	12	57	outpatient	outpatient	NOUN
dpc-1817	12	58	management	management	NOUN
dpc-1817	12	59	of	of	ADP
dpc-1817	12	60	acne	acne	NOUN
dpc-1817	12	61	has	have	AUX
dpc-1817	12	62	changed	change	VERB
dpc-1817	12	63	during	during	ADP
dpc-1817	12	64	this	this	DET
dpc-1817	12	65	period	period	NOUN
dpc-1817	12	66	.	.	PUNCT
dpc-1817	13	1	objectives	objective	NOUN
dpc-1817	13	2	:	:	PUNCT
dpc-1817	13	3	we	we	PRON
dpc-1817	13	4	aimed	aim	VERB
dpc-1817	13	5	to	to	PART
dpc-1817	13	6	investigate	investigate	VERB
dpc-1817	13	7	treatment	treatment	NOUN
dpc-1817	13	8	practices	practice	NOUN
dpc-1817	13	9	,	,	PUNCT
dpc-1817	13	10	outcomes	outcome	NOUN
dpc-1817	13	11	and	and	CCONJ
dpc-1817	13	12	identify	identify	VERB
dpc-1817	13	13	modified	modified	ADJ
dpc-1817	13	14	follow	follow	NOUN
dpc-1817	13	15	-	-	PUNCT
dpc-1817	13	16	up	up	ADP
dpc-1817	13	17	schedules	schedule	NOUN
dpc-1817	13	18	applied	apply	VERB
dpc-1817	13	19	during	during	ADP
dpc-1817	13	20	the	the	DET
dpc-1817	13	21	pandemic	pandemic	NOUN
dpc-1817	13	22	.	.	PUNCT
dpc-1817	14	1	methods	method	NOUN
dpc-1817	14	2	:	:	PUNCT
dpc-1817	14	3	the	the	DET
dpc-1817	14	4	patients	patient	NOUN
dpc-1817	14	5	who	who	PRON
dpc-1817	14	6	were	be	AUX
dpc-1817	14	7	admitted	admit	VERB
dpc-1817	14	8	to	to	ADP
dpc-1817	14	9	dermatology	dermatology	NOUN
dpc-1817	14	10	outpatient	outpatient	NOUN
dpc-1817	14	11	clinic	clinic	NOUN
dpc-1817	14	12	between	between	ADP
dpc-1817	14	13	march	march	PROPN
dpc-1817	14	14	13	13	NUM
dpc-1817	14	15	and	and	CCONJ
dpc-1817	14	16	july	july	PROPN
dpc-1817	14	17	13	13	NUM
dpc-1817	14	18	,	,	PUNCT
dpc-1817	14	19	2020	2020	NUM
dpc-1817	14	20	,	,	PUNCT
dpc-1817	14	21	were	be	AUX
dpc-1817	14	22	included	include	VERB
dpc-1817	14	23	.	.	PUNCT
dpc-1817	15	1	patients	patient	NOUN
dpc-1817	15	2	who	who	PRON
dpc-1817	15	3	were	be	AUX
dpc-1817	15	4	admitted	admit	VERB
dpc-1817	15	5	between	between	ADP
dpc-1817	15	6	march	march	PROPN
dpc-1817	15	7	13	13	NUM
dpc-1817	15	8	and	and	CCONJ
dpc-1817	15	9	july	july	PROPN
dpc-1817	15	10	13	13	NUM
dpc-1817	15	11	,	,	PUNCT
dpc-1817	15	12	2019	2019	NUM
dpc-1817	15	13	,	,	PUNCT
dpc-1817	15	14	were	be	AUX
dpc-1817	15	15	served	serve	VERB
dpc-1817	15	16	as	as	ADP
dpc-1817	15	17	controls	control	NOUN
dpc-1817	15	18	for	for	ADP
dpc-1817	15	19	the	the	DET
dpc-1817	15	20	study	study	NOUN
dpc-1817	15	21	.	.	PUNCT
dpc-1817	16	1	for	for	ADP
dpc-1817	16	2	each	each	DET
dpc-1817	16	3	patient	patient	NOUN
dpc-1817	16	4	,	,	PUNCT
dpc-1817	16	5	age	age	NOUN
dpc-1817	16	6	,	,	PUNCT
dpc-1817	16	7	gender	gender	NOUN
dpc-1817	16	8	,	,	PUNCT
dpc-1817	16	9	treatment	treatment	NOUN
dpc-1817	16	10	protocols	protocol	NOUN
dpc-1817	16	11	,	,	PUNCT
dpc-1817	16	12	treatment	treatment	NOUN
dpc-1817	16	13	intervals	interval	NOUN
dpc-1817	16	14	,	,	PUNCT
dpc-1817	16	15	compliance	compliance	NOUN
dpc-1817	16	16	with	with	ADP
dpc-1817	16	17	the	the	DET
dpc-1817	16	18	treatment	treatment	NOUN
dpc-1817	16	19	,	,	PUNCT
dpc-1817	16	20	treatment	treatment	NOUN
dpc-1817	16	21	modifications	modification	NOUN
dpc-1817	16	22	,	,	PUNCT
dpc-1817	16	23	and	and	CCONJ
dpc-1817	16	24	adverse	adverse	ADJ
dpc-1817	16	25	events	event	NOUN
dpc-1817	16	26	were	be	AUX
dpc-1817	16	27	recorded	record	VERB
dpc-1817	16	28	.	.	PUNCT
dpc-1817	17	1	results	result	NOUN
dpc-1817	17	2	:	:	PUNCT
dpc-1817	17	3	the	the	DET
dpc-1817	17	4	total	total	ADJ
dpc-1817	17	5	number	number	NOUN
dpc-1817	17	6	of	of	ADP
dpc-1817	17	7	acne	acne	NOUN
dpc-1817	17	8	patients	patient	NOUN
dpc-1817	17	9	admitted	admit	VERB
dpc-1817	17	10	to	to	ADP
dpc-1817	17	11	dermatology	dermatology	NOUN
dpc-1817	17	12	outpatient	outpatient	NOUN
dpc-1817	17	13	clinics	clinic	NOUN
dpc-1817	17	14	during	during	ADP
dpc-1817	17	15	the	the	DET
dpc-1817	17	16	pandemic	pandemic	ADJ
dpc-1817	17	17	period	period	NOUN
dpc-1817	17	18	was	be	AUX
dpc-1817	17	19	278	278	NUM
dpc-1817	17	20	and	and	CCONJ
dpc-1817	17	21	consisted	consist	VERB
dpc-1817	17	22	of	of	ADP
dpc-1817	17	23	12.3	12.3	NUM
dpc-1817	17	24	%	%	NOUN
dpc-1817	17	25	(	(	PUNCT
dpc-1817	17	26	278	278	NUM
dpc-1817	17	27	)	)	PUNCT
dpc-1817	17	28	of	of	ADP
dpc-1817	17	29	all	all	DET
dpc-1817	17	30	admissions	admission	NOUN
dpc-1817	17	31	.	.	PUNCT
dpc-1817	18	1	isotretinoin	isotretinoin	PROPN
dpc-1817	18	2	treatment	treatment	NOUN
dpc-1817	18	3	was	be	AUX
dpc-1817	18	4	started	start	VERB
dpc-1817	18	5	in	in	ADP
dpc-1817	18	6	only	only	ADV
dpc-1817	18	7	16	16	NUM
dpc-1817	18	8	(	(	PUNCT
dpc-1817	18	9	5.8	5.8	NUM
dpc-1817	18	10	%	%	NOUN
dpc-1817	18	11	)	)	PUNCT
dpc-1817	18	12	of	of	ADP
dpc-1817	18	13	the	the	DET
dpc-1817	18	14	patients	patient	NOUN
dpc-1817	18	15	.	.	PUNCT
dpc-1817	19	1	the	the	DET
dpc-1817	19	2	proportion	proportion	NOUN
dpc-1817	19	3	of	of	ADP
dpc-1817	19	4	patients	patient	NOUN
dpc-1817	19	5	who	who	PRON
dpc-1817	19	6	were	be	AUX
dpc-1817	19	7	under	under	ADP
dpc-1817	19	8	follow	follow	NOUN
dpc-1817	19	9	-	-	PUNCT
dpc-1817	19	10	up	up	NOUN
dpc-1817	19	11	was	be	AUX
dpc-1817	19	12	significantly	significantly	ADV
dpc-1817	19	13	higher	high	ADJ
dpc-1817	19	14	during	during	ADP
dpc-1817	19	15	the	the	DET
dpc-1817	19	16	pandemic	pandemic	ADJ
dpc-1817	19	17	period	period	NOUN
dpc-1817	19	18	(	(	PUNCT
dpc-1817	19	19	p	p	X
dpc-1817	19	20	<	<	X
dpc-1817	19	21	0.005	0.005	NUM
dpc-1817	19	22	)	)	PUNCT
dpc-1817	19	23	.	.	PUNCT
dpc-1817	20	1	there	there	PRON
dpc-1817	20	2	was	be	VERB
dpc-1817	20	3	no	no	DET
dpc-1817	20	4	difference	difference	NOUN
dpc-1817	20	5	between	between	ADP
dpc-1817	20	6	the	the	DET
dpc-1817	20	7	pandemic	pandemic	ADJ
dpc-1817	20	8	period	period	NOUN
dpc-1817	20	9	and	and	CCONJ
dpc-1817	20	10	the	the	DET
dpc-1817	20	11	non	non	ADJ
dpc-1817	20	12	-	-	ADJ
dpc-1817	20	13	pandemic	pandemic	ADJ
dpc-1817	20	14	period	period	NOUN
dpc-1817	20	15	in	in	ADP
dpc-1817	20	16	terms	term	NOUN
dpc-1817	20	17	of	of	ADP
dpc-1817	20	18	starting	start	VERB
dpc-1817	20	19	isotretinoin	isotretinoin	PROPN
dpc-1817	20	20	treatment	treatment	NOUN
dpc-1817	20	21	(	(	PUNCT
dpc-1817	20	22	p	p	X
dpc-1817	20	23	>	>	X
dpc-1817	20	24	0.05	0.05	NUM
dpc-1817	20	25	)	)	PUNCT
dpc-1817	20	26	.	.	PUNCT
dpc-1817	21	1	during	during	ADP
dpc-1817	21	2	pandemic	pandemic	ADJ
dpc-1817	21	3	period	period	NOUN
dpc-1817	21	4	,	,	PUNCT
dpc-1817	21	5	79	79	NUM
dpc-1817	21	6	%	%	NOUN
dpc-1817	21	7	of	of	ADP
dpc-1817	21	8	the	the	DET
dpc-1817	21	9	patients	patient	NOUN
dpc-1817	21	10	who	who	PRON
dpc-1817	21	11	used	use	VERB
dpc-1817	21	12	isotretinoin	isotretinoin	PROPN
dpc-1817	21	13	were	be	AUX
dpc-1817	21	14	followed	follow	VERB
dpc-1817	21	15	-	-	PUNCT
dpc-1817	21	16	up	up	ADP
dpc-1817	21	17	every	every	DET
dpc-1817	21	18	two	two	NUM
dpc-1817	21	19	or	or	CCONJ
dpc-1817	21	20	more	more	ADJ
dpc-1817	21	21	months	month	NOUN
dpc-1817	21	22	.	.	PUNCT
dpc-1817	22	1	extended	extended	ADJ
dpc-1817	22	2	follow	follow	NOUN
dpc-1817	22	3	-	-	PUNCT
dpc-1817	22	4	up	up	ADP
dpc-1817	22	5	intervals	interval	NOUN
dpc-1817	22	6	showed	show	VERB
dpc-1817	22	7	no	no	DET
dpc-1817	22	8	difference	difference	NOUN
dpc-1817	22	9	for	for	ADP
dpc-1817	22	10	detecting	detect	VERB
dpc-1817	22	11	side	side	NOUN
dpc-1817	22	12	effects	effect	NOUN
dpc-1817	22	13	(	(	PUNCT
dpc-1817	22	14	p	p	X
dpc-1817	22	15	>	>	X
dpc-1817	22	16	0.05	0.05	NUM
dpc-1817	22	17	)	)	PUNCT
dpc-1817	22	18	.	.	PUNCT
dpc-1817	23	1	abstract	abstract	ADJ
dpc-1817	23	2	2	2	NUM
dpc-1817	23	3	original	original	ADJ
dpc-1817	23	4	article	article	NOUN
dpc-1817	23	5	|	|	ADV
dpc-1817	23	6	dermatol	dermatol	ADJ
dpc-1817	23	7	pract	pract	NOUN
dpc-1817	23	8	concept	concept	NOUN
dpc-1817	23	9	.	.	PUNCT
dpc-1817	24	1	2022;12(1):e2022036	2022;12(1):e2022036	NUM
dpc-1817	24	2	introduction	introduction	NOUN
dpc-1817	24	3	covid-19	covid-19	PROPN
dpc-1817	24	4	pandemic	pandemic	NOUN
dpc-1817	24	5	affected	affect	VERB
dpc-1817	24	6	the	the	DET
dpc-1817	24	7	healthcare	healthcare	NOUN
dpc-1817	24	8	practices	practice	NOUN
dpc-1817	24	9	all	all	ADV
dpc-1817	24	10	over	over	ADP
dpc-1817	24	11	the	the	DET
dpc-1817	24	12	world	world	NOUN
dpc-1817	24	13	in	in	ADP
dpc-1817	24	14	2020	2020	NUM
dpc-1817	24	15	.	.	PUNCT
dpc-1817	25	1	it	it	PRON
dpc-1817	25	2	drastically	drastically	ADV
dpc-1817	25	3	changed	change	VERB
dpc-1817	25	4	the	the	DET
dpc-1817	25	5	priorities	priority	NOUN
dpc-1817	25	6	in	in	ADP
dpc-1817	25	7	healthcare	healthcare	PROPN
dpc-1817	25	8	services	service	NOUN
dpc-1817	25	9	,	,	PUNCT
dpc-1817	25	10	thus	thus	ADV
dpc-1817	25	11	outpatient	outpatient	NOUN
dpc-1817	25	12	management	management	NOUN
dpc-1817	25	13	of	of	ADP
dpc-1817	25	14	elective	elective	ADJ
dpc-1817	25	15	diseases	disease	NOUN
dpc-1817	25	16	such	such	ADJ
dpc-1817	25	17	as	as	ADP
dpc-1817	25	18	acne	acne	NOUN
dpc-1817	25	19	have	have	AUX
dpc-1817	25	20	also	also	ADV
dpc-1817	25	21	been	be	AUX
dpc-1817	25	22	shaped	shape	VERB
dpc-1817	25	23	during	during	ADP
dpc-1817	25	24	this	this	DET
dpc-1817	25	25	period	period	NOUN
dpc-1817	25	26	[	[	X
dpc-1817	25	27	1	1	NUM
dpc-1817	25	28	]	]	PUNCT
dpc-1817	25	29	.	.	PUNCT
dpc-1817	26	1	restrictions	restriction	NOUN
dpc-1817	26	2	and	and	CCONJ
dpc-1817	26	3	the	the	DET
dpc-1817	26	4	fear	fear	NOUN
dpc-1817	26	5	of	of	ADP
dpc-1817	26	6	infection	infection	NOUN
dpc-1817	26	7	altered	alter	VERB
dpc-1817	26	8	outpatient	outpatient	NOUN
dpc-1817	26	9	clinic	clinic	NOUN
dpc-1817	26	10	patient	patient	NOUN
dpc-1817	26	11	profile	profile	NOUN
dpc-1817	26	12	in	in	ADP
dpc-1817	26	13	dermatology	dermatology	NOUN
dpc-1817	26	14	clinics	clinic	NOUN
dpc-1817	26	15	and	and	CCONJ
dpc-1817	26	16	resulted	result	VERB
dpc-1817	26	17	implementation	implementation	NOUN
dpc-1817	26	18	of	of	ADP
dpc-1817	26	19	teledermatology	teledermatology	NOUN
dpc-1817	26	20	visits	visit	NOUN
dpc-1817	26	21	[	[	X
dpc-1817	26	22	2	2	NUM
dpc-1817	26	23	]	]	PUNCT
dpc-1817	26	24	.	.	PUNCT
dpc-1817	27	1	the	the	DET
dpc-1817	27	2	effects	effect	NOUN
dpc-1817	27	3	of	of	ADP
dpc-1817	27	4	pandemic	pandemic	ADJ
dpc-1817	27	5	on	on	ADP
dpc-1817	27	6	dermatological	dermatological	ADJ
dpc-1817	27	7	practices	practice	NOUN
dpc-1817	27	8	have	have	AUX
dpc-1817	27	9	been	be	AUX
dpc-1817	27	10	investigated	investigate	VERB
dpc-1817	27	11	especially	especially	ADV
dpc-1817	27	12	in	in	ADP
dpc-1817	27	13	chronic	chronic	ADJ
dpc-1817	27	14	diseases	disease	NOUN
dpc-1817	27	15	treating	treat	VERB
dpc-1817	27	16	with	with	ADP
dpc-1817	27	17	immunosuppressive	immunosuppressive	ADJ
dpc-1817	27	18	or	or	CCONJ
dpc-1817	27	19	immunomodulatory	immunomodulatory	ADJ
dpc-1817	27	20	drugs	drug	NOUN
dpc-1817	27	21	,	,	PUNCT
dpc-1817	27	22	but	but	CCONJ
dpc-1817	27	23	there	there	PRON
dpc-1817	27	24	are	be	VERB
dpc-1817	27	25	not	not	PART
dpc-1817	27	26	enough	enough	ADJ
dpc-1817	27	27	studies	study	NOUN
dpc-1817	27	28	focusing	focus	VERB
dpc-1817	27	29	on	on	ADP
dpc-1817	27	30	the	the	DET
dpc-1817	27	31	effects	effect	NOUN
dpc-1817	27	32	of	of	ADP
dpc-1817	27	33	acne	acne	NOUN
dpc-1817	27	34	and	and	CCONJ
dpc-1817	27	35	its	its	PRON
dpc-1817	27	36	management	management	NOUN
dpc-1817	27	37	during	during	ADP
dpc-1817	27	38	the	the	DET
dpc-1817	27	39	pandemic	pandemic	NOUN
dpc-1817	27	40	.	.	PUNCT
dpc-1817	28	1	acne	acne	NOUN
dpc-1817	28	2	patients	patient	NOUN
dpc-1817	28	3	consist	consist	VERB
dpc-1817	28	4	of	of	ADP
dpc-1817	28	5	an	an	DET
dpc-1817	28	6	important	important	ADJ
dpc-1817	28	7	part	part	NOUN
dpc-1817	28	8	of	of	ADP
dpc-1817	28	9	the	the	DET
dpc-1817	28	10	routine	routine	ADJ
dpc-1817	28	11	dermatology	dermatology	NOUN
dpc-1817	28	12	outpatient	outpatient	NOUN
dpc-1817	28	13	clinics	clinic	NOUN
dpc-1817	28	14	,	,	PUNCT
dpc-1817	28	15	thus	thus	ADV
dpc-1817	28	16	further	further	ADJ
dpc-1817	28	17	studies	study	NOUN
dpc-1817	28	18	are	be	AUX
dpc-1817	28	19	required	require	VERB
dpc-1817	28	20	to	to	PART
dpc-1817	28	21	establish	establish	VERB
dpc-1817	28	22	the	the	DET
dpc-1817	28	23	management	management	NOUN
dpc-1817	28	24	of	of	ADP
dpc-1817	28	25	acne	acne	NOUN
dpc-1817	28	26	[	[	X
dpc-1817	28	27	3	3	NUM
dpc-1817	28	28	]	]	PUNCT
dpc-1817	28	29	.	.	PUNCT
dpc-1817	29	1	objectives	objective	NOUN
dpc-1817	29	2	we	we	PRON
dpc-1817	29	3	aimed	aim	VERB
dpc-1817	29	4	to	to	PART
dpc-1817	29	5	investigate	investigate	VERB
dpc-1817	29	6	the	the	DET
dpc-1817	29	7	treatment	treatment	NOUN
dpc-1817	29	8	practices	practice	NOUN
dpc-1817	29	9	,	,	PUNCT
dpc-1817	29	10	treatment	treatment	NOUN
dpc-1817	29	11	outcomes	outcome	NOUN
dpc-1817	29	12	,	,	PUNCT
dpc-1817	29	13	adherence	adherence	NOUN
dpc-1817	29	14	of	of	ADP
dpc-1817	29	15	acne	acne	NOUN
dpc-1817	29	16	patients	patient	NOUN
dpc-1817	29	17	and	and	CCONJ
dpc-1817	29	18	to	to	PART
dpc-1817	29	19	identify	identify	VERB
dpc-1817	29	20	modified	modify	VERB
dpc-1817	29	21	follow	follow	VERB
dpc-1817	29	22	-	-	PUNCT
dpc-1817	29	23	up	up	ADP
dpc-1817	29	24	schedules	schedule	NOUN
dpc-1817	29	25	during	during	ADP
dpc-1817	29	26	the	the	DET
dpc-1817	29	27	pandemic	pandemic	ADJ
dpc-1817	29	28	period	period	NOUN
dpc-1817	29	29	.	.	PUNCT
dpc-1817	30	1	methods	method	NOUN
dpc-1817	30	2	the	the	DET
dpc-1817	30	3	irb	irb	NOUN
dpc-1817	30	4	approval	approval	NOUN
dpc-1817	30	5	for	for	ADP
dpc-1817	30	6	the	the	DET
dpc-1817	30	7	study	study	NOUN
dpc-1817	30	8	was	be	AUX
dpc-1817	30	9	obtained	obtain	VERB
dpc-1817	30	10	from	from	ADP
dpc-1817	30	11	the	the	DET
dpc-1817	30	12	ankara	ankara	PROPN
dpc-1817	30	13	university	university	PROPN
dpc-1817	30	14	ethics	ethic	NOUN
dpc-1817	30	15	committee	committee	PROPN
dpc-1817	30	16	on	on	ADP
dpc-1817	30	17	april	april	PROPN
dpc-1817	30	18	2021	2021	NUM
dpc-1817	30	19	.	.	PUNCT
dpc-1817	31	1	the	the	DET
dpc-1817	31	2	patients	patient	NOUN
dpc-1817	31	3	visited	visit	VERB
dpc-1817	31	4	the	the	DET
dpc-1817	31	5	dermatology	dermatology	NOUN
dpc-1817	31	6	clinic	clinic	NOUN
dpc-1817	31	7	between	between	ADP
dpc-1817	31	8	march	march	PROPN
dpc-1817	31	9	13	13	NUM
dpc-1817	31	10	and	and	CCONJ
dpc-1817	31	11	july	july	PROPN
dpc-1817	31	12	13	13	NUM
dpc-1817	31	13	,	,	PUNCT
dpc-1817	31	14	2020	2020	NUM
dpc-1817	31	15	,	,	PUNCT
dpc-1817	31	16	when	when	SCONJ
dpc-1817	31	17	first	first	ADJ
dpc-1817	31	18	restrictions	restriction	NOUN
dpc-1817	31	19	were	be	AUX
dpc-1817	31	20	imposed	impose	VERB
dpc-1817	31	21	by	by	ADP
dpc-1817	31	22	the	the	DET
dpc-1817	31	23	turkish	turkish	ADJ
dpc-1817	31	24	government	government	NOUN
dpc-1817	31	25	due	due	ADP
dpc-1817	31	26	to	to	ADP
dpc-1817	31	27	pandemic	pandemic	ADJ
dpc-1817	31	28	,	,	PUNCT
dpc-1817	31	29	have	have	AUX
dpc-1817	31	30	been	be	AUX
dpc-1817	31	31	retrospectively	retrospectively	ADV
dpc-1817	31	32	reviewed	review	VERB
dpc-1817	31	33	for	for	ADP
dpc-1817	31	34	the	the	DET
dpc-1817	31	35	clinical	clinical	ADJ
dpc-1817	31	36	diagnosis	diagnosis	NOUN
dpc-1817	31	37	of	of	ADP
dpc-1817	31	38	acne	acne	NOUN
dpc-1817	31	39	vulgaris	vulgaris	NOUN
dpc-1817	31	40	through	through	ADP
dpc-1817	31	41	electronic	electronic	ADJ
dpc-1817	31	42	medical	medical	ADJ
dpc-1817	31	43	record	record	NOUN
dpc-1817	31	44	system	system	NOUN
dpc-1817	31	45	.	.	PUNCT
dpc-1817	32	1	a	a	DET
dpc-1817	32	2	total	total	ADJ
dpc-1817	32	3	number	number	NOUN
dpc-1817	32	4	of	of	ADP
dpc-1817	32	5	278	278	NUM
dpc-1817	32	6	acne	acne	NOUN
dpc-1817	32	7	patients	patient	NOUN
dpc-1817	32	8	seen	see	VERB
dpc-1817	32	9	in	in	ADP
dpc-1817	32	10	our	our	PRON
dpc-1817	32	11	clinic	clinic	NOUN
dpc-1817	32	12	for	for	ADP
dpc-1817	32	13	4	4	NUM
dpc-1817	32	14	months	month	NOUN
dpc-1817	32	15	period	period	NOUN
dpc-1817	32	16	during	during	ADP
dpc-1817	32	17	the	the	DET
dpc-1817	32	18	pandemic	pandemic	NOUN
dpc-1817	32	19	was	be	AUX
dpc-1817	32	20	included	include	VERB
dpc-1817	32	21	in	in	ADP
dpc-1817	32	22	the	the	DET
dpc-1817	32	23	study	study	NOUN
dpc-1817	32	24	.	.	PUNCT
dpc-1817	33	1	for	for	ADP
dpc-1817	33	2	each	each	DET
dpc-1817	33	3	patient	patient	ADJ
dpc-1817	33	4	age	age	NOUN
dpc-1817	33	5	,	,	PUNCT
dpc-1817	33	6	gender	gender	NOUN
dpc-1817	33	7	,	,	PUNCT
dpc-1817	33	8	treatment	treatment	NOUN
dpc-1817	33	9	protocols	protocol	NOUN
dpc-1817	33	10	,	,	PUNCT
dpc-1817	33	11	treatment	treatment	NOUN
dpc-1817	33	12	intervals	interval	NOUN
dpc-1817	33	13	,	,	PUNCT
dpc-1817	33	14	compliance	compliance	NOUN
dpc-1817	33	15	with	with	ADP
dpc-1817	33	16	the	the	DET
dpc-1817	33	17	treatment	treatment	NOUN
dpc-1817	33	18	,	,	PUNCT
dpc-1817	33	19	adverse	adverse	ADJ
dpc-1817	33	20	events	event	NOUN
dpc-1817	33	21	were	be	AUX
dpc-1817	33	22	recorded	record	VERB
dpc-1817	33	23	.	.	PUNCT
dpc-1817	34	1	patients	patient	NOUN
dpc-1817	34	2	were	be	AUX
dpc-1817	34	3	stratified	stratify	VERB
dpc-1817	34	4	according	accord	VERB
dpc-1817	34	5	to	to	ADP
dpc-1817	34	6	age	age	NOUN
dpc-1817	34	7	as	as	SCONJ
dpc-1817	34	8	follow	follow	VERB
dpc-1817	34	9	:	:	PUNCT
dpc-1817	34	10	younger	young	ADJ
dpc-1817	34	11	than	than	ADP
dpc-1817	34	12	18	18	NUM
dpc-1817	34	13	years	year	NOUN
dpc-1817	34	14	of	of	ADP
dpc-1817	34	15	age	age	NOUN
dpc-1817	34	16	,	,	PUNCT
dpc-1817	34	17	and	and	CCONJ
dpc-1817	34	18	18	18	NUM
dpc-1817	34	19	years	year	NOUN
dpc-1817	34	20	or	or	CCONJ
dpc-1817	34	21	older	old	ADJ
dpc-1817	34	22	.	.	PUNCT
dpc-1817	35	1	treatment	treatment	NOUN
dpc-1817	35	2	protocols	protocol	NOUN
dpc-1817	35	3	were	be	AUX
dpc-1817	35	4	assessed	assess	VERB
dpc-1817	35	5	in	in	ADP
dpc-1817	35	6	three	three	NUM
dpc-1817	35	7	categories	category	NOUN
dpc-1817	35	8	as	as	SCONJ
dpc-1817	35	9	follows	follow	VERB
dpc-1817	35	10	:	:	PUNCT
dpc-1817	35	11	topical	topical	ADJ
dpc-1817	35	12	treatment	treatment	NOUN
dpc-1817	35	13	,	,	PUNCT
dpc-1817	35	14	systemic	systemic	ADJ
dpc-1817	35	15	antibiotic	antibiotic	ADJ
dpc-1817	35	16	treatment	treatment	NOUN
dpc-1817	35	17	with	with	ADP
dpc-1817	35	18	topical	topical	ADJ
dpc-1817	35	19	treatments	treatment	NOUN
dpc-1817	35	20	,	,	PUNCT
dpc-1817	35	21	and	and	CCONJ
dpc-1817	35	22	oral	oral	ADJ
dpc-1817	35	23	isotretinoin	isotretinoin	PROPN
dpc-1817	35	24	treatment	treatment	NOUN
dpc-1817	35	25	.	.	PUNCT
dpc-1817	36	1	treatment	treatment	NOUN
dpc-1817	36	2	intervals	interval	NOUN
dpc-1817	36	3	were	be	AUX
dpc-1817	36	4	determined	determine	VERB
dpc-1817	36	5	in	in	ADP
dpc-1817	36	6	two	two	NUM
dpc-1817	36	7	different	different	ADJ
dpc-1817	36	8	categories	category	NOUN
dpc-1817	36	9	as	as	SCONJ
dpc-1817	36	10	follows	follow	VERB
dpc-1817	36	11	:	:	PUNCT
dpc-1817	36	12	monthly	monthly	ADJ
dpc-1817	36	13	or	or	CCONJ
dpc-1817	36	14	in	in	ADP
dpc-1817	36	15	every	every	DET
dpc-1817	36	16	two	two	NUM
dpc-1817	36	17	months	month	NOUN
dpc-1817	36	18	or	or	CCONJ
dpc-1817	36	19	longer	long	ADJ
dpc-1817	36	20	.	.	PUNCT
dpc-1817	37	1	adverse	adverse	ADJ
dpc-1817	37	2	events	event	NOUN
dpc-1817	37	3	were	be	AUX
dpc-1817	37	4	recorded	record	VERB
dpc-1817	37	5	.	.	PUNCT
dpc-1817	38	1	the	the	DET
dpc-1817	38	2	patients	patient	NOUN
dpc-1817	38	3	admitted	admit	VERB
dpc-1817	38	4	in	in	ADP
dpc-1817	38	5	the	the	DET
dpc-1817	38	6	outpatient	outpatient	NOUN
dpc-1817	38	7	clinic	clinic	NOUN
dpc-1817	38	8	between	between	ADP
dpc-1817	38	9	march	march	PROPN
dpc-1817	38	10	13	13	NUM
dpc-1817	38	11	and	and	CCONJ
dpc-1817	38	12	july	july	PROPN
dpc-1817	38	13	13	13	NUM
dpc-1817	38	14	,	,	PUNCT
dpc-1817	38	15	2019	2019	NUM
dpc-1817	38	16	,	,	PUNCT
dpc-1817	38	17	served	serve	VERB
dpc-1817	38	18	as	as	ADP
dpc-1817	38	19	controls	control	NOUN
dpc-1817	38	20	for	for	ADP
dpc-1817	38	21	the	the	DET
dpc-1817	38	22	study	study	NOUN
dpc-1817	38	23	.	.	PUNCT
dpc-1817	39	1	statistical	statistical	ADJ
dpc-1817	39	2	analysis	analysis	NOUN
dpc-1817	39	3	was	be	AUX
dpc-1817	39	4	performed	perform	VERB
dpc-1817	39	5	using	use	VERB
dpc-1817	39	6	the	the	DET
dpc-1817	39	7	spss	spss	PROPN
dpc-1817	39	8	22.0	22.0	NUM
dpc-1817	39	9	program	program	NOUN
dpc-1817	39	10	.	.	PUNCT
dpc-1817	40	1	mean	mean	VERB
dpc-1817	40	2	,	,	PUNCT
dpc-1817	40	3	standard	standard	ADJ
dpc-1817	40	4	deviation	deviation	NOUN
dpc-1817	40	5	and	and	CCONJ
dpc-1817	40	6	percentage	percentage	NOUN
dpc-1817	40	7	were	be	AUX
dpc-1817	40	8	used	use	VERB
dpc-1817	40	9	for	for	ADP
dpc-1817	40	10	descriptive	descriptive	ADJ
dpc-1817	40	11	statistics	statistic	NOUN
dpc-1817	40	12	.	.	PUNCT
dpc-1817	41	1	chi	chi	ADJ
dpc-1817	41	2	-	-	PUNCT
dpc-1817	41	3	square	square	PROPN
dpc-1817	41	4	test	test	NOUN
dpc-1817	41	5	was	be	AUX
dpc-1817	41	6	performed	perform	VERB
dpc-1817	41	7	to	to	PART
dpc-1817	41	8	examine	examine	VERB
dpc-1817	41	9	differences	difference	NOUN
dpc-1817	41	10	between	between	ADP
dpc-1817	41	11	categorical	categorical	ADJ
dpc-1817	41	12	variables	variable	NOUN
dpc-1817	41	13	in	in	ADP
dpc-1817	41	14	same	same	ADJ
dpc-1817	41	15	groups	group	NOUN
dpc-1817	41	16	and	and	CCONJ
dpc-1817	41	17	the	the	DET
dpc-1817	41	18	p	p	NOUN
dpc-1817	41	19	value	value	NOUN
dpc-1817	41	20	of	of	ADP
dpc-1817	41	21	less	less	ADJ
dpc-1817	41	22	than	than	ADP
dpc-1817	41	23	0.05	0.05	NUM
dpc-1817	41	24	was	be	AUX
dpc-1817	41	25	accepted	accept	VERB
dpc-1817	41	26	as	as	ADP
dpc-1817	41	27	statistically	statistically	ADV
dpc-1817	41	28	significant	significant	ADJ
dpc-1817	41	29	.	.	PUNCT
dpc-1817	42	1	results	result	VERB
dpc-1817	42	2	the	the	DET
dpc-1817	42	3	total	total	ADJ
dpc-1817	42	4	number	number	NOUN
dpc-1817	42	5	of	of	ADP
dpc-1817	42	6	patients	patient	NOUN
dpc-1817	42	7	admitted	admit	VERB
dpc-1817	42	8	to	to	ADP
dpc-1817	42	9	outpatient	outpatient	NOUN
dpc-1817	42	10	clinic	clinic	NOUN
dpc-1817	42	11	during	during	ADP
dpc-1817	42	12	pandemic	pandemic	ADJ
dpc-1817	42	13	period	period	NOUN
dpc-1817	42	14	was	be	AUX
dpc-1817	42	15	2265	2265	NUM
dpc-1817	42	16	.	.	PUNCT
dpc-1817	43	1	acne	acne	NOUN
dpc-1817	43	2	patients	patient	NOUN
dpc-1817	43	3	consisted	consist	VERB
dpc-1817	43	4	of	of	ADP
dpc-1817	43	5	12.3	12.3	NUM
dpc-1817	43	6	%	%	NOUN
dpc-1817	43	7	(	(	PUNCT
dpc-1817	43	8	278	278	NUM
dpc-1817	43	9	)	)	PUNCT
dpc-1817	43	10	of	of	ADP
dpc-1817	43	11	all	all	DET
dpc-1817	43	12	admissions	admission	NOUN
dpc-1817	43	13	.	.	PUNCT
dpc-1817	44	1	on	on	ADP
dpc-1817	44	2	the	the	DET
dpc-1817	44	3	other	other	ADJ
dpc-1817	44	4	hand	hand	NOUN
dpc-1817	44	5	,	,	PUNCT
dpc-1817	44	6	the	the	DET
dpc-1817	44	7	total	total	ADJ
dpc-1817	44	8	number	number	NOUN
dpc-1817	44	9	of	of	ADP
dpc-1817	44	10	patients	patient	NOUN
dpc-1817	44	11	admitted	admit	VERB
dpc-1817	44	12	to	to	ADP
dpc-1817	44	13	dermatology	dermatology	NOUN
dpc-1817	44	14	outpatient	outpatient	NOUN
dpc-1817	44	15	clinic	clinic	NOUN
dpc-1817	44	16	during	during	ADP
dpc-1817	44	17	non	non	ADJ
dpc-1817	44	18	-	-	ADJ
dpc-1817	44	19	pandemic	pandemic	ADJ
dpc-1817	44	20	period	period	NOUN
dpc-1817	44	21	was	be	AUX
dpc-1817	44	22	7604	7604	NUM
dpc-1817	44	23	and	and	CCONJ
dpc-1817	44	24	7.5	7.5	NUM
dpc-1817	44	25	%	%	NOUN
dpc-1817	44	26	(	(	PUNCT
dpc-1817	44	27	577	577	NUM
dpc-1817	44	28	)	)	PUNCT
dpc-1817	44	29	were	be	AUX
dpc-1817	44	30	acne	acne	NOUN
dpc-1817	44	31	patients	patient	NOUN
dpc-1817	44	32	.	.	PUNCT
dpc-1817	45	1	the	the	DET
dpc-1817	45	2	distribution	distribution	NOUN
dpc-1817	45	3	of	of	ADP
dpc-1817	45	4	the	the	DET
dpc-1817	45	5	patients	patient	NOUN
dpc-1817	45	6	according	accord	VERB
dpc-1817	45	7	to	to	ADP
dpc-1817	45	8	the	the	DET
dpc-1817	45	9	gender	gender	NOUN
dpc-1817	45	10	and	and	CCONJ
dpc-1817	45	11	age	age	NOUN
dpc-1817	45	12	is	be	AUX
dpc-1817	45	13	shown	show	VERB
dpc-1817	45	14	in	in	ADP
dpc-1817	45	15	table	table	NOUN
dpc-1817	45	16	1	1	NUM
dpc-1817	45	17	,	,	PUNCT
dpc-1817	45	18	and	and	CCONJ
dpc-1817	45	19	there	there	PRON
dpc-1817	45	20	was	be	VERB
dpc-1817	45	21	no	no	DET
dpc-1817	45	22	significant	significant	ADJ
dpc-1817	45	23	difference	difference	NOUN
dpc-1817	45	24	between	between	ADP
dpc-1817	45	25	two	two	NUM
dpc-1817	45	26	periods	period	NOUN
dpc-1817	45	27	according	accord	VERB
dpc-1817	45	28	to	to	ADP
dpc-1817	45	29	gender	gender	NOUN
dpc-1817	45	30	and	and	CCONJ
dpc-1817	45	31	age	age	NOUN
dpc-1817	45	32	(	(	PUNCT
dpc-1817	45	33	p	p	X
dpc-1817	45	34	>	>	X
dpc-1817	45	35	0.05	0.05	NUM
dpc-1817	45	36	)	)	PUNCT
dpc-1817	45	37	.	.	PUNCT
dpc-1817	46	1	table	table	NOUN
dpc-1817	46	2	1	1	NUM
dpc-1817	46	3	.	.	PUNCT
dpc-1817	47	1	demographic	demographic	ADJ
dpc-1817	47	2	characteristics	characteristic	NOUN
dpc-1817	47	3	of	of	ADP
dpc-1817	47	4	patients	patient	NOUN
dpc-1817	47	5	before	before	ADP
dpc-1817	47	6	and	and	CCONJ
dpc-1817	47	7	after	after	ADP
dpc-1817	47	8	the	the	DET
dpc-1817	47	9	pandemic	pandemic	ADJ
dpc-1817	47	10	period	period	NOUN
dpc-1817	47	11	demographic	demographic	ADJ
dpc-1817	47	12	characteristics	characteristic	NOUN
dpc-1817	47	13	of	of	ADP
dpc-1817	47	14	the	the	DET
dpc-1817	47	15	acne	acne	NOUN
dpc-1817	47	16	patients	patient	NOUN
dpc-1817	47	17	pandemic	pandemic	ADJ
dpc-1817	47	18	period	period	NOUN
dpc-1817	47	19	(	(	PUNCT
dpc-1817	47	20	n	n	NOUN
dpc-1817	47	21	=	=	SYM
dpc-1817	47	22	278	278	NUM
dpc-1817	47	23	)	)	PUNCT
dpc-1817	47	24	non	non	ADJ
dpc-1817	47	25	-	-	ADJ
dpc-1817	47	26	pandemic	pandemic	ADJ
dpc-1817	47	27	period	period	NOUN
dpc-1817	47	28	(	(	PUNCT
dpc-1817	47	29	n	n	NOUN
dpc-1817	47	30	=	=	SYM
dpc-1817	47	31	577	577	NUM
dpc-1817	47	32	)	)	PUNCT
dpc-1817	47	33	p	p	NOUN
dpc-1817	47	34	values	value	NOUN
dpc-1817	47	35	sex	sex	NOUN
dpc-1817	47	36	male	male	NOUN
dpc-1817	47	37	179	179	NUM
dpc-1817	47	38	(	(	PUNCT
dpc-1817	47	39	64.4	64.4	NUM
dpc-1817	47	40	%	%	NOUN
dpc-1817	47	41	)	)	PUNCT
dpc-1817	47	42	383	383	NUM
dpc-1817	47	43	(	(	PUNCT
dpc-1817	47	44	66.4	66.4	NUM
dpc-1817	47	45	%	%	NOUN
dpc-1817	47	46	)	)	PUNCT
dpc-1817	47	47	0.57	0.57	NUM
dpc-1817	47	48	female	female	NOUN
dpc-1817	47	49	99	99	NUM
dpc-1817	47	50	(	(	PUNCT
dpc-1817	47	51	35.6	35.6	NUM
dpc-1817	47	52	%	%	NOUN
dpc-1817	47	53	)	)	PUNCT
dpc-1817	47	54	194	194	NUM
dpc-1817	47	55	(	(	PUNCT
dpc-1817	47	56	33.6	33.6	NUM
dpc-1817	47	57	%	%	NOUN
dpc-1817	47	58	)	)	PUNCT
dpc-1817	47	59	age	age	NOUN
dpc-1817	47	60	,	,	PUNCT
dpc-1817	47	61	years	year	NOUN
dpc-1817	47	62	(	(	PUNCT
dpc-1817	47	63	mean	mean	NOUN
dpc-1817	47	64	)	)	PUNCT
dpc-1817	47	65	22.80	22.80	NUM
dpc-1817	47	66	(	(	PUNCT
dpc-1817	47	67	sd	sd	ADP
dpc-1817	47	68	±	±	NUM
dpc-1817	47	69	7.12	7.12	NUM
dpc-1817	47	70	)	)	PUNCT
dpc-1817	47	71	22.16	22.16	NUM
dpc-1817	47	72	(	(	PUNCT
dpc-1817	47	73	sd	sd	ADP
dpc-1817	47	74	±	±	NUM
dpc-1817	47	75	6.98	6.98	NUM
dpc-1817	47	76	)	)	PUNCT
dpc-1817	47	77	0.22	0.22	NUM
dpc-1817	47	78	<	<	X
dpc-1817	47	79	18	18	NUM
dpc-1817	47	80	64	64	NUM
dpc-1817	47	81	(	(	PUNCT
dpc-1817	47	82	23	23	NUM
dpc-1817	47	83	%	%	NOUN
dpc-1817	47	84	)	)	PUNCT
dpc-1817	47	85	122	122	NUM
dpc-1817	47	86	(	(	PUNCT
dpc-1817	47	87	21.1	21.1	NUM
dpc-1817	47	88	%	%	NOUN
dpc-1817	47	89	)	)	PUNCT
dpc-1817	47	90	0.53	0.53	NUM
dpc-1817	47	91	>	>	SYM
dpc-1817	47	92	18	18	NUM
dpc-1817	47	93	214	214	NUM
dpc-1817	47	94	(	(	PUNCT
dpc-1817	47	95	87	87	NUM
dpc-1817	47	96	%	%	NOUN
dpc-1817	47	97	)	)	PUNCT
dpc-1817	47	98	455	455	NUM
dpc-1817	47	99	(	(	PUNCT
dpc-1817	47	100	88.9	88.9	NUM
dpc-1817	47	101	%	%	NOUN
dpc-1817	47	102	)	)	PUNCT
dpc-1817	47	103	sd	sd	PROPN
dpc-1817	47	104	:	:	PUNCT
dpc-1817	47	105	standard	standard	ADJ
dpc-1817	47	106	deviation	deviation	NOUN
dpc-1817	47	107	.	.	PUNCT
dpc-1817	48	1	conclusions	conclusion	NOUN
dpc-1817	48	2	:	:	PUNCT
dpc-1817	48	3	acne	acne	NOUN
dpc-1817	48	4	patients	patient	NOUN
dpc-1817	48	5	constitute	constitute	VERB
dpc-1817	48	6	an	an	DET
dpc-1817	48	7	important	important	ADJ
dpc-1817	48	8	part	part	NOUN
dpc-1817	48	9	of	of	ADP
dpc-1817	48	10	dermatology	dermatology	NOUN
dpc-1817	48	11	outpatient	outpatient	NOUN
dpc-1817	48	12	clinics	clinic	NOUN
dpc-1817	48	13	.	.	PUNCT
dpc-1817	49	1	during	during	ADP
dpc-1817	49	2	the	the	DET
dpc-1817	49	3	pandemic	pandemic	ADJ
dpc-1817	49	4	period	period	NOUN
dpc-1817	49	5	,	,	PUNCT
dpc-1817	49	6	majority	majority	NOUN
dpc-1817	49	7	of	of	ADP
dpc-1817	49	8	acne	acne	NOUN
dpc-1817	49	9	patients	patient	NOUN
dpc-1817	49	10	came	come	VERB
dpc-1817	49	11	for	for	ADP
dpc-1817	49	12	follow	follow	NOUN
dpc-1817	49	13	-	-	PUNCT
dpc-1817	49	14	up	up	NOUN
dpc-1817	49	15	.	.	PUNCT
dpc-1817	50	1	extended	extended	ADJ
dpc-1817	50	2	follow	follow	NOUN
dpc-1817	50	3	-	-	PUNCT
dpc-1817	50	4	up	up	ADP
dpc-1817	50	5	periods	period	NOUN
dpc-1817	50	6	were	be	AUX
dpc-1817	50	7	adopted	adopt	VERB
dpc-1817	50	8	by	by	ADP
dpc-1817	50	9	physicians	physician	NOUN
dpc-1817	50	10	and	and	CCONJ
dpc-1817	50	11	were	be	AUX
dpc-1817	50	12	found	find	VERB
dpc-1817	50	13	safe	safe	ADJ
dpc-1817	50	14	and	and	CCONJ
dpc-1817	50	15	effective	effective	ADJ
dpc-1817	50	16	in	in	ADP
dpc-1817	50	17	the	the	DET
dpc-1817	50	18	current	current	ADJ
dpc-1817	50	19	study	study	NOUN
dpc-1817	50	20	.	.	PUNCT
dpc-1817	51	1	thus	thus	ADV
dpc-1817	51	2	,	,	PUNCT
dpc-1817	51	3	isotretinoin	isotretinoin	PROPN
dpc-1817	51	4	treatment	treatment	NOUN
dpc-1817	51	5	seems	seem	VERB
dpc-1817	51	6	efficacious	efficacious	ADJ
dpc-1817	51	7	and	and	CCONJ
dpc-1817	51	8	safe	safe	ADJ
dpc-1817	51	9	during	during	ADP
dpc-1817	51	10	pandemic	pandemic	ADJ
dpc-1817	51	11	period	period	NOUN
dpc-1817	51	12	.	.	PUNCT
dpc-1817	52	1	original	original	ADJ
dpc-1817	52	2	article	article	NOUN
dpc-1817	52	3	|	|	ADV
dpc-1817	52	4	dermatol	dermatol	ADJ
dpc-1817	52	5	pract	pract	NOUN
dpc-1817	52	6	concept	concept	NOUN
dpc-1817	52	7	.	.	PUNCT
dpc-1817	53	1	2022;12(1):e2022036	2022;12(1):e2022036	NUM
dpc-1817	53	2	3	3	NUM
dpc-1817	53	3	table	table	NOUN
dpc-1817	53	4	2	2	NUM
dpc-1817	53	5	summarizes	summarize	NOUN
dpc-1817	53	6	the	the	DET
dpc-1817	53	7	treatment	treatment	NOUN
dpc-1817	53	8	modalities	modality	NOUN
dpc-1817	53	9	of	of	ADP
dpc-1817	53	10	the	the	DET
dpc-1817	53	11	patients	patient	NOUN
dpc-1817	53	12	with	with	ADP
dpc-1817	53	13	the	the	DET
dpc-1817	53	14	first	first	ADJ
dpc-1817	53	15	admission	admission	NOUN
dpc-1817	53	16	and	and	CCONJ
dpc-1817	53	17	under	under	ADP
dpc-1817	53	18	follow	follow	NOUN
dpc-1817	53	19	-	-	PUNCT
dpc-1817	53	20	up	up	NOUN
dpc-1817	53	21	in	in	ADP
dpc-1817	53	22	both	both	CCONJ
dpc-1817	53	23	pandemic	pandemic	ADJ
dpc-1817	53	24	and	and	CCONJ
dpc-1817	53	25	non	non	ADJ
dpc-1817	53	26	-	-	ADJ
dpc-1817	53	27	pandemic	pandemic	ADJ
dpc-1817	53	28	periods	period	NOUN
dpc-1817	53	29	.	.	PUNCT
dpc-1817	54	1	among	among	ADP
dpc-1817	54	2	the	the	DET
dpc-1817	54	3	patients	patient	NOUN
dpc-1817	54	4	who	who	PRON
dpc-1817	54	5	applied	apply	VERB
dpc-1817	54	6	to	to	ADP
dpc-1817	54	7	dermatology	dermatology	NOUN
dpc-1817	54	8	outpatient	outpatient	NOUN
dpc-1817	54	9	clinic	clinic	NOUN
dpc-1817	54	10	during	during	ADP
dpc-1817	54	11	pandemic	pandemic	ADJ
dpc-1817	54	12	period	period	NOUN
dpc-1817	54	13	,	,	PUNCT
dpc-1817	54	14	124	124	NUM
dpc-1817	54	15	(	(	PUNCT
dpc-1817	54	16	44.6	44.6	NUM
dpc-1817	54	17	%	%	NOUN
dpc-1817	54	18	)	)	PUNCT
dpc-1817	54	19	had	have	VERB
dpc-1817	54	20	first	first	ADJ
dpc-1817	54	21	admission	admission	NOUN
dpc-1817	54	22	and	and	CCONJ
dpc-1817	54	23	150	150	NUM
dpc-1817	54	24	(	(	PUNCT
dpc-1817	54	25	54	54	NUM
dpc-1817	54	26	%	%	NOUN
dpc-1817	54	27	)	)	PUNCT
dpc-1817	54	28	were	be	AUX
dpc-1817	54	29	under	under	ADP
dpc-1817	54	30	follow	follow	NOUN
dpc-1817	54	31	-	-	PUNCT
dpc-1817	54	32	up	up	NOUN
dpc-1817	54	33	for	for	ADP
dpc-1817	54	34	different	different	ADJ
dpc-1817	54	35	acne	acne	NOUN
dpc-1817	54	36	treatments	treatment	NOUN
dpc-1817	54	37	,	,	PUNCT
dpc-1817	54	38	and	and	CCONJ
dpc-1817	54	39	4	4	NUM
dpc-1817	54	40	of	of	ADP
dpc-1817	54	41	them	they	PRON
dpc-1817	54	42	were	be	AUX
dpc-1817	54	43	consultation	consultation	NOUN
dpc-1817	54	44	patients	patient	NOUN
dpc-1817	54	45	.	.	PUNCT
dpc-1817	55	1	one	one	NUM
dpc-1817	55	2	hundred	hundred	NUM
dpc-1817	55	3	and	and	CCONJ
dpc-1817	55	4	sixteen	sixteen	NUM
dpc-1817	55	5	(	(	PUNCT
dpc-1817	55	6	93.5	93.5	NUM
dpc-1817	55	7	%	%	NOUN
dpc-1817	55	8	)	)	PUNCT
dpc-1817	55	9	patients	patient	NOUN
dpc-1817	55	10	with	with	ADP
dpc-1817	55	11	first	first	ADJ
dpc-1817	55	12	admission	admission	NOUN
dpc-1817	55	13	did	do	AUX
dpc-1817	55	14	not	not	PART
dpc-1817	55	15	receive	receive	VERB
dpc-1817	55	16	treatment	treatment	NOUN
dpc-1817	55	17	for	for	ADP
dpc-1817	55	18	acne	acne	NOUN
dpc-1817	55	19	previously	previously	ADV
dpc-1817	55	20	,	,	PUNCT
dpc-1817	55	21	whereas	whereas	SCONJ
dpc-1817	55	22	8	8	NUM
dpc-1817	55	23	of	of	ADP
dpc-1817	55	24	them	they	PRON
dpc-1817	55	25	were	be	AUX
dpc-1817	55	26	under	under	ADP
dpc-1817	55	27	systemic	systemic	ADJ
dpc-1817	55	28	treatments	treatment	NOUN
dpc-1817	55	29	(	(	PUNCT
dpc-1817	55	30	oral	oral	ADJ
dpc-1817	55	31	isotretinoin	isotretinoin	PROPN
dpc-1817	55	32	n	n	NOUN
dpc-1817	55	33	=	=	SYM
dpc-1817	55	34	2	2	NUM
dpc-1817	55	35	,	,	PUNCT
dpc-1817	55	36	doxycycline	doxycycline	NOUN
dpc-1817	55	37	n	n	NOUN
dpc-1817	55	38	=	=	PROPN
dpc-1817	55	39	6	6	NUM
dpc-1817	55	40	)	)	PUNCT
dpc-1817	55	41	.	.	PUNCT
dpc-1817	56	1	of	of	ADP
dpc-1817	56	2	the	the	DET
dpc-1817	56	3	116	116	NUM
dpc-1817	56	4	treatment	treatment	NOUN
dpc-1817	56	5	naïve	naïve	ADJ
dpc-1817	56	6	patients	patient	NOUN
dpc-1817	56	7	,	,	PUNCT
dpc-1817	56	8	topical	topical	ADJ
dpc-1817	56	9	treatment	treatment	NOUN
dpc-1817	56	10	was	be	AUX
dpc-1817	56	11	given	give	VERB
dpc-1817	56	12	to	to	ADP
dpc-1817	56	13	77	77	NUM
dpc-1817	56	14	(	(	PUNCT
dpc-1817	56	15	n	n	NOUN
dpc-1817	56	16	=	=	SYM
dpc-1817	56	17	27.7	27.7	NUM
dpc-1817	56	18	%	%	NOUN
dpc-1817	56	19	)	)	PUNCT
dpc-1817	56	20	,	,	PUNCT
dpc-1817	56	21	oral	oral	ADJ
dpc-1817	56	22	isotretinoin	isotretinoin	PROPN
dpc-1817	56	23	treatment	treatment	NOUN
dpc-1817	56	24	to	to	ADP
dpc-1817	56	25	16	16	NUM
dpc-1817	56	26	(	(	PUNCT
dpc-1817	56	27	5.8	5.8	NUM
dpc-1817	56	28	%	%	NOUN
dpc-1817	56	29	)	)	PUNCT
dpc-1817	56	30	and	and	CCONJ
dpc-1817	56	31	systemic	systemic	ADJ
dpc-1817	56	32	antibiotic	antibiotic	ADJ
dpc-1817	56	33	treatment	treatment	NOUN
dpc-1817	56	34	with	with	ADP
dpc-1817	56	35	topicals	topical	NOUN
dpc-1817	56	36	to	to	ADP
dpc-1817	56	37	23	23	NUM
dpc-1817	56	38	(	(	PUNCT
dpc-1817	56	39	8.3	8.3	NUM
dpc-1817	56	40	%	%	NOUN
dpc-1817	56	41	)	)	PUNCT
dpc-1817	56	42	patients	patient	NOUN
dpc-1817	56	43	.	.	PUNCT
dpc-1817	57	1	of	of	ADP
dpc-1817	57	2	the	the	DET
dpc-1817	57	3	8	8	NUM
dpc-1817	57	4	patients	patient	NOUN
dpc-1817	57	5	taking	take	VERB
dpc-1817	57	6	systemic	systemic	ADJ
dpc-1817	57	7	treatment	treatment	NOUN
dpc-1817	57	8	at	at	ADP
dpc-1817	57	9	first	first	ADJ
dpc-1817	57	10	admission	admission	NOUN
dpc-1817	57	11	,	,	PUNCT
dpc-1817	57	12	doxycycline	doxycycline	NOUN
dpc-1817	57	13	treatment	treatment	NOUN
dpc-1817	57	14	was	be	AUX
dpc-1817	57	15	switched	switch	VERB
dpc-1817	57	16	to	to	ADP
dpc-1817	57	17	oral	oral	ADJ
dpc-1817	57	18	isotretinoin	isotretinoin	NOUN
dpc-1817	57	19	for	for	ADP
dpc-1817	57	20	3	3	NUM
dpc-1817	57	21	patients	patient	NOUN
dpc-1817	57	22	and	and	CCONJ
dpc-1817	57	23	to	to	PART
dpc-1817	57	24	azithromycin	azithromycin	VERB
dpc-1817	57	25	for	for	ADP
dpc-1817	57	26	one	one	NUM
dpc-1817	57	27	patient	patient	NOUN
dpc-1817	57	28	,	,	PUNCT
dpc-1817	57	29	and	and	CCONJ
dpc-1817	57	30	the	the	DET
dpc-1817	57	31	others	other	NOUN
dpc-1817	57	32	continued	continue	VERB
dpc-1817	57	33	their	their	PRON
dpc-1817	57	34	current	current	ADJ
dpc-1817	57	35	systemic	systemic	ADJ
dpc-1817	57	36	treatment	treatment	NOUN
dpc-1817	57	37	(	(	PUNCT
dpc-1817	57	38	oral	oral	ADJ
dpc-1817	57	39	isotretinoin	isotretinoin	PROPN
dpc-1817	58	1	n	n	PROPN
dpc-1817	58	2	=	=	PUNCT
dpc-1817	58	3	,	,	PUNCT
dpc-1817	58	4	doxycycline	doxycycline	NOUN
dpc-1817	58	5	n	n	NOUN
dpc-1817	58	6	=	=	SYM
dpc-1817	58	7	2	2	NUM
dpc-1817	58	8	)	)	PUNCT
dpc-1817	58	9	.	.	PUNCT
dpc-1817	59	1	during	during	ADP
dpc-1817	59	2	the	the	DET
dpc-1817	59	3	pandemic	pandemic	ADJ
dpc-1817	59	4	,	,	PUNCT
dpc-1817	59	5	26	26	NUM
dpc-1817	59	6	(	(	PUNCT
dpc-1817	59	7	9.4	9.4	NUM
dpc-1817	59	8	%	%	NOUN
dpc-1817	59	9	)	)	PUNCT
dpc-1817	59	10	of	of	ADP
dpc-1817	59	11	the	the	DET
dpc-1817	59	12	follow	follow	VERB
dpc-1817	59	13	-	-	PUNCT
dpc-1817	59	14	up	up	ADP
dpc-1817	59	15	patients	patient	NOUN
dpc-1817	59	16	were	be	AUX
dpc-1817	59	17	under	under	ADP
dpc-1817	59	18	only	only	ADJ
dpc-1817	59	19	topical	topical	ADJ
dpc-1817	59	20	treatments	treatment	NOUN
dpc-1817	59	21	,	,	PUNCT
dpc-1817	59	22	10	10	NUM
dpc-1817	59	23	patients	patient	NOUN
dpc-1817	59	24	(	(	PUNCT
dpc-1817	59	25	3.6	3.6	NUM
dpc-1817	59	26	%	%	NOUN
dpc-1817	59	27	)	)	PUNCT
dpc-1817	59	28	were	be	AUX
dpc-1817	59	29	under	under	ADP
dpc-1817	59	30	systemic	systemic	ADJ
dpc-1817	59	31	antibiotic	antibiotic	ADJ
dpc-1817	59	32	treatment	treatment	NOUN
dpc-1817	59	33	with	with	ADP
dpc-1817	59	34	topical	topical	ADJ
dpc-1817	59	35	treatment	treatment	NOUN
dpc-1817	59	36	,	,	PUNCT
dpc-1817	59	37	and	and	CCONJ
dpc-1817	59	38	114	114	NUM
dpc-1817	59	39	patients	patient	NOUN
dpc-1817	59	40	(	(	PUNCT
dpc-1817	59	41	41	41	NUM
dpc-1817	59	42	%	%	NOUN
dpc-1817	59	43	)	)	PUNCT
dpc-1817	59	44	were	be	AUX
dpc-1817	59	45	under	under	ADP
dpc-1817	59	46	oral	oral	ADJ
dpc-1817	59	47	isotretinoin	isotretinoin	PROPN
dpc-1817	59	48	treatment	treatment	NOUN
dpc-1817	59	49	.	.	PUNCT
dpc-1817	60	1	during	during	ADP
dpc-1817	60	2	this	this	DET
dpc-1817	60	3	period	period	NOUN
dpc-1817	60	4	,	,	PUNCT
dpc-1817	60	5	for	for	ADP
dpc-1817	60	6	3	3	NUM
dpc-1817	60	7	patients	patient	NOUN
dpc-1817	60	8	topical	topical	ADJ
dpc-1817	60	9	treatments	treatment	NOUN
dpc-1817	60	10	were	be	AUX
dpc-1817	60	11	switched	switch	VERB
dpc-1817	60	12	to	to	ADP
dpc-1817	60	13	oral	oral	ADJ
dpc-1817	60	14	isotretinoin	isotretinoin	NOUN
dpc-1817	60	15	because	because	SCONJ
dpc-1817	60	16	of	of	ADP
dpc-1817	60	17	the	the	DET
dpc-1817	60	18	severity	severity	NOUN
dpc-1817	60	19	of	of	ADP
dpc-1817	60	20	acne	acne	NOUN
dpc-1817	60	21	and	and	CCONJ
dpc-1817	60	22	1	1	NUM
dpc-1817	60	23	of	of	ADP
dpc-1817	60	24	the	the	DET
dpc-1817	60	25	patients	patient	NOUN
dpc-1817	60	26	under	under	ADP
dpc-1817	60	27	doxycycline	doxycycline	NOUN
dpc-1817	60	28	treatment	treatment	NOUN
dpc-1817	60	29	was	be	AUX
dpc-1817	60	30	switched	switch	VERB
dpc-1817	60	31	to	to	ADP
dpc-1817	60	32	isotretinoin	isotretinoin	PROPN
dpc-1817	60	33	due	due	ADP
dpc-1817	60	34	to	to	ADP
dpc-1817	60	35	lack	lack	NOUN
dpc-1817	60	36	of	of	ADP
dpc-1817	60	37	efficacy	efficacy	NOUN
dpc-1817	60	38	.	.	PUNCT
dpc-1817	61	1	the	the	DET
dpc-1817	61	2	rate	rate	NOUN
dpc-1817	61	3	of	of	ADP
dpc-1817	61	4	total	total	ADJ
dpc-1817	61	5	acne	acne	NOUN
dpc-1817	61	6	patients	patient	NOUN
dpc-1817	61	7	treated	treat	VERB
dpc-1817	61	8	with	with	ADP
dpc-1817	61	9	isotretinoin	isotretinoin	PROPN
dpc-1817	61	10	during	during	ADP
dpc-1817	61	11	the	the	DET
dpc-1817	61	12	pandemic	pandemic	ADJ
dpc-1817	61	13	period	period	NOUN
dpc-1817	61	14	was	be	AUX
dpc-1817	61	15	50	50	NUM
dpc-1817	61	16	%	%	NOUN
dpc-1817	61	17	(	(	PUNCT
dpc-1817	61	18	139	139	NUM
dpc-1817	61	19	patients	patient	NOUN
dpc-1817	61	20	)	)	PUNCT
dpc-1817	61	21	.	.	PUNCT
dpc-1817	62	1	of	of	ADP
dpc-1817	62	2	these	these	DET
dpc-1817	62	3	patients	patient	NOUN
dpc-1817	62	4	,	,	PUNCT
dpc-1817	62	5	114	114	NUM
dpc-1817	62	6	(	(	PUNCT
dpc-1817	62	7	41	41	NUM
dpc-1817	62	8	%	%	NOUN
dpc-1817	62	9	)	)	PUNCT
dpc-1817	62	10	were	be	AUX
dpc-1817	62	11	follow	follow	VERB
dpc-1817	62	12	-	-	PUNCT
dpc-1817	62	13	up	up	ADP
dpc-1817	62	14	ones	one	NOUN
dpc-1817	62	15	,	,	PUNCT
dpc-1817	62	16	16	16	NUM
dpc-1817	62	17	(	(	PUNCT
dpc-1817	62	18	5.8	5.8	NUM
dpc-1817	62	19	%	%	NOUN
dpc-1817	62	20	)	)	PUNCT
dpc-1817	62	21	of	of	ADP
dpc-1817	62	22	them	they	PRON
dpc-1817	62	23	were	be	AUX
dpc-1817	62	24	started	start	VERB
dpc-1817	62	25	isotretinoin	isotretinoin	PROPN
dpc-1817	62	26	treatment	treatment	NOUN
dpc-1817	62	27	in	in	ADP
dpc-1817	62	28	their	their	PRON
dpc-1817	62	29	first	first	ADJ
dpc-1817	62	30	visits	visit	NOUN
dpc-1817	62	31	.	.	PUNCT
dpc-1817	63	1	the	the	DET
dpc-1817	63	2	number	number	NOUN
dpc-1817	63	3	of	of	ADP
dpc-1817	63	4	patients	patient	NOUN
dpc-1817	63	5	with	with	ADP
dpc-1817	63	6	first	first	ADJ
dpc-1817	63	7	admission	admission	NOUN
dpc-1817	63	8	was	be	AUX
dpc-1817	63	9	statistically	statistically	ADV
dpc-1817	63	10	higher	high	ADJ
dpc-1817	63	11	in	in	ADP
dpc-1817	63	12	non	non	ADJ
dpc-1817	63	13	-	-	ADJ
dpc-1817	63	14	pandemic	pandemic	ADJ
dpc-1817	63	15	period	period	NOUN
dpc-1817	63	16	and	and	CCONJ
dpc-1817	63	17	the	the	DET
dpc-1817	63	18	number	number	NOUN
dpc-1817	63	19	of	of	ADP
dpc-1817	63	20	follow	follow	NOUN
dpc-1817	63	21	-	-	PUNCT
dpc-1817	63	22	up	up	ADP
dpc-1817	63	23	patients	patient	NOUN
dpc-1817	63	24	was	be	AUX
dpc-1817	63	25	statistically	statistically	ADV
dpc-1817	63	26	higher	high	ADJ
dpc-1817	63	27	in	in	ADP
dpc-1817	63	28	pandemic	pandemic	ADJ
dpc-1817	63	29	period	period	NOUN
dpc-1817	63	30	(	(	PUNCT
dpc-1817	63	31	p	p	X
dpc-1817	63	32	<	<	X
dpc-1817	63	33	0.05	0.05	NUM
dpc-1817	63	34	)	)	PUNCT
dpc-1817	63	35	.	.	PUNCT
dpc-1817	64	1	there	there	PRON
dpc-1817	64	2	was	be	VERB
dpc-1817	64	3	no	no	DET
dpc-1817	64	4	statistically	statistically	ADV
dpc-1817	64	5	significant	significant	ADJ
dpc-1817	64	6	difference	difference	NOUN
dpc-1817	64	7	in	in	ADP
dpc-1817	64	8	the	the	DET
dpc-1817	64	9	two	two	NUM
dpc-1817	64	10	periods	period	NOUN
dpc-1817	64	11	according	accord	VERB
dpc-1817	64	12	to	to	ADP
dpc-1817	64	13	the	the	DET
dpc-1817	64	14	number	number	NOUN
dpc-1817	64	15	of	of	ADP
dpc-1817	64	16	treatment	treatment	NOUN
dpc-1817	64	17	naïve	naïve	ADJ
dpc-1817	64	18	patients	patient	NOUN
dpc-1817	64	19	,	,	PUNCT
dpc-1817	64	20	the	the	DET
dpc-1817	64	21	first	first	ADJ
dpc-1817	64	22	admission	admission	NOUN
dpc-1817	64	23	patients	patient	NOUN
dpc-1817	64	24	previously	previously	ADV
dpc-1817	64	25	treated	treat	VERB
dpc-1817	64	26	with	with	ADP
dpc-1817	64	27	any	any	DET
dpc-1817	64	28	systemic	systemic	ADJ
dpc-1817	64	29	agent	agent	NOUN
dpc-1817	64	30	,	,	PUNCT
dpc-1817	64	31	and	and	CCONJ
dpc-1817	64	32	patients	patient	NOUN
dpc-1817	64	33	to	to	PART
dpc-1817	64	34	whom	whom	PRON
dpc-1817	64	35	was	be	AUX
dpc-1817	64	36	given	give	VERB
dpc-1817	64	37	systemic	systemic	ADJ
dpc-1817	64	38	treatment	treatment	NOUN
dpc-1817	64	39	in	in	ADP
dpc-1817	64	40	first	first	ADJ
dpc-1817	64	41	admission	admission	NOUN
dpc-1817	64	42	(	(	PUNCT
dpc-1817	64	43	p	p	X
dpc-1817	64	44	>	>	X
dpc-1817	64	45	0.05	0.05	NUM
dpc-1817	64	46	)	)	PUNCT
dpc-1817	64	47	.	.	PUNCT
dpc-1817	65	1	the	the	DET
dpc-1817	65	2	rate	rate	NOUN
dpc-1817	65	3	of	of	ADP
dpc-1817	65	4	acne	acne	NOUN
dpc-1817	65	5	patients	patient	NOUN
dpc-1817	65	6	treated	treat	VERB
dpc-1817	65	7	with	with	ADP
dpc-1817	65	8	isotretinoin	isotretinoin	PROPN
dpc-1817	65	9	during	during	ADP
dpc-1817	65	10	the	the	DET
dpc-1817	65	11	pandemic	pandemic	ADJ
dpc-1817	65	12	period	period	NOUN
dpc-1817	65	13	and	and	CCONJ
dpc-1817	65	14	non	non	ADJ
dpc-1817	65	15	-	-	ADJ
dpc-1817	65	16	pandemic	pandemic	ADJ
dpc-1817	65	17	period	period	NOUN
dpc-1817	65	18	were	be	AUX
dpc-1817	65	19	50	50	NUM
dpc-1817	65	20	%	%	NOUN
dpc-1817	65	21	and	and	CCONJ
dpc-1817	65	22	%	%	NOUN
dpc-1817	65	23	39.3	39.3	NUM
dpc-1817	65	24	,	,	PUNCT
dpc-1817	65	25	respectively	respectively	ADV
dpc-1817	65	26	.	.	PUNCT
dpc-1817	66	1	isotretinoin	isotretinoin	PROPN
dpc-1817	66	2	use	use	NOUN
dpc-1817	66	3	was	be	AUX
dpc-1817	66	4	found	find	VERB
dpc-1817	66	5	significantly	significantly	ADV
dpc-1817	66	6	higher	high	ADJ
dpc-1817	66	7	in	in	ADP
dpc-1817	66	8	the	the	DET
dpc-1817	66	9	pandemic	pandemic	ADJ
dpc-1817	66	10	period	period	NOUN
dpc-1817	66	11	(	(	PUNCT
dpc-1817	66	12	p	p	X
dpc-1817	66	13	=	=	NOUN
dpc-1817	66	14	0.003	0.003	NUM
dpc-1817	66	15	)	)	PUNCT
dpc-1817	66	16	.	.	PUNCT
dpc-1817	67	1	there	there	PRON
dpc-1817	67	2	was	be	VERB
dpc-1817	67	3	no	no	DET
dpc-1817	67	4	statistically	statistically	ADV
dpc-1817	67	5	significant	significant	ADJ
dpc-1817	67	6	difference	difference	NOUN
dpc-1817	67	7	between	between	ADP
dpc-1817	67	8	the	the	DET
dpc-1817	67	9	pandemic	pandemic	ADJ
dpc-1817	67	10	period	period	NOUN
dpc-1817	67	11	and	and	CCONJ
dpc-1817	67	12	the	the	DET
dpc-1817	67	13	non	non	ADJ
dpc-1817	67	14	-	-	ADJ
dpc-1817	67	15	pandemic	pandemic	ADJ
dpc-1817	67	16	period	period	NOUN
dpc-1817	67	17	in	in	ADP
dpc-1817	67	18	terms	term	NOUN
dpc-1817	67	19	of	of	ADP
dpc-1817	67	20	starting	start	VERB
dpc-1817	67	21	isotretinoin	isotretinoin	PROPN
dpc-1817	67	22	treatment	treatment	NOUN
dpc-1817	67	23	in	in	ADP
dpc-1817	67	24	patients	patient	NOUN
dpc-1817	67	25	with	with	ADP
dpc-1817	67	26	first	first	ADJ
dpc-1817	67	27	admission	admission	NOUN
dpc-1817	67	28	(	(	PUNCT
dpc-1817	67	29	p	p	X
dpc-1817	67	30	>	>	X
dpc-1817	67	31	0.05	0.05	NUM
dpc-1817	67	32	)	)	PUNCT
dpc-1817	67	33	.	.	PUNCT
dpc-1817	68	1	there	there	PRON
dpc-1817	68	2	was	be	VERB
dpc-1817	68	3	no	no	DET
dpc-1817	68	4	significant	significant	ADJ
dpc-1817	68	5	difference	difference	NOUN
dpc-1817	68	6	for	for	ADP
dpc-1817	68	7	using	use	VERB
dpc-1817	68	8	isotretinoin	isotretinoin	PROPN
dpc-1817	68	9	treatment	treatment	NOUN
dpc-1817	68	10	in	in	ADP
dpc-1817	68	11	patients	patient	NOUN
dpc-1817	68	12	who	who	PRON
dpc-1817	68	13	were	be	AUX
dpc-1817	68	14	under	under	ADP
dpc-1817	68	15	follow	follow	NOUN
dpc-1817	68	16	-	-	PUNCT
dpc-1817	68	17	up	up	NOUN
dpc-1817	68	18	in	in	ADP
dpc-1817	68	19	the	the	DET
dpc-1817	68	20	two	two	NUM
dpc-1817	68	21	groups	group	NOUN
dpc-1817	68	22	(	(	PUNCT
dpc-1817	68	23	p	p	X
dpc-1817	68	24	=	=	NOUN
dpc-1817	68	25	0.17	0.17	NUM
dpc-1817	68	26	)	)	PUNCT
dpc-1817	68	27	.	.	PUNCT
dpc-1817	69	1	follow	follow	VERB
dpc-1817	69	2	-	-	PUNCT
dpc-1817	69	3	up	up	ADP
dpc-1817	69	4	intervals	interval	NOUN
dpc-1817	69	5	,	,	PUNCT
dpc-1817	69	6	drop	drop	NOUN
dpc-1817	69	7	-	-	PUNCT
dpc-1817	69	8	out	out	ADP
dpc-1817	69	9	rates	rate	NOUN
dpc-1817	69	10	and	and	CCONJ
dpc-1817	69	11	reported	report	VERB
dpc-1817	69	12	adverse	adverse	ADJ
dpc-1817	69	13	events	event	NOUN
dpc-1817	69	14	in	in	ADP
dpc-1817	69	15	patients	patient	NOUN
dpc-1817	69	16	treated	treat	VERB
dpc-1817	69	17	with	with	ADP
dpc-1817	69	18	isotretinoin	isotretinoin	PROPN
dpc-1817	69	19	during	during	ADP
dpc-1817	69	20	pandemic	pandemic	ADJ
dpc-1817	69	21	and	and	CCONJ
dpc-1817	69	22	non	non	ADJ
dpc-1817	69	23	-	-	ADJ
dpc-1817	69	24	pandemic	pandemic	ADJ
dpc-1817	69	25	period	period	NOUN
dpc-1817	69	26	are	be	AUX
dpc-1817	69	27	given	give	VERB
dpc-1817	69	28	in	in	ADP
dpc-1817	69	29	table	table	NOUN
dpc-1817	69	30	3	3	NUM
dpc-1817	69	31	.	.	PUNCT
dpc-1817	70	1	the	the	DET
dpc-1817	70	2	rate	rate	NOUN
dpc-1817	70	3	of	of	ADP
dpc-1817	70	4	patients	patient	NOUN
dpc-1817	70	5	who	who	PRON
dpc-1817	70	6	used	use	VERB
dpc-1817	70	7	isotretinoin	isotretinoin	PROPN
dpc-1817	70	8	and	and	CCONJ
dpc-1817	70	9	dropped	drop	VERB
dpc-1817	70	10	out	out	ADP
dpc-1817	70	11	from	from	ADP
dpc-1817	70	12	follow	follow	NOUN
dpc-1817	70	13	-	-	PUNCT
dpc-1817	70	14	up	up	NOUN
dpc-1817	70	15	during	during	ADP
dpc-1817	70	16	the	the	DET
dpc-1817	70	17	pandemic	pandemic	ADJ
dpc-1817	70	18	period	period	NOUN
dpc-1817	70	19	was	be	AUX
dpc-1817	70	20	significantly	significantly	ADV
dpc-1817	70	21	higher	high	ADJ
dpc-1817	70	22	than	than	ADP
dpc-1817	70	23	the	the	DET
dpc-1817	70	24	control	control	NOUN
dpc-1817	70	25	group	group	NOUN
dpc-1817	70	26	(	(	PUNCT
dpc-1817	70	27	p	p	X
dpc-1817	70	28	<	<	X
dpc-1817	70	29	0.001	0.001	NUM
dpc-1817	70	30	)	)	PUNCT
dpc-1817	70	31	.	.	PUNCT
dpc-1817	71	1	during	during	ADP
dpc-1817	71	2	the	the	DET
dpc-1817	71	3	pandemic	pandemic	ADJ
dpc-1817	71	4	period	period	NOUN
dpc-1817	71	5	,	,	PUNCT
dpc-1817	71	6	the	the	DET
dpc-1817	71	7	rate	rate	NOUN
dpc-1817	71	8	of	of	ADP
dpc-1817	71	9	patients	patient	NOUN
dpc-1817	71	10	using	use	VERB
dpc-1817	71	11	isotretinoin	isotretinoin	PROPN
dpc-1817	71	12	,	,	PUNCT
dpc-1817	71	13	which	which	PRON
dpc-1817	71	14	was	be	AUX
dpc-1817	71	15	followed	follow	VERB
dpc-1817	71	16	in	in	ADP
dpc-1817	71	17	every	every	DET
dpc-1817	71	18	two	two	NUM
dpc-1817	71	19	or	or	CCONJ
dpc-1817	71	20	more	more	ADJ
dpc-1817	71	21	-	-	PUNCT
dpc-1817	71	22	months	month	NOUN
dpc-1817	71	23	,	,	PUNCT
dpc-1817	71	24	was	be	AUX
dpc-1817	71	25	significantly	significantly	ADV
dpc-1817	71	26	higher	high	ADJ
dpc-1817	71	27	than	than	ADP
dpc-1817	71	28	the	the	DET
dpc-1817	71	29	control	control	NOUN
dpc-1817	71	30	group	group	NOUN
dpc-1817	71	31	(	(	PUNCT
dpc-1817	71	32	p	p	X
dpc-1817	71	33	<	<	X
dpc-1817	71	34	0.001	0.001	NUM
dpc-1817	71	35	)	)	PUNCT
dpc-1817	71	36	.	.	PUNCT
dpc-1817	72	1	side	side	NOUN
dpc-1817	72	2	effects	effect	NOUN
dpc-1817	72	3	in	in	ADP
dpc-1817	72	4	pandemic	pandemic	ADJ
dpc-1817	72	5	and	and	CCONJ
dpc-1817	72	6	non	non	ADJ
dpc-1817	72	7	-	-	ADJ
dpc-1817	72	8	pandemic	pandemic	ADJ
dpc-1817	72	9	period	period	NOUN
dpc-1817	72	10	were	be	AUX
dpc-1817	72	11	seen	see	VERB
dpc-1817	72	12	in	in	ADP
dpc-1817	72	13	10.1	10.1	NUM
dpc-1817	72	14	%	%	NOUN
dpc-1817	72	15	and	and	CCONJ
dpc-1817	72	16	19.8	19.8	NUM
dpc-1817	72	17	%	%	NOUN
dpc-1817	72	18	of	of	ADP
dpc-1817	72	19	the	the	DET
dpc-1817	72	20	patients	patient	NOUN
dpc-1817	72	21	,	,	PUNCT
dpc-1817	72	22	respectively	respectively	ADV
dpc-1817	72	23	.	.	PUNCT
dpc-1817	73	1	the	the	DET
dpc-1817	73	2	rate	rate	NOUN
dpc-1817	73	3	of	of	ADP
dpc-1817	73	4	patients	patient	NOUN
dpc-1817	73	5	using	use	VERB
dpc-1817	73	6	isotretinoin	isotretinoin	PROPN
dpc-1817	73	7	who	who	PRON
dpc-1817	73	8	developed	develop	VERB
dpc-1817	73	9	side	side	NOUN
dpc-1817	73	10	effects	effect	NOUN
dpc-1817	73	11	was	be	AUX
dpc-1817	73	12	found	find	VERB
dpc-1817	73	13	significantly	significantly	ADV
dpc-1817	73	14	higher	high	ADJ
dpc-1817	73	15	in	in	ADP
dpc-1817	73	16	the	the	DET
dpc-1817	73	17	non	non	ADJ
dpc-1817	73	18	-	-	ADJ
dpc-1817	73	19	pandemic	pandemic	ADJ
dpc-1817	73	20	period	period	NOUN
dpc-1817	73	21	compared	compare	VERB
dpc-1817	73	22	to	to	ADP
dpc-1817	73	23	the	the	DET
dpc-1817	73	24	pandemic	pandemic	ADJ
dpc-1817	73	25	period	period	NOUN
dpc-1817	73	26	(	(	PUNCT
dpc-1817	73	27	p	p	X
dpc-1817	73	28	=	=	NOUN
dpc-1817	73	29	0.01	0.01	NUM
dpc-1817	73	30	)	)	PUNCT
dpc-1817	73	31	.	.	PUNCT
dpc-1817	74	1	in	in	ADP
dpc-1817	74	2	the	the	DET
dpc-1817	74	3	4	4	NUM
dpc-1817	74	4	-	-	PUNCT
dpc-1817	74	5	month	month	NOUN
dpc-1817	74	6	pandemic	pandemic	ADJ
dpc-1817	74	7	period	period	NOUN
dpc-1817	74	8	(	(	PUNCT
dpc-1817	74	9	march	march	PROPN
dpc-1817	74	10	-	-	PUNCT
dpc-1817	74	11	july	july	PROPN
dpc-1817	74	12	2020	2020	NUM
dpc-1817	74	13	)	)	PUNCT
dpc-1817	74	14	,	,	PUNCT
dpc-1817	74	15	only	only	ADV
dpc-1817	74	16	two	two	NUM
dpc-1817	74	17	patients	patient	NOUN
dpc-1817	74	18	were	be	AUX
dpc-1817	74	19	diagnosed	diagnose	VERB
dpc-1817	74	20	with	with	ADP
dpc-1817	74	21	sars	sar	NOUN
dpc-1817	74	22	-	-	PUNCT
dpc-1817	74	23	cov-2	cov-2	PART
dpc-1817	74	24	infection	infection	NOUN
dpc-1817	74	25	.	.	PUNCT
dpc-1817	75	1	one	one	NUM
dpc-1817	75	2	of	of	ADP
dpc-1817	75	3	the	the	DET
dpc-1817	75	4	patients	patient	NOUN
dpc-1817	75	5	(	(	PUNCT
dpc-1817	75	6	aged	aged	ADJ
dpc-1817	75	7	27	27	NUM
dpc-1817	75	8	years	year	NOUN
dpc-1817	75	9	)	)	PUNCT
dpc-1817	75	10	was	be	AUX
dpc-1817	75	11	using	use	VERB
dpc-1817	75	12	isotretinoin	isotretinoin	PROPN
dpc-1817	76	1	and	and	CCONJ
dpc-1817	76	2	she	she	PRON
dpc-1817	76	3	only	only	ADV
dpc-1817	76	4	showed	show	VERB
dpc-1817	76	5	mild	mild	ADJ
dpc-1817	76	6	upper	upper	ADJ
dpc-1817	76	7	respiratory	respiratory	ADJ
dpc-1817	76	8	tract	tract	NOUN
dpc-1817	76	9	infection	infection	NOUN
dpc-1817	76	10	symptoms	symptom	NOUN
dpc-1817	76	11	.	.	PUNCT
dpc-1817	77	1	other	other	ADJ
dpc-1817	77	2	patient	patient	NOUN
dpc-1817	77	3	(	(	PUNCT
dpc-1817	77	4	aged	aged	ADJ
dpc-1817	77	5	39	39	NUM
dpc-1817	77	6	years	year	NOUN
dpc-1817	77	7	)	)	PUNCT
dpc-1817	77	8	was	be	AUX
dpc-1817	77	9	using	use	VERB
dpc-1817	77	10	topical	topical	ADJ
dpc-1817	77	11	treatments	treatment	NOUN
dpc-1817	77	12	.	.	PUNCT
dpc-1817	78	1	neither	neither	PRON
dpc-1817	78	2	of	of	ADP
dpc-1817	78	3	them	they	PRON
dpc-1817	78	4	was	be	AUX
dpc-1817	78	5	hospitalized	hospitalize	VERB
dpc-1817	78	6	.	.	PUNCT
dpc-1817	79	1	table	table	NOUN
dpc-1817	79	2	2	2	NUM
dpc-1817	79	3	.	.	PUNCT
dpc-1817	79	4	treatment	treatment	NOUN
dpc-1817	79	5	status	status	NOUN
dpc-1817	79	6	of	of	ADP
dpc-1817	79	7	patients	patient	NOUN
dpc-1817	79	8	admitted	admit	VERB
dpc-1817	79	9	during	during	ADP
dpc-1817	79	10	the	the	DET
dpc-1817	79	11	pandemic	pandemic	ADJ
dpc-1817	79	12	and	and	CCONJ
dpc-1817	79	13	non	non	ADJ
dpc-1817	79	14	-	-	ADJ
dpc-1817	79	15	pandemic	pandemic	ADJ
dpc-1817	79	16	period	period	NOUN
dpc-1817	79	17	pandemic	pandemic	ADJ
dpc-1817	79	18	period	period	NOUN
dpc-1817	79	19	(	(	PUNCT
dpc-1817	79	20	n	n	NOUN
dpc-1817	79	21	=	=	SYM
dpc-1817	79	22	278	278	NUM
dpc-1817	79	23	)	)	PUNCT
dpc-1817	79	24	non	non	ADJ
dpc-1817	79	25	-	-	ADJ
dpc-1817	79	26	pandemic	pandemic	ADJ
dpc-1817	79	27	period	period	NOUN
dpc-1817	79	28	(	(	PUNCT
dpc-1817	79	29	n	n	NOUN
dpc-1817	79	30	=	=	SYM
dpc-1817	79	31	577	577	NUM
dpc-1817	79	32	)	)	PUNCT
dpc-1817	79	33	p	p	NOUN
dpc-1817	79	34	values	value	NOUN
dpc-1817	79	35	patients	patient	NOUN
dpc-1817	79	36	with	with	ADP
dpc-1817	79	37	first	first	ADJ
dpc-1817	79	38	admission	admission	NOUN
dpc-1817	79	39	124	124	NUM
dpc-1817	79	40	(	(	PUNCT
dpc-1817	79	41	44.6	44.6	NUM
dpc-1817	79	42	%	%	NOUN
dpc-1817	79	43	)	)	PUNCT
dpc-1817	79	44	336	336	NUM
dpc-1817	79	45	(	(	PUNCT
dpc-1817	79	46	58.2	58.2	NUM
dpc-1817	79	47	%	%	NOUN
dpc-1817	79	48	)	)	PUNCT
dpc-1817	79	49	<	<	X
dpc-1817	79	50	0.005	0.005	NUM
dpc-1817	79	51	treatment	treatment	NOUN
dpc-1817	79	52	naïve	naïve	ADJ
dpc-1817	79	53	116	116	NUM
dpc-1817	79	54	(	(	PUNCT
dpc-1817	79	55	93.5	93.5	NUM
dpc-1817	79	56	%	%	NOUN
dpc-1817	79	57	)	)	PUNCT
dpc-1817	79	58	318	318	NUM
dpc-1817	79	59	(	(	PUNCT
dpc-1817	79	60	94.6	94.6	NUM
dpc-1817	79	61	%	%	NOUN
dpc-1817	79	62	)	)	PUNCT
dpc-1817	79	63	0.652	0.652	NUM
dpc-1817	79	64	treated	treat	VERB
dpc-1817	79	65	with	with	ADP
dpc-1817	79	66	any	any	DET
dpc-1817	79	67	systemic	systemic	ADJ
dpc-1817	79	68	agent	agent	NOUN
dpc-1817	79	69	(	(	PUNCT
dpc-1817	79	70	antibiotics	antibiotic	NOUN
dpc-1817	79	71	and	and	CCONJ
dpc-1817	79	72	oral	oral	ADJ
dpc-1817	79	73	isotretinoin	isotretinoin	PROPN
dpc-1817	79	74	)	)	PUNCT
dpc-1817	79	75	8	8	NUM
dpc-1817	79	76	(	(	PUNCT
dpc-1817	79	77	6.5	6.5	NUM
dpc-1817	79	78	%	%	NOUN
dpc-1817	79	79	)	)	PUNCT
dpc-1817	79	80	18	18	NUM
dpc-1817	79	81	(	(	PUNCT
dpc-1817	79	82	5.4	5.4	NUM
dpc-1817	79	83	%	%	NOUN
dpc-1817	79	84	)	)	PUNCT
dpc-1817	79	85	treatment	treatment	NOUN
dpc-1817	79	86	naive	naive	ADJ
dpc-1817	79	87	patients	patient	NOUN
dpc-1817	79	88	started	start	VERB
dpc-1817	79	89	systemic	systemic	ADJ
dpc-1817	79	90	isotretinoin	isotretinoin	PROPN
dpc-1817	79	91	39	39	NUM
dpc-1817	79	92	(	(	PUNCT
dpc-1817	79	93	31.4	31.4	NUM
dpc-1817	79	94	%	%	NOUN
dpc-1817	79	95	)	)	PUNCT
dpc-1817	79	96	129	129	NUM
dpc-1817	79	97	(	(	PUNCT
dpc-1817	79	98	38.3	38.3	NUM
dpc-1817	79	99	%	%	NOUN
dpc-1817	79	100	)	)	PUNCT
dpc-1817	79	101	0.34	0.34	NUM
dpc-1817	79	102	follow	follow	VERB
dpc-1817	79	103	-	-	PUNCT
dpc-1817	79	104	up	up	ADP
dpc-1817	79	105	patients	patient	NOUN
dpc-1817	79	106	150	150	NUM
dpc-1817	79	107	(	(	PUNCT
dpc-1817	79	108	54	54	NUM
dpc-1817	79	109	%	%	NOUN
dpc-1817	79	110	)	)	PUNCT
dpc-1817	79	111	239	239	NUM
dpc-1817	79	112	(	(	PUNCT
dpc-1817	79	113	41.4	41.4	NUM
dpc-1817	79	114	%	%	NOUN
dpc-1817	79	115	)	)	PUNCT
dpc-1817	79	116	<	<	X
dpc-1817	79	117	0.005	0.005	NUM
dpc-1817	79	118	isotretinoin	isotretinoin	NOUN
dpc-1817	79	119	treatment	treatment	NOUN
dpc-1817	79	120	114	114	NUM
dpc-1817	79	121	(	(	PUNCT
dpc-1817	79	122	76	76	NUM
dpc-1817	79	123	%	%	NOUN
dpc-1817	79	124	)	)	PUNCT
dpc-1817	79	125	173	173	NUM
dpc-1817	79	126	(	(	PUNCT
dpc-1817	79	127	72.4	72.4	NUM
dpc-1817	79	128	%	%	NOUN
dpc-1817	79	129	)	)	PUNCT
dpc-1817	79	130	0.17	0.17	NUM
dpc-1817	79	131	systemic	systemic	ADJ
dpc-1817	79	132	antibiotic	antibiotic	ADJ
dpc-1817	79	133	treatment	treatment	NOUN
dpc-1817	79	134	and	and	CCONJ
dpc-1817	79	135	topical	topical	ADJ
dpc-1817	79	136	treatments	treatment	NOUN
dpc-1817	79	137	10	10	NUM
dpc-1817	79	138	(	(	PUNCT
dpc-1817	79	139	6.7	6.7	NUM
dpc-1817	79	140	%	%	NOUN
dpc-1817	79	141	)	)	PUNCT
dpc-1817	79	142	8	8	NUM
dpc-1817	79	143	(	(	PUNCT
dpc-1817	79	144	3.3	3.3	NUM
dpc-1817	79	145	%	%	NOUN
dpc-1817	79	146	)	)	PUNCT
dpc-1817	79	147	0.06	0.06	NUM
dpc-1817	79	148	only	only	ADJ
dpc-1817	79	149	topical	topical	ADJ
dpc-1817	79	150	treatments	treatment	NOUN
dpc-1817	79	151	26	26	NUM
dpc-1817	79	152	(	(	PUNCT
dpc-1817	79	153	17.3	17.3	NUM
dpc-1817	79	154	%	%	NOUN
dpc-1817	79	155	)	)	PUNCT
dpc-1817	79	156	58	58	NUM
dpc-1817	79	157	(	(	PUNCT
dpc-1817	79	158	24.3	24.3	NUM
dpc-1817	79	159	%	%	NOUN
dpc-1817	79	160	)	)	PUNCT
dpc-1817	79	161	0.06	0.06	NUM
dpc-1817	79	162	treatment	treatment	NOUN
dpc-1817	79	163	status	status	NOUN
dpc-1817	79	164	in	in	ADP
dpc-1817	79	165	all	all	DET
dpc-1817	79	166	patients	patient	NOUN
dpc-1817	79	167	isotretinoin	isotretinoin	PROPN
dpc-1817	79	168	treatment	treatment	NOUN
dpc-1817	79	169	139	139	NUM
dpc-1817	79	170	(	(	PUNCT
dpc-1817	79	171	50	50	NUM
dpc-1817	79	172	%	%	NOUN
dpc-1817	79	173	)	)	PUNCT
dpc-1817	79	174	227	227	NUM
dpc-1817	79	175	(	(	PUNCT
dpc-1817	79	176	39.3	39.3	NUM
dpc-1817	79	177	%	%	NOUN
dpc-1817	79	178	)	)	PUNCT
dpc-1817	79	179	0.003	0.003	NUM
dpc-1817	79	180	systemic	systemic	ADJ
dpc-1817	79	181	antibiotic	antibiotic	ADJ
dpc-1817	79	182	and	and	CCONJ
dpc-1817	79	183	topicals	topical	NOUN
dpc-1817	79	184	36	36	NUM
dpc-1817	79	185	(	(	PUNCT
dpc-1817	79	186	12.9	12.9	NUM
dpc-1817	79	187	%	%	NOUN
dpc-1817	79	188	)	)	PUNCT
dpc-1817	79	189	103	103	NUM
dpc-1817	79	190	(	(	PUNCT
dpc-1817	79	191	17.9	17.9	NUM
dpc-1817	79	192	%	%	NOUN
dpc-1817	79	193	)	)	PUNCT
dpc-1817	79	194	0.43	0.43	NUM
dpc-1817	79	195	only	only	ADV
dpc-1817	79	196	topical	topical	ADJ
dpc-1817	79	197	treatment	treatment	NOUN
dpc-1817	79	198	103	103	NUM
dpc-1817	79	199	(	(	PUNCT
dpc-1817	79	200	37.1	37.1	NUM
dpc-1817	79	201	%	%	NOUN
dpc-1817	79	202	)	)	PUNCT
dpc-1817	79	203	247	247	NUM
dpc-1817	79	204	(	(	PUNCT
dpc-1817	79	205	42.8	42.8	NUM
dpc-1817	79	206	%	%	NOUN
dpc-1817	79	207	)	)	PUNCT
dpc-1817	79	208	0.43	0.43	NUM
dpc-1817	79	209	4	4	NUM
dpc-1817	79	210	original	original	ADJ
dpc-1817	79	211	article	article	NOUN
dpc-1817	79	212	|	|	ADV
dpc-1817	79	213	dermatol	dermatol	ADJ
dpc-1817	79	214	pract	pract	NOUN
dpc-1817	79	215	concept	concept	NOUN
dpc-1817	79	216	.	.	PUNCT
dpc-1817	80	1	2022;12(1):e2022036	2022;12(1):e2022036	PRON
dpc-1817	80	2	table	table	NOUN
dpc-1817	80	3	3	3	NUM
dpc-1817	80	4	.	.	PUNCT
dpc-1817	80	5	changes	change	NOUN
dpc-1817	80	6	in	in	ADP
dpc-1817	80	7	follow	follow	NOUN
dpc-1817	80	8	-	-	PUNCT
dpc-1817	80	9	up	up	ADP
dpc-1817	80	10	intervals	interval	NOUN
dpc-1817	80	11	,	,	PUNCT
dpc-1817	80	12	patient	patient	ADJ
dpc-1817	80	13	drop	drop	NOUN
dpc-1817	80	14	-	-	PUNCT
dpc-1817	80	15	out	out	ADP
dpc-1817	80	16	rates	rate	NOUN
dpc-1817	80	17	,	,	PUNCT
dpc-1817	80	18	and	and	CCONJ
dpc-1817	80	19	reported	report	VERB
dpc-1817	80	20	adverse	adverse	ADJ
dpc-1817	80	21	events	event	NOUN
dpc-1817	80	22	in	in	ADP
dpc-1817	80	23	isotretinoin	isotretinoin	PROPN
dpc-1817	80	24	patients	patient	NOUN
dpc-1817	80	25	number	number	NOUN
dpc-1817	80	26	of	of	ADP
dpc-1817	80	27	isotretinoin	isotretinoin	PROPN
dpc-1817	80	28	patients	patient	NOUN
dpc-1817	80	29	pandemic	pandemic	ADJ
dpc-1817	80	30	period	period	NOUN
dpc-1817	80	31	(	(	PUNCT
dpc-1817	80	32	n	n	NOUN
dpc-1817	80	33	=	=	SYM
dpc-1817	80	34	139	139	NUM
dpc-1817	80	35	)	)	PUNCT
dpc-1817	80	36	non	non	ADJ
dpc-1817	80	37	-	-	ADJ
dpc-1817	80	38	pandemic	pandemic	ADJ
dpc-1817	80	39	period	period	NOUN
dpc-1817	80	40	(	(	PUNCT
dpc-1817	80	41	n	n	NOUN
dpc-1817	80	42	=	=	SYM
dpc-1817	80	43	227	227	NUM
dpc-1817	80	44	)	)	PUNCT
dpc-1817	80	45	p	p	NOUN
dpc-1817	80	46	values	value	NOUN
dpc-1817	80	47	followed	follow	VERB
dpc-1817	80	48	-	-	PUNCT
dpc-1817	80	49	up	up	NOUN
dpc-1817	80	50	for	for	ADP
dpc-1817	80	51	extended	extended	ADJ
dpc-1817	80	52	intervals	interval	NOUN
dpc-1817	80	53	79	79	NUM
dpc-1817	80	54	(	(	PUNCT
dpc-1817	80	55	56.8	56.8	NUM
dpc-1817	80	56	%	%	NOUN
dpc-1817	80	57	)	)	PUNCT
dpc-1817	80	58	65	65	NUM
dpc-1817	80	59	(	(	PUNCT
dpc-1817	80	60	28.6	28.6	NUM
dpc-1817	80	61	%	%	NOUN
dpc-1817	80	62	)	)	PUNCT
dpc-1817	80	63	<	<	X
dpc-1817	80	64	0.001	0.001	NUM
dpc-1817	80	65	lost	lose	VERB
dpc-1817	80	66	to	to	PART
dpc-1817	80	67	follow	follow	VERB
dpc-1817	80	68	-	-	PUNCT
dpc-1817	80	69	up	up	NOUN
dpc-1817	80	70	30	30	NUM
dpc-1817	80	71	(	(	PUNCT
dpc-1817	80	72	21.6	21.6	NUM
dpc-1817	80	73	%	%	NOUN
dpc-1817	80	74	)	)	PUNCT
dpc-1817	80	75	6	6	NUM
dpc-1817	80	76	(	(	PUNCT
dpc-1817	80	77	2.6	2.6	NUM
dpc-1817	80	78	%	%	NOUN
dpc-1817	80	79	)	)	PUNCT
dpc-1817	80	80	<	<	X
dpc-1817	80	81	0.001	0.001	NUM
dpc-1817	80	82	reported	report	VERB
dpc-1817	80	83	adverse	adverse	ADJ
dpc-1817	80	84	events	event	NOUN
dpc-1817	80	85	14	14	NUM
dpc-1817	80	86	(	(	PUNCT
dpc-1817	80	87	10.1	10.1	NUM
dpc-1817	80	88	%	%	NOUN
dpc-1817	80	89	)	)	PUNCT
dpc-1817	80	90	45	45	NUM
dpc-1817	80	91	(	(	PUNCT
dpc-1817	80	92	19.8	19.8	NUM
dpc-1817	80	93	%	%	NOUN
dpc-1817	80	94	)	)	PUNCT
dpc-1817	80	95	0.01	0.01	NUM
dpc-1817	80	96	liver	liver	NOUN
dpc-1817	80	97	enzyme	enzyme	NOUN
dpc-1817	80	98	abnormality	abnormality	NOUN
dpc-1817	80	99	5	5	NUM
dpc-1817	80	100	(	(	PUNCT
dpc-1817	80	101	3.6	3.6	NUM
dpc-1817	80	102	%	%	NOUN
dpc-1817	80	103	)	)	PUNCT
dpc-1817	80	104	10	10	NUM
dpc-1817	80	105	(	(	PUNCT
dpc-1817	80	106	4.4	4.4	NUM
dpc-1817	80	107	%	%	NOUN
dpc-1817	80	108	)	)	PUNCT
dpc-1817	80	109	hypertriglyceridemia	hypertriglyceridemia	NOUN
dpc-1817	80	110	2	2	NUM
dpc-1817	80	111	(	(	PUNCT
dpc-1817	80	112	1.4	1.4	NUM
dpc-1817	80	113	%	%	NOUN
dpc-1817	80	114	)	)	PUNCT
dpc-1817	80	115	6	6	NUM
dpc-1817	80	116	(	(	PUNCT
dpc-1817	80	117	2.6	2.6	NUM
dpc-1817	80	118	%	%	NOUN
dpc-1817	80	119	)	)	PUNCT
dpc-1817	80	120	back	back	ADV
dpc-1817	80	121	pain	pain	NOUN
dpc-1817	80	122	2	2	NUM
dpc-1817	80	123	(	(	PUNCT
dpc-1817	80	124	1.4	1.4	NUM
dpc-1817	80	125	%	%	NOUN
dpc-1817	80	126	)	)	PUNCT
dpc-1817	80	127	9	9	NUM
dpc-1817	80	128	(	(	PUNCT
dpc-1817	80	129	4	4	NUM
dpc-1817	80	130	%	%	NOUN
dpc-1817	80	131	)	)	PUNCT
dpc-1817	80	132	nasal	nasal	NOUN
dpc-1817	80	133	bleeding	bleed	VERB
dpc-1817	80	134	2	2	NUM
dpc-1817	80	135	(	(	PUNCT
dpc-1817	80	136	1.4	1.4	NUM
dpc-1817	80	137	%	%	NOUN
dpc-1817	80	138	)	)	PUNCT
dpc-1817	80	139	3	3	NUM
dpc-1817	80	140	(	(	PUNCT
dpc-1817	80	141	1.3	1.3	NUM
dpc-1817	80	142	%	%	NOUN
dpc-1817	80	143	)	)	PUNCT
dpc-1817	80	144	psychiatric	psychiatric	ADJ
dpc-1817	80	145	symptoms	symptom	NOUN
dpc-1817	80	146	1	1	NUM
dpc-1817	80	147	(	(	PUNCT
dpc-1817	80	148	0.8	0.8	NUM
dpc-1817	80	149	%	%	NOUN
dpc-1817	80	150	)	)	PUNCT
dpc-1817	80	151	3	3	NUM
dpc-1817	80	152	(	(	PUNCT
dpc-1817	80	153	1.3	1.3	NUM
dpc-1817	80	154	%	%	NOUN
dpc-1817	80	155	)	)	PUNCT
dpc-1817	80	156	headache	headache	NOUN
dpc-1817	80	157	1	1	NUM
dpc-1817	80	158	(	(	PUNCT
dpc-1817	80	159	0.8	0.8	NUM
dpc-1817	80	160	%	%	NOUN
dpc-1817	80	161	)	)	PUNCT
dpc-1817	80	162	1	1	NUM
dpc-1817	80	163	(	(	PUNCT
dpc-1817	80	164	0.4	0.4	NUM
dpc-1817	80	165	%	%	NOUN
dpc-1817	80	166	)	)	PUNCT
dpc-1817	80	167	severe	severe	ADJ
dpc-1817	80	168	xerosis	xerosis	NOUN
dpc-1817	80	169	-	-	PUNCT
dpc-1817	80	170	eczematous	eczematous	ADJ
dpc-1817	80	171	dermatitis	dermatitis	NOUN
dpc-1817	80	172	1	1	NUM
dpc-1817	80	173	(	(	PUNCT
dpc-1817	80	174	0.8	0.8	NUM
dpc-1817	80	175	%	%	NOUN
dpc-1817	80	176	)	)	PUNCT
dpc-1817	80	177	4	4	NUM
dpc-1817	80	178	(	(	PUNCT
dpc-1817	80	179	1.8	1.8	NUM
dpc-1817	80	180	%	%	NOUN
dpc-1817	80	181	)	)	PUNCT
dpc-1817	80	182	dry	dry	ADJ
dpc-1817	80	183	eye	eye	NOUN
dpc-1817	80	184	syndrome	syndrome	NOUN
dpc-1817	80	185	7	7	NUM
dpc-1817	80	186	(	(	PUNCT
dpc-1817	80	187	3.1	3.1	NUM
dpc-1817	80	188	%	%	NOUN
dpc-1817	80	189	)	)	PUNCT
dpc-1817	80	190	photosensitivity	photosensitivity	NOUN
dpc-1817	80	191	1	1	NUM
dpc-1817	80	192	(	(	PUNCT
dpc-1817	80	193	0.4	0.4	NUM
dpc-1817	80	194	%	%	NOUN
dpc-1817	80	195	)	)	PUNCT
dpc-1817	80	196	anal	anal	ADJ
dpc-1817	80	197	fissure	fissure	NOUN
dpc-1817	80	198	1	1	NUM
dpc-1817	80	199	(	(	PUNCT
dpc-1817	80	200	0.4	0.4	NUM
dpc-1817	80	201	%	%	NOUN
dpc-1817	80	202	)	)	PUNCT
dpc-1817	80	203	conclusions	conclusion	NOUN
dpc-1817	80	204	novel	novel	ADJ
dpc-1817	80	205	coronavirus	coronavirus	NOUN
dpc-1817	80	206	pandemic	pandemic	ADJ
dpc-1817	80	207	has	have	AUX
dpc-1817	80	208	caused	cause	VERB
dpc-1817	80	209	significant	significant	ADJ
dpc-1817	80	210	changes	change	NOUN
dpc-1817	80	211	in	in	ADP
dpc-1817	80	212	dermatology	dermatology	NOUN
dpc-1817	80	213	practices	practice	NOUN
dpc-1817	80	214	[	[	X
dpc-1817	80	215	3	3	NUM
dpc-1817	80	216	]	]	PUNCT
dpc-1817	80	217	.	.	PUNCT
dpc-1817	81	1	as	as	SCONJ
dpc-1817	81	2	depicted	depict	VERB
dpc-1817	81	3	in	in	ADP
dpc-1817	81	4	our	our	PRON
dpc-1817	81	5	study	study	NOUN
dpc-1817	81	6	,	,	PUNCT
dpc-1817	81	7	the	the	DET
dpc-1817	81	8	accessibility	accessibility	NOUN
dpc-1817	81	9	to	to	ADP
dpc-1817	81	10	outpatient	outpatient	NOUN
dpc-1817	81	11	clinics	clinic	NOUN
dpc-1817	81	12	and	and	CCONJ
dpc-1817	81	13	patient	patient	ADJ
dpc-1817	81	14	compliance	compliance	NOUN
dpc-1817	81	15	with	with	ADP
dpc-1817	81	16	systemic	systemic	ADJ
dpc-1817	81	17	treatments	treatment	NOUN
dpc-1817	81	18	were	be	AUX
dpc-1817	81	19	affected	affect	VERB
dpc-1817	81	20	by	by	ADP
dpc-1817	81	21	the	the	DET
dpc-1817	81	22	pandemic	pandemic	NOUN
dpc-1817	81	23	.	.	PUNCT
dpc-1817	82	1	according	accord	VERB
dpc-1817	82	2	to	to	ADP
dpc-1817	82	3	recent	recent	ADJ
dpc-1817	82	4	literature	literature	NOUN
dpc-1817	82	5	,	,	PUNCT
dpc-1817	82	6	acne	acne	NOUN
dpc-1817	82	7	patients	patient	NOUN
dpc-1817	82	8	consisted	consist	VERB
dpc-1817	82	9	of	of	ADP
dpc-1817	82	10	the	the	DET
dpc-1817	82	11	majority	majority	NOUN
dpc-1817	82	12	of	of	ADP
dpc-1817	82	13	the	the	DET
dpc-1817	82	14	patients	patient	NOUN
dpc-1817	82	15	who	who	PRON
dpc-1817	82	16	are	be	AUX
dpc-1817	82	17	admitted	admit	VERB
dpc-1817	82	18	to	to	ADP
dpc-1817	82	19	dermatology	dermatology	NOUN
dpc-1817	82	20	outpatient	outpatient	NOUN
dpc-1817	82	21	clinics	clinic	NOUN
dpc-1817	82	22	[	[	X
dpc-1817	82	23	1	1	NUM
dpc-1817	82	24	]	]	PUNCT
dpc-1817	82	25	,	,	PUNCT
dpc-1817	82	26	and	and	CCONJ
dpc-1817	82	27	treatment	treatment	NOUN
dpc-1817	82	28	compliance	compliance	NOUN
dpc-1817	82	29	was	be	AUX
dpc-1817	82	30	the	the	DET
dpc-1817	82	31	highest	high	ADJ
dpc-1817	82	32	in	in	ADP
dpc-1817	82	33	this	this	DET
dpc-1817	82	34	group	group	NOUN
dpc-1817	83	1	[	[	X
dpc-1817	83	2	3	3	NUM
dpc-1817	83	3	]	]	PUNCT
dpc-1817	83	4	.	.	PUNCT
dpc-1817	84	1	this	this	PRON
dpc-1817	84	2	might	might	AUX
dpc-1817	84	3	be	be	AUX
dpc-1817	84	4	due	due	ADJ
dpc-1817	84	5	to	to	ADP
dpc-1817	84	6	that	that	DET
dpc-1817	84	7	acne	acne	NOUN
dpc-1817	84	8	is	be	AUX
dpc-1817	84	9	relatively	relatively	ADV
dpc-1817	84	10	common	common	ADJ
dpc-1817	84	11	condition	condition	NOUN
dpc-1817	84	12	in	in	ADP
dpc-1817	84	13	younger	young	ADJ
dpc-1817	84	14	individuals	individual	NOUN
dpc-1817	84	15	and	and	CCONJ
dpc-1817	84	16	younger	young	ADJ
dpc-1817	84	17	patients	patient	NOUN
dpc-1817	84	18	seek	seek	VERB
dpc-1817	84	19	more	more	ADJ
dpc-1817	84	20	care	care	NOUN
dpc-1817	84	21	because	because	SCONJ
dpc-1817	84	22	of	of	ADP
dpc-1817	84	23	the	the	DET
dpc-1817	84	24	psychosocial	psychosocial	ADJ
dpc-1817	84	25	effect	effect	NOUN
dpc-1817	84	26	of	of	ADP
dpc-1817	84	27	the	the	DET
dpc-1817	84	28	disease	disease	NOUN
dpc-1817	84	29	[	[	X
dpc-1817	84	30	4	4	NUM
dpc-1817	84	31	]	]	PUNCT
dpc-1817	84	32	.	.	PUNCT
dpc-1817	85	1	additionally	additionally	ADV
dpc-1817	85	2	,	,	PUNCT
dpc-1817	85	3	the	the	DET
dpc-1817	85	4	knowledge	knowledge	NOUN
dpc-1817	85	5	of	of	ADP
dpc-1817	85	6	the	the	DET
dpc-1817	85	7	mild	mild	ADJ
dpc-1817	85	8	disease	disease	NOUN
dpc-1817	85	9	course	course	NOUN
dpc-1817	85	10	of	of	ADP
dpc-1817	85	11	covid-19	covid-19	PROPN
dpc-1817	85	12	infection	infection	NOUN
dpc-1817	85	13	might	might	AUX
dpc-1817	85	14	cause	cause	VERB
dpc-1817	85	15	young	young	ADJ
dpc-1817	85	16	patients	patient	NOUN
dpc-1817	85	17	to	to	PART
dpc-1817	85	18	reach	reach	VERB
dpc-1817	85	19	hospital	hospital	NOUN
dpc-1817	85	20	clinics	clinic	NOUN
dpc-1817	85	21	without	without	ADP
dpc-1817	85	22	fear	fear	NOUN
dpc-1817	85	23	compared	compare	VERB
dpc-1817	85	24	to	to	ADP
dpc-1817	85	25	elderly	elderly	ADJ
dpc-1817	85	26	population	population	NOUN
dpc-1817	85	27	]	]	X
dpc-1817	85	28	.	.	PUNCT
dpc-1817	86	1	another	another	DET
dpc-1817	86	2	reason	reason	NOUN
dpc-1817	86	3	for	for	ADP
dpc-1817	86	4	increased	increased	ADJ
dpc-1817	86	5	percentage	percentage	NOUN
dpc-1817	86	6	of	of	ADP
dpc-1817	86	7	acne	acne	NOUN
dpc-1817	86	8	patients	patient	NOUN
dpc-1817	86	9	can	can	AUX
dpc-1817	86	10	be	be	AUX
dpc-1817	86	11	intense	intense	ADJ
dpc-1817	86	12	use	use	NOUN
dpc-1817	86	13	of	of	ADP
dpc-1817	86	14	masks	mask	NOUN
dpc-1817	86	15	,	,	PUNCT
dpc-1817	86	16	thus	thus	ADV
dpc-1817	86	17	causing	cause	VERB
dpc-1817	86	18	increased	increase	VERB
dpc-1817	86	19	prevalence	prevalence	NOUN
dpc-1817	86	20	of	of	ADP
dpc-1817	86	21	‘	'	PUNCT
dpc-1817	86	22	mask	mask	NOUN
dpc-1817	86	23	acne	acne	NOUN
dpc-1817	86	24	’	'	PUNCT
dpc-1817	86	25	,	,	PUNCT
dpc-1817	86	26	likely	likely	ADJ
dpc-1817	86	27	result	result	NOUN
dpc-1817	86	28	of	of	ADP
dpc-1817	86	29	increased	increase	VERB
dpc-1817	86	30	usage	usage	NOUN
dpc-1817	86	31	of	of	ADP
dpc-1817	86	32	personal	personal	ADJ
dpc-1817	86	33	protective	protective	ADJ
dpc-1817	86	34	equipment	equipment	NOUN
dpc-1817	86	35	with	with	ADP
dpc-1817	86	36	the	the	DET
dpc-1817	86	37	current	current	ADJ
dpc-1817	86	38	pandemic	pandemic	NOUN
dpc-1817	86	39	]	]	PUNCT
dpc-1817	86	40	.	.	PUNCT
dpc-1817	87	1	the	the	DET
dpc-1817	87	2	percentage	percentage	NOUN
dpc-1817	87	3	of	of	ADP
dpc-1817	87	4	acne	acne	NOUN
dpc-1817	87	5	patients	patient	NOUN
dpc-1817	87	6	admitted	admit	VERB
dpc-1817	87	7	to	to	ADP
dpc-1817	87	8	dermatology	dermatology	NOUN
dpc-1817	87	9	outpatient	outpatient	NOUN
dpc-1817	87	10	clinic	clinic	NOUN
dpc-1817	87	11	during	during	ADP
dpc-1817	87	12	the	the	DET
dpc-1817	87	13	pandemic	pandemic	ADJ
dpc-1817	87	14	period	period	NOUN
dpc-1817	87	15	was	be	AUX
dpc-1817	87	16	found	find	VERB
dpc-1817	87	17	significantly	significantly	ADV
dpc-1817	87	18	increased	increase	VERB
dpc-1817	87	19	compared	compare	VERB
dpc-1817	87	20	to	to	ADP
dpc-1817	87	21	non	non	ADJ
dpc-1817	87	22	-	-	ADJ
dpc-1817	87	23	pandemic	pandemic	ADJ
dpc-1817	87	24	period	period	NOUN
dpc-1817	87	25	in	in	ADP
dpc-1817	87	26	the	the	DET
dpc-1817	87	27	current	current	ADJ
dpc-1817	87	28	study	study	NOUN
dpc-1817	87	29	.	.	PUNCT
dpc-1817	88	1	starting	start	VERB
dpc-1817	88	2	from	from	ADP
dpc-1817	88	3	march	march	PROPN
dpc-1817	88	4	2020	2020	NUM
dpc-1817	88	5	,	,	PUNCT
dpc-1817	88	6	social	social	ADJ
dpc-1817	88	7	distancing	distancing	NOUN
dpc-1817	88	8	measures	measure	NOUN
dpc-1817	88	9	and	and	CCONJ
dpc-1817	88	10	restrictions	restriction	NOUN
dpc-1817	88	11	were	be	AUX
dpc-1817	88	12	imposed	impose	VERB
dpc-1817	88	13	to	to	PART
dpc-1817	88	14	prevent	prevent	VERB
dpc-1817	88	15	the	the	DET
dpc-1817	88	16	spread	spread	NOUN
dpc-1817	88	17	of	of	ADP
dpc-1817	88	18	the	the	DET
dpc-1817	88	19	virus	virus	NOUN
dpc-1817	88	20	by	by	ADP
dpc-1817	88	21	turkish	turkish	ADJ
dpc-1817	88	22	authorities	authority	NOUN
dpc-1817	88	23	,	,	PUNCT
dpc-1817	88	24	however	however	ADV
dpc-1817	88	25	,	,	PUNCT
dpc-1817	88	26	hospital	hospital	NOUN
dpc-1817	88	27	admissions	admission	NOUN
dpc-1817	88	28	were	be	AUX
dpc-1817	88	29	exempted	exempt	VERB
dpc-1817	88	30	.	.	PUNCT
dpc-1817	89	1	these	these	DET
dpc-1817	89	2	restrictions	restriction	NOUN
dpc-1817	89	3	were	be	AUX
dpc-1817	89	4	thought	think	VERB
dpc-1817	89	5	to	to	PART
dpc-1817	89	6	not	not	PART
dpc-1817	89	7	affect	affect	VERB
dpc-1817	89	8	the	the	DET
dpc-1817	89	9	admissions	admission	NOUN
dpc-1817	89	10	of	of	ADP
dpc-1817	89	11	acne	acne	NOUN
dpc-1817	89	12	patients	patient	NOUN
dpc-1817	89	13	.	.	PUNCT
dpc-1817	90	1	while	while	SCONJ
dpc-1817	90	2	the	the	DET
dpc-1817	90	3	rate	rate	NOUN
dpc-1817	90	4	of	of	ADP
dpc-1817	90	5	acne	acne	NOUN
dpc-1817	90	6	patients	patient	NOUN
dpc-1817	90	7	admitted	admit	VERB
dpc-1817	90	8	for	for	ADP
dpc-1817	90	9	their	their	PRON
dpc-1817	90	10	first	first	ADJ
dpc-1817	90	11	visit	visit	NOUN
dpc-1817	90	12	was	be	AUX
dpc-1817	90	13	significantly	significantly	ADV
dpc-1817	90	14	low	low	ADJ
dpc-1817	90	15	in	in	ADP
dpc-1817	90	16	pandemic	pandemic	ADJ
dpc-1817	90	17	period	period	NOUN
dpc-1817	90	18	,	,	PUNCT
dpc-1817	90	19	the	the	DET
dpc-1817	90	20	rate	rate	NOUN
dpc-1817	90	21	of	of	ADP
dpc-1817	90	22	patients	patient	NOUN
dpc-1817	90	23	who	who	PRON
dpc-1817	90	24	were	be	AUX
dpc-1817	90	25	admitted	admit	VERB
dpc-1817	90	26	for	for	ADP
dpc-1817	90	27	follow	follow	VERB
dpc-1817	90	28	-	-	PUNCT
dpc-1817	90	29	up	up	ADP
dpc-1817	90	30	visits	visit	NOUN
dpc-1817	90	31	was	be	AUX
dpc-1817	90	32	significantly	significantly	ADV
dpc-1817	90	33	higher	high	ADJ
dpc-1817	90	34	.	.	PUNCT
dpc-1817	91	1	this	this	PRON
dpc-1817	91	2	is	be	AUX
dpc-1817	91	3	probably	probably	ADV
dpc-1817	91	4	as	as	ADP
dpc-1817	91	5	a	a	DET
dpc-1817	91	6	result	result	NOUN
dpc-1817	91	7	of	of	ADP
dpc-1817	91	8	avoidance	avoidance	NOUN
dpc-1817	91	9	of	of	ADP
dpc-1817	91	10	hospital	hospital	NOUN
dpc-1817	91	11	visits	visit	NOUN
dpc-1817	91	12	due	due	ADP
dpc-1817	91	13	to	to	ADP
dpc-1817	91	14	non	non	ADJ
dpc-1817	91	15	-	-	ADJ
dpc-1817	91	16	emergent	emergent	ADJ
dpc-1817	91	17	conditions	condition	NOUN
dpc-1817	91	18	during	during	ADP
dpc-1817	91	19	the	the	DET
dpc-1817	91	20	pandemic	pandemic	ADJ
dpc-1817	91	21	period	period	NOUN
dpc-1817	91	22	and	and	CCONJ
dpc-1817	91	23	high	high	ADJ
dpc-1817	91	24	treatment	treatment	NOUN
dpc-1817	91	25	compliance	compliance	NOUN
dpc-1817	91	26	rate	rate	NOUN
dpc-1817	91	27	of	of	ADP
dpc-1817	91	28	our	our	PRON
dpc-1817	91	29	patient	patient	ADJ
dpc-1817	91	30	population	population	NOUN
dpc-1817	91	31	.	.	PUNCT
dpc-1817	92	1	theoretically	theoretically	ADV
dpc-1817	92	2	,	,	PUNCT
dpc-1817	92	3	isotretinoin	isotretinoin	PROPN
dpc-1817	92	4	treatment	treatment	NOUN
dpc-1817	92	5	may	may	AUX
dpc-1817	92	6	cause	cause	VERB
dpc-1817	92	7	disruption	disruption	NOUN
dpc-1817	92	8	of	of	ADP
dpc-1817	92	9	the	the	DET
dpc-1817	92	10	basement	basement	NOUN
dpc-1817	92	11	membrane	membrane	NOUN
dpc-1817	92	12	of	of	ADP
dpc-1817	92	13	the	the	DET
dpc-1817	92	14	mucosal	mucosal	NOUN
dpc-1817	92	15	surfaces	surface	NOUN
dpc-1817	92	16	by	by	ADP
dpc-1817	92	17	causing	cause	VERB
dpc-1817	92	18	mucosal	mucosal	ADJ
dpc-1817	92	19	dryness	dryness	NOUN
dpc-1817	92	20	and	and	CCONJ
dpc-1817	92	21	thinning	thinning	NOUN
dpc-1817	92	22	.	.	PUNCT
dpc-1817	93	1	this	this	PRON
dpc-1817	93	2	,	,	PUNCT
dpc-1817	93	3	hypothetically	hypothetically	ADV
dpc-1817	93	4	,	,	PUNCT
dpc-1817	93	5	can	can	AUX
dpc-1817	93	6	increase	increase	VERB
dpc-1817	93	7	the	the	DET
dpc-1817	93	8	risk	risk	NOUN
dpc-1817	93	9	of	of	ADP
dpc-1817	93	10	covid-19	covid-19	PROPN
dpc-1817	93	11	transmission	transmission	NOUN
dpc-1817	93	12	[	[	X
dpc-1817	93	13	9	9	NUM
dpc-1817	93	14	]	]	PUNCT
dpc-1817	93	15	.	.	PUNCT
dpc-1817	94	1	there	there	PRON
dpc-1817	94	2	is	be	VERB
dpc-1817	94	3	no	no	DET
dpc-1817	94	4	established	establish	VERB
dpc-1817	94	5	guideline	guideline	NOUN
dpc-1817	94	6	regarding	regard	VERB
dpc-1817	94	7	the	the	DET
dpc-1817	94	8	use	use	NOUN
dpc-1817	94	9	of	of	ADP
dpc-1817	94	10	isotretinoin	isotretinoin	PROPN
dpc-1817	94	11	during	during	ADP
dpc-1817	94	12	the	the	DET
dpc-1817	94	13	pandemic	pandemic	ADJ
dpc-1817	94	14	period	period	NOUN
dpc-1817	94	15	.	.	PUNCT
dpc-1817	95	1	in	in	ADP
dpc-1817	95	2	the	the	DET
dpc-1817	95	3	beginning	beginning	NOUN
dpc-1817	95	4	of	of	ADP
dpc-1817	95	5	the	the	DET
dpc-1817	95	6	pandemic	pandemic	ADJ
dpc-1817	95	7	british	british	PROPN
dpc-1817	95	8	association	association	PROPN
dpc-1817	95	9	of	of	ADP
dpc-1817	95	10	dermatologists	dermatologists	PROPN
dpc-1817	95	11	recommended	recommend	VERB
dpc-1817	95	12	starting	starting	NOUN
dpc-1817	95	13	or	or	CCONJ
dpc-1817	95	14	continuing	continue	VERB
dpc-1817	95	15	oral	oral	ADJ
dpc-1817	95	16	isotretinoin	isotretinoin	PROPN
dpc-1817	95	17	treatment	treatment	NOUN
dpc-1817	95	18	where	where	SCONJ
dpc-1817	95	19	the	the	DET
dpc-1817	95	20	risks	risk	NOUN
dpc-1817	95	21	are	be	AUX
dpc-1817	95	22	outweighed	outweigh	VERB
dpc-1817	95	23	by	by	ADP
dpc-1817	95	24	the	the	DET
dpc-1817	95	25	benefits	benefit	NOUN
dpc-1817	95	26	with	with	ADP
dpc-1817	95	27	monthly	monthly	ADJ
dpc-1817	95	28	follow	follow	NOUN
dpc-1817	95	29	-	-	PUNCT
dpc-1817	95	30	up	up	NOUN
dpc-1817	95	31	[	[	X
dpc-1817	95	32	10	10	NUM
dpc-1817	95	33	]	]	PUNCT
dpc-1817	95	34	.	.	PUNCT
dpc-1817	96	1	according	accord	VERB
dpc-1817	96	2	to	to	ADP
dpc-1817	96	3	this	this	DET
dpc-1817	96	4	statement	statement	NOUN
dpc-1817	96	5	,	,	PUNCT
dpc-1817	96	6	if	if	SCONJ
dpc-1817	96	7	there	there	PRON
dpc-1817	96	8	is	be	VERB
dpc-1817	96	9	no	no	DET
dpc-1817	96	10	risk	risk	NOUN
dpc-1817	96	11	of	of	ADP
dpc-1817	96	12	pregnancy	pregnancy	NOUN
dpc-1817	96	13	,	,	PUNCT
dpc-1817	96	14	the	the	DET
dpc-1817	96	15	prescriptions	prescription	NOUN
dpc-1817	96	16	for	for	ADP
dpc-1817	96	17	several	several	ADJ
dpc-1817	96	18	months	month	NOUN
dpc-1817	96	19	could	could	AUX
dpc-1817	96	20	be	be	AUX
dpc-1817	96	21	given	give	VERB
dpc-1817	96	22	taking	take	VERB
dpc-1817	96	23	into	into	ADP
dpc-1817	96	24	account	account	NOUN
dpc-1817	96	25	the	the	DET
dpc-1817	96	26	need	need	NOUN
dpc-1817	96	27	to	to	PART
dpc-1817	96	28	monitor	monitor	VERB
dpc-1817	96	29	blood	blood	NOUN
dpc-1817	96	30	test	test	NOUN
dpc-1817	96	31	and	and	CCONJ
dpc-1817	96	32	side	side	NOUN
dpc-1817	96	33	effects	effect	NOUN
dpc-1817	96	34	with	with	ADP
dpc-1817	96	35	remote	remote	ADJ
dpc-1817	96	36	consultations	consultation	NOUN
dpc-1817	96	37	.	.	PUNCT
dpc-1817	97	1	in	in	ADP
dpc-1817	97	2	situations	situation	NOUN
dpc-1817	97	3	where	where	SCONJ
dpc-1817	97	4	it	it	PRON
dpc-1817	97	5	is	be	AUX
dpc-1817	97	6	not	not	PART
dpc-1817	97	7	possible	possible	ADJ
dpc-1817	97	8	to	to	PART
dpc-1817	97	9	perform	perform	VERB
dpc-1817	97	10	monthly	monthly	ADJ
dpc-1817	97	11	pregnancy	pregnancy	NOUN
dpc-1817	97	12	tests	test	NOUN
dpc-1817	97	13	,	,	PUNCT
dpc-1817	97	14	home	home	NOUN
dpc-1817	97	15	pregnancy	pregnancy	NOUN
dpc-1817	97	16	tests	test	NOUN
dpc-1817	97	17	are	be	AUX
dpc-1817	97	18	recommended	recommend	VERB
dpc-1817	97	19	as	as	ADP
dpc-1817	97	20	a	a	DET
dpc-1817	97	21	suitable	suitable	ADJ
dpc-1817	97	22	alternative	alternative	NOUN
dpc-1817	97	23	[	[	X
dpc-1817	97	24	11	11	NUM
dpc-1817	97	25	]	]	PUNCT
dpc-1817	97	26	.	.	PUNCT
dpc-1817	98	1	with	with	ADP
dpc-1817	98	2	the	the	DET
dpc-1817	98	3	rapid	rapid	ADJ
dpc-1817	98	4	growth	growth	NOUN
dpc-1817	98	5	of	of	ADP
dpc-1817	98	6	teledermatology	teledermatology	NOUN
dpc-1817	98	7	,	,	PUNCT
dpc-1817	98	8	these	these	DET
dpc-1817	98	9	recommendations	recommendation	NOUN
dpc-1817	98	10	have	have	AUX
dpc-1817	98	11	been	be	AUX
dpc-1817	98	12	practiced	practice	VERB
dpc-1817	98	13	and	and	CCONJ
dpc-1817	98	14	the	the	DET
dpc-1817	98	15	patients	patient	NOUN
dpc-1817	98	16	were	be	AUX
dpc-1817	98	17	able	able	ADJ
dpc-1817	98	18	get	get	VERB
dpc-1817	98	19	their	their	PRON
dpc-1817	98	20	prescriptions	prescription	NOUN
dpc-1817	98	21	instead	instead	ADV
dpc-1817	98	22	of	of	ADP
dpc-1817	98	23	in	in	ADP
dpc-1817	98	24	-	-	PUNCT
dpc-1817	98	25	person	person	NOUN
dpc-1817	98	26	visits	visit	NOUN
dpc-1817	98	27	[	[	X
dpc-1817	98	28	2	2	NUM
dpc-1817	98	29	]	]	PUNCT
dpc-1817	98	30	.	.	PUNCT
dpc-1817	99	1	a	a	DET
dpc-1817	99	2	recent	recent	ADJ
dpc-1817	99	3	study	study	NOUN
dpc-1817	99	4	by	by	ADP
dpc-1817	99	5	ruggiero	ruggiero	PROPN
dpc-1817	99	6	et	et	PROPN
dpc-1817	99	7	al	al	PROPN
dpc-1817	99	8	reported	report	VERB
dpc-1817	99	9	high	high	ADJ
dpc-1817	99	10	degree	degree	NOUN
dpc-1817	99	11	of	of	ADP
dpc-1817	99	12	satisfaction	satisfaction	NOUN
dpc-1817	99	13	and	and	CCONJ
dpc-1817	99	14	well	well	ADV
dpc-1817	99	15	-	-	PUNCT
dpc-1817	99	16	being	being	NOUN
dpc-1817	99	17	after	after	ADP
dpc-1817	99	18	teledermatology	teledermatology	NOUN
dpc-1817	99	19	visits	visit	NOUN
dpc-1817	99	20	[	[	X
dpc-1817	99	21	12	12	NUM
dpc-1817	99	22	]	]	PUNCT
dpc-1817	99	23	.	.	PUNCT
dpc-1817	100	1	between	between	ADP
dpc-1817	100	2	the	the	DET
dpc-1817	100	3	pandemic	pandemic	ADJ
dpc-1817	100	4	and	and	CCONJ
dpc-1817	100	5	non	non	ADJ
dpc-1817	100	6	-	-	ADJ
dpc-1817	100	7	pandemic	pandemic	ADJ
dpc-1817	100	8	periods	period	NOUN
dpc-1817	100	9	,	,	PUNCT
dpc-1817	100	10	there	there	PRON
dpc-1817	100	11	was	be	VERB
dpc-1817	100	12	no	no	DET
dpc-1817	100	13	significant	significant	ADJ
dpc-1817	100	14	difference	difference	NOUN
dpc-1817	100	15	in	in	ADP
dpc-1817	100	16	the	the	DET
dpc-1817	100	17	rate	rate	NOUN
dpc-1817	100	18	of	of	ADP
dpc-1817	100	19	starting	start	VERB
dpc-1817	100	20	systemic	systemic	ADJ
dpc-1817	100	21	treatment	treatment	NOUN
dpc-1817	100	22	for	for	ADP
dpc-1817	100	23	acne	acne	NOUN
dpc-1817	100	24	patients	patient	NOUN
dpc-1817	100	25	who	who	PRON
dpc-1817	100	26	were	be	AUX
dpc-1817	100	27	admitted	admit	VERB
dpc-1817	100	28	for	for	ADP
dpc-1817	100	29	their	their	PRON
dpc-1817	100	30	first	first	ADJ
dpc-1817	100	31	visit	visit	NOUN
dpc-1817	100	32	.	.	PUNCT
dpc-1817	101	1	additionally	additionally	ADV
dpc-1817	101	2	,	,	PUNCT
dpc-1817	101	3	the	the	DET
dpc-1817	101	4	percentage	percentage	NOUN
dpc-1817	101	5	of	of	ADP
dpc-1817	101	6	patients	patient	NOUN
dpc-1817	101	7	using	use	VERB
dpc-1817	101	8	isotretinoin	isotretinoin	PROPN
dpc-1817	101	9	during	during	ADP
dpc-1817	101	10	pandemic	pandemic	ADJ
dpc-1817	101	11	period	period	NOUN
dpc-1817	101	12	was	be	AUX
dpc-1817	101	13	significantly	significantly	ADV
dpc-1817	101	14	higher	high	ADJ
dpc-1817	101	15	compared	compare	VERB
dpc-1817	101	16	to	to	ADP
dpc-1817	101	17	non	non	ADJ
dpc-1817	101	18	-	-	ADJ
dpc-1817	101	19	pandemic	pandemic	ADJ
dpc-1817	101	20	period	period	NOUN
dpc-1817	101	21	.	.	PUNCT
dpc-1817	102	1	this	this	PRON
dpc-1817	102	2	was	be	AUX
dpc-1817	102	3	due	due	ADJ
dpc-1817	102	4	to	to	ADP
dpc-1817	102	5	a	a	DET
dpc-1817	102	6	relative	relative	ADJ
dpc-1817	102	7	increase	increase	NOUN
dpc-1817	102	8	of	of	ADP
dpc-1817	102	9	the	the	DET
dpc-1817	102	10	number	number	NOUN
dpc-1817	102	11	of	of	ADP
dpc-1817	102	12	patients	patient	NOUN
dpc-1817	102	13	who	who	PRON
dpc-1817	102	14	were	be	AUX
dpc-1817	102	15	followed	follow	VERB
dpc-1817	102	16	-	-	PUNCT
dpc-1817	102	17	up	up	NOUN
dpc-1817	102	18	with	with	ADP
dpc-1817	102	19	their	their	PRON
dpc-1817	102	20	current	current	ADJ
dpc-1817	102	21	isotretinoin	isotretinoin	PROPN
dpc-1817	102	22	treatment	treatment	NOUN
dpc-1817	102	23	.	.	PUNCT
dpc-1817	103	1	in	in	ADP
dpc-1817	103	2	our	our	PRON
dpc-1817	103	3	clinic	clinic	NOUN
dpc-1817	103	4	,	,	PUNCT
dpc-1817	103	5	isotretinoin	isotretinoin	PROPN
dpc-1817	103	6	therapy	therapy	NOUN
dpc-1817	103	7	was	be	AUX
dpc-1817	103	8	not	not	PART
dpc-1817	103	9	avoided	avoid	VERB
dpc-1817	103	10	during	during	ADP
dpc-1817	103	11	the	the	DET
dpc-1817	103	12	pandemic	pandemic	ADJ
dpc-1817	103	13	period	period	NOUN
dpc-1817	103	14	.	.	PUNCT
dpc-1817	104	1	isotretinoin	isotretinoin	PROPN
dpc-1817	104	2	treatment	treatment	NOUN
dpc-1817	104	3	needs	need	VERB
dpc-1817	104	4	to	to	PART
dpc-1817	104	5	be	be	AUX
dpc-1817	104	6	monitored	monitor	VERB
dpc-1817	104	7	in	in	ADP
dpc-1817	104	8	terms	term	NOUN
dpc-1817	104	9	of	of	ADP
dpc-1817	104	10	both	both	DET
dpc-1817	104	11	teratogenesis	teratogenesis	NOUN
dpc-1817	104	12	and	and	CCONJ
dpc-1817	104	13	bone	bone	NOUN
dpc-1817	104	14	marrow	marrow	NOUN
dpc-1817	104	15	and	and	CCONJ
dpc-1817	104	16	metabolic	metabolic	NOUN
dpc-1817	104	17	side	side	NOUN
dpc-1817	104	18	effects	effect	NOUN
dpc-1817	104	19	(	(	PUNCT
dpc-1817	104	20	leukopenia	leukopenia	NOUN
dpc-1817	104	21	,	,	PUNCT
dpc-1817	104	22	hypertriglyceridemia	hypertriglyceridemia	NOUN
dpc-1817	104	23	,	,	PUNCT
dpc-1817	104	24	liver	liver	NOUN
dpc-1817	104	25	enzyme	enzyme	NOUN
dpc-1817	104	26	abnormalities	abnormality	NOUN
dpc-1817	104	27	)	)	PUNCT
dpc-1817	105	1	[	[	X
dpc-1817	105	2	14,15	14,15	NUM
dpc-1817	105	3	]	]	PUNCT
dpc-1817	105	4	)	)	PUNCT
dpc-1817	105	5	.	.	PUNCT
dpc-1817	106	1	although	although	SCONJ
dpc-1817	106	2	there	there	PRON
dpc-1817	106	3	are	be	VERB
dpc-1817	106	4	many	many	ADJ
dpc-1817	106	5	studies	study	NOUN
dpc-1817	106	6	that	that	SCONJ
dpc-1817	106	7	original	original	ADJ
dpc-1817	106	8	article	article	NOUN
dpc-1817	106	9	|	|	ADV
dpc-1817	106	10	dermatol	dermatol	ADJ
dpc-1817	106	11	pract	pract	NOUN
dpc-1817	106	12	concept	concept	NOUN
dpc-1817	106	13	.	.	PUNCT
dpc-1817	107	1	2022;12(1):e2022036	2022;12(1):e2022036	NUM
dpc-1817	107	2	5	5	NUM
dpc-1817	107	3	do	do	AUX
dpc-1817	107	4	not	not	PART
dpc-1817	107	5	support	support	VERB
dpc-1817	107	6	monthly	monthly	ADJ
dpc-1817	107	7	laboratory	laboratory	NOUN
dpc-1817	107	8	testing	testing	NOUN
dpc-1817	107	9	for	for	ADP
dpc-1817	107	10	isotretinoin	isotretinoin	PROPN
dpc-1817	108	1	[	[	X
dpc-1817	108	2	15	15	NUM
dpc-1817	108	3	]	]	X
dpc-1817	108	4	,	,	PUNCT
dpc-1817	108	5	there	there	PRON
dpc-1817	108	6	are	be	VERB
dpc-1817	108	7	many	many	ADJ
dpc-1817	108	8	centers	center	NOUN
dpc-1817	108	9	that	that	PRON
dpc-1817	108	10	apply	apply	VERB
dpc-1817	108	11	monthly	monthly	ADJ
dpc-1817	108	12	laboratory	laboratory	NOUN
dpc-1817	108	13	follow	follow	NOUN
dpc-1817	108	14	-	-	PUNCT
dpc-1817	108	15	up	up	NOUN
dpc-1817	108	16	in	in	ADP
dpc-1817	108	17	clinical	clinical	ADJ
dpc-1817	108	18	practice	practice	NOUN
dpc-1817	108	19	,	,	PUNCT
dpc-1817	108	20	especially	especially	ADV
dpc-1817	108	21	in	in	ADP
dpc-1817	108	22	terms	term	NOUN
dpc-1817	108	23	of	of	ADP
dpc-1817	108	24	teratogenicity	teratogenicity	NOUN
dpc-1817	108	25	[	[	X
dpc-1817	108	26	16	16	NUM
dpc-1817	108	27	]	]	PUNCT
dpc-1817	108	28	.	.	PUNCT
dpc-1817	109	1	monthly	monthly	ADJ
dpc-1817	109	2	laboratory	laboratory	NOUN
dpc-1817	109	3	monitoring	monitoring	NOUN
dpc-1817	109	4	is	be	AUX
dpc-1817	109	5	also	also	ADV
dpc-1817	109	6	a	a	DET
dpc-1817	109	7	common	common	ADJ
dpc-1817	109	8	practice	practice	NOUN
dpc-1817	109	9	among	among	ADP
dpc-1817	109	10	physicians	physician	NOUN
dpc-1817	109	11	in	in	ADP
dpc-1817	109	12	our	our	PRON
dpc-1817	109	13	clinic	clinic	NOUN
dpc-1817	109	14	.	.	PUNCT
dpc-1817	110	1	when	when	SCONJ
dpc-1817	110	2	we	we	PRON
dpc-1817	110	3	compared	compare	VERB
dpc-1817	110	4	the	the	DET
dpc-1817	110	5	monthly	monthly	ADJ
dpc-1817	110	6	follow	follow	NOUN
dpc-1817	110	7	-	-	PUNCT
dpc-1817	110	8	up	up	NOUN
dpc-1817	110	9	to	to	ADP
dpc-1817	110	10	in	in	ADP
dpc-1817	110	11	every	every	DET
dpc-1817	110	12	two	two	NUM
dpc-1817	110	13	or	or	CCONJ
dpc-1817	110	14	more	more	ADJ
dpc-1817	110	15	-	-	PUNCT
dpc-1817	110	16	month	month	NOUN
dpc-1817	110	17	follow	follow	NOUN
dpc-1817	110	18	-	-	PUNCT
dpc-1817	110	19	up	up	ADP
dpc-1817	110	20	rate	rate	NOUN
dpc-1817	110	21	between	between	ADP
dpc-1817	110	22	the	the	DET
dpc-1817	110	23	2	2	NUM
dpc-1817	110	24	groups	group	NOUN
dpc-1817	110	25	,	,	PUNCT
dpc-1817	110	26	in	in	ADP
dpc-1817	110	27	every	every	DET
dpc-1817	110	28	2	2	NUM
dpc-1817	110	29	or	or	CCONJ
dpc-1817	110	30	more	more	ADJ
dpc-1817	110	31	-	-	PUNCT
dpc-1817	110	32	month	month	NOUN
dpc-1817	110	33	follow	follow	NOUN
dpc-1817	110	34	-	-	PUNCT
dpc-1817	110	35	up	up	NOUN
dpc-1817	110	36	the	the	DET
dpc-1817	110	37	rate	rate	NOUN
dpc-1817	110	38	was	be	AUX
dpc-1817	110	39	higher	high	ADJ
dpc-1817	110	40	during	during	ADP
dpc-1817	110	41	the	the	DET
dpc-1817	110	42	pandemic	pandemic	ADJ
dpc-1817	110	43	period	period	NOUN
dpc-1817	110	44	.	.	PUNCT
dpc-1817	111	1	our	our	PRON
dpc-1817	111	2	retrospective	retrospective	ADJ
dpc-1817	111	3	analysis	analysis	NOUN
dpc-1817	111	4	showed	show	VERB
dpc-1817	111	5	that	that	SCONJ
dpc-1817	111	6	extended	extended	ADJ
dpc-1817	111	7	follow	follow	NOUN
dpc-1817	111	8	-	-	PUNCT
dpc-1817	111	9	up	up	ADP
dpc-1817	111	10	intervals	interval	NOUN
dpc-1817	111	11	showed	show	VERB
dpc-1817	111	12	no	no	DET
dpc-1817	111	13	significant	significant	ADJ
dpc-1817	111	14	difference	difference	NOUN
dpc-1817	111	15	for	for	ADP
dpc-1817	111	16	detecting	detect	VERB
dpc-1817	111	17	side	side	ADJ
dpc-1817	111	18	effects	effect	NOUN
dpc-1817	111	19	of	of	ADP
dpc-1817	111	20	isotretinoin	isotretinoin	PROPN
dpc-1817	111	21	.	.	PUNCT
dpc-1817	112	1	additionally	additionally	ADV
dpc-1817	112	2	,	,	PUNCT
dpc-1817	112	3	the	the	DET
dpc-1817	112	4	reported	report	VERB
dpc-1817	112	5	side	side	NOUN
dpc-1817	112	6	effect	effect	NOUN
dpc-1817	112	7	rate	rate	NOUN
dpc-1817	112	8	was	be	AUX
dpc-1817	112	9	significantly	significantly	ADV
dpc-1817	112	10	lower	low	ADJ
dpc-1817	112	11	during	during	ADP
dpc-1817	112	12	the	the	DET
dpc-1817	112	13	pandemic	pandemic	ADJ
dpc-1817	112	14	period	period	NOUN
dpc-1817	112	15	.	.	PUNCT
dpc-1817	113	1	this	this	PRON
dpc-1817	113	2	might	might	AUX
dpc-1817	113	3	be	be	AUX
dpc-1817	113	4	due	due	ADJ
dpc-1817	113	5	to	to	ADP
dpc-1817	113	6	the	the	DET
dpc-1817	113	7	lock	lock	NOUN
dpc-1817	113	8	-	-	PUNCT
dpc-1817	113	9	down	down	NOUN
dpc-1817	113	10	and	and	CCONJ
dpc-1817	113	11	increased	increase	VERB
dpc-1817	113	12	use	use	NOUN
dpc-1817	113	13	of	of	ADP
dpc-1817	113	14	skin	skin	NOUN
dpc-1817	113	15	care	care	NOUN
dpc-1817	113	16	products	product	NOUN
dpc-1817	113	17	due	due	ADP
dpc-1817	113	18	to	to	ADP
dpc-1817	113	19	easy	easy	ADJ
dpc-1817	113	20	accessibility	accessibility	NOUN
dpc-1817	113	21	to	to	ADP
dpc-1817	113	22	emollients	emollient	NOUN
dpc-1817	113	23	and	and	CCONJ
dpc-1817	113	24	other	other	ADJ
dpc-1817	113	25	protective	protective	ADJ
dpc-1817	113	26	measures	measure	NOUN
dpc-1817	113	27	.	.	PUNCT
dpc-1817	114	1	in	in	ADP
dpc-1817	114	2	the	the	DET
dpc-1817	114	3	4	4	NUM
dpc-1817	114	4	-	-	PUNCT
dpc-1817	114	5	month	month	NOUN
dpc-1817	114	6	follow	follow	NOUN
dpc-1817	114	7	-	-	PUNCT
dpc-1817	114	8	up	up	NOUN
dpc-1817	114	9	,	,	PUNCT
dpc-1817	114	10	only	only	ADV
dpc-1817	114	11	one	one	NUM
dpc-1817	114	12	patient	patient	NOUN
dpc-1817	114	13	under	under	ADP
dpc-1817	114	14	isotretinoin	isotretinoin	PROPN
dpc-1817	114	15	treatment	treatment	NOUN
dpc-1817	114	16	had	have	VERB
dpc-1817	114	17	a	a	DET
dpc-1817	114	18	positive	positive	ADJ
dpc-1817	114	19	sars	sar	NOUN
dpc-1817	114	20	-	-	PUNCT
dpc-1817	114	21	cov-2	cov-2	NOUN
dpc-1817	114	22	pcr	pcr	ADJ
dpc-1817	114	23	result	result	NOUN
dpc-1817	114	24	and	and	CCONJ
dpc-1817	114	25	she	she	PRON
dpc-1817	114	26	showed	show	VERB
dpc-1817	114	27	only	only	ADV
dpc-1817	114	28	mild	mild	ADJ
dpc-1817	114	29	upper	upper	ADJ
dpc-1817	114	30	respiratory	respiratory	ADJ
dpc-1817	114	31	tract	tract	NOUN
dpc-1817	114	32	infection	infection	NOUN
dpc-1817	114	33	symptoms	symptom	NOUN
dpc-1817	114	34	.	.	PUNCT
dpc-1817	115	1	thus	thus	ADV
dpc-1817	115	2	,	,	PUNCT
dpc-1817	115	3	isotretinoin	isotretinoin	PROPN
dpc-1817	115	4	treatment	treatment	NOUN
dpc-1817	115	5	seems	seem	VERB
dpc-1817	115	6	efficacious	efficacious	ADJ
dpc-1817	115	7	and	and	CCONJ
dpc-1817	115	8	safe	safe	ADJ
dpc-1817	115	9	during	during	ADP
dpc-1817	115	10	pandemic	pandemic	ADJ
dpc-1817	115	11	.	.	PUNCT
dpc-1817	116	1	we	we	PRON
dpc-1817	116	2	recommend	recommend	VERB
dpc-1817	116	3	extended	extend	VERB
dpc-1817	116	4	intermittent	intermittent	ADJ
dpc-1817	116	5	laboratory	laboratory	NOUN
dpc-1817	116	6	follow	follow	NOUN
dpc-1817	116	7	-	-	PUNCT
dpc-1817	116	8	up	up	NOUN
dpc-1817	116	9	to	to	PART
dpc-1817	116	10	reduce	reduce	VERB
dpc-1817	116	11	the	the	DET
dpc-1817	116	12	risk	risk	NOUN
dpc-1817	116	13	of	of	ADP
dpc-1817	116	14	sars	sar	NOUN
dpc-1817	116	15	-	-	PUNCT
dpc-1817	116	16	cov-2	cov-2	NOUN
dpc-1817	116	17	transmission	transmission	NOUN
dpc-1817	116	18	,	,	PUNCT
dpc-1817	116	19	however	however	ADV
dpc-1817	116	20	further	far	ADV
dpc-1817	116	21	large	large	ADJ
dpc-1817	116	22	cohort	cohort	NOUN
dpc-1817	116	23	studies	study	NOUN
dpc-1817	116	24	are	be	AUX
dpc-1817	116	25	required	require	VERB
dpc-1817	116	26	to	to	PART
dpc-1817	116	27	elaborate	elaborate	VERB
dpc-1817	116	28	the	the	DET
dpc-1817	116	29	risks	risk	NOUN
dpc-1817	116	30	.	.	PUNCT
dpc-1817	117	1	acne	acne	NOUN
dpc-1817	117	2	patients	patient	NOUN
dpc-1817	117	3	constitutes	constitute	VERB
dpc-1817	117	4	an	an	DET
dpc-1817	117	5	important	important	ADJ
dpc-1817	117	6	part	part	NOUN
dpc-1817	117	7	of	of	ADP
dpc-1817	117	8	dermatology	dermatology	NOUN
dpc-1817	117	9	outpatient	outpatient	NOUN
dpc-1817	117	10	clinics	clinic	NOUN
dpc-1817	117	11	.	.	PUNCT
dpc-1817	118	1	the	the	DET
dpc-1817	118	2	proportion	proportion	NOUN
dpc-1817	118	3	of	of	ADP
dpc-1817	118	4	acne	acne	NOUN
dpc-1817	118	5	patients	patient	NOUN
dpc-1817	118	6	was	be	AUX
dpc-1817	118	7	observed	observe	VERB
dpc-1817	118	8	as	as	ADP
dpc-1817	118	9	significantly	significantly	ADV
dpc-1817	118	10	higher	high	ADJ
dpc-1817	118	11	during	during	ADP
dpc-1817	118	12	the	the	DET
dpc-1817	118	13	pandemic	pandemic	ADJ
dpc-1817	118	14	period	period	NOUN
dpc-1817	118	15	.	.	PUNCT
dpc-1817	119	1	this	this	PRON
dpc-1817	119	2	most	most	ADV
dpc-1817	119	3	likely	likely	ADV
dpc-1817	119	4	reflects	reflect	VERB
dpc-1817	119	5	young	young	ADJ
dpc-1817	119	6	individuals	individual	NOUN
dpc-1817	119	7	seek	seek	VERB
dpc-1817	119	8	for	for	ADP
dpc-1817	119	9	more	more	ADJ
dpc-1817	119	10	care	care	NOUN
dpc-1817	119	11	due	due	ADP
dpc-1817	119	12	to	to	ADP
dpc-1817	119	13	psychosocial	psychosocial	ADJ
dpc-1817	119	14	effects	effect	NOUN
dpc-1817	119	15	of	of	ADP
dpc-1817	119	16	the	the	DET
dpc-1817	119	17	disease	disease	NOUN
dpc-1817	119	18	and	and	CCONJ
dpc-1817	119	19	less	less	ADJ
dpc-1817	119	20	fear	fear	NOUN
dpc-1817	119	21	of	of	ADP
dpc-1817	119	22	infection	infection	NOUN
dpc-1817	119	23	by	by	ADP
dpc-1817	119	24	sars	sar	NOUN
dpc-1817	119	25	-	-	PUNCT
dpc-1817	119	26	cov-2	cov-2	NOUN
dpc-1817	119	27	.	.	PUNCT
dpc-1817	120	1	another	another	DET
dpc-1817	120	2	reason	reason	NOUN
dpc-1817	120	3	for	for	ADP
dpc-1817	120	4	increased	increased	ADJ
dpc-1817	120	5	percentage	percentage	NOUN
dpc-1817	120	6	of	of	ADP
dpc-1817	120	7	acne	acne	NOUN
dpc-1817	120	8	patients	patient	NOUN
dpc-1817	120	9	is	be	AUX
dpc-1817	120	10	intense	intense	ADJ
dpc-1817	120	11	use	use	NOUN
dpc-1817	120	12	of	of	ADP
dpc-1817	120	13	masks	mask	NOUN
dpc-1817	120	14	,	,	PUNCT
dpc-1817	120	15	causing	cause	VERB
dpc-1817	120	16	increased	increase	VERB
dpc-1817	120	17	prevalence	prevalence	NOUN
dpc-1817	120	18	of	of	ADP
dpc-1817	120	19	‘	'	PUNCT
dpc-1817	120	20	mask	mask	NOUN
dpc-1817	120	21	acne	acne	NOUN
dpc-1817	120	22	’	'	PUNCT
dpc-1817	120	23	,	,	PUNCT
dpc-1817	120	24	likely	likely	ADJ
dpc-1817	120	25	result	result	NOUN
dpc-1817	120	26	of	of	ADP
dpc-1817	120	27	increased	increase	VERB
dpc-1817	120	28	usage	usage	NOUN
dpc-1817	120	29	of	of	ADP
dpc-1817	120	30	personal	personal	ADJ
dpc-1817	120	31	protective	protective	ADJ
dpc-1817	120	32	equipment	equipment	NOUN
dpc-1817	120	33	with	with	ADP
dpc-1817	120	34	the	the	DET
dpc-1817	120	35	current	current	ADJ
dpc-1817	120	36	pandemic	pandemic	NOUN
dpc-1817	120	37	.	.	PUNCT
dpc-1817	121	1	during	during	ADP
dpc-1817	121	2	pandemic	pandemic	ADJ
dpc-1817	121	3	period	period	NOUN
dpc-1817	121	4	,	,	PUNCT
dpc-1817	121	5	the	the	DET
dpc-1817	121	6	majority	majority	NOUN
dpc-1817	121	7	of	of	ADP
dpc-1817	121	8	acne	acne	NOUN
dpc-1817	121	9	patients	patient	NOUN
dpc-1817	121	10	was	be	AUX
dpc-1817	121	11	admitted	admit	VERB
dpc-1817	121	12	for	for	ADP
dpc-1817	121	13	follow	follow	NOUN
dpc-1817	121	14	-	-	PUNCT
dpc-1817	121	15	up	up	NOUN
dpc-1817	121	16	and	and	CCONJ
dpc-1817	121	17	physicians	physician	NOUN
dpc-1817	121	18	did	do	AUX
dpc-1817	121	19	not	not	PART
dpc-1817	121	20	avoid	avoid	VERB
dpc-1817	121	21	using	use	VERB
dpc-1817	121	22	isotretinoin	isotretinoin	PROPN
dpc-1817	121	23	treatment	treatment	NOUN
dpc-1817	121	24	in	in	ADP
dpc-1817	121	25	the	the	DET
dpc-1817	121	26	follow	follow	VERB
dpc-1817	121	27	-	-	PUNCT
dpc-1817	121	28	up	up	ADP
dpc-1817	121	29	patients	patient	NOUN
dpc-1817	121	30	.	.	PUNCT
dpc-1817	122	1	extended	extended	ADJ
dpc-1817	122	2	follow	follow	NOUN
dpc-1817	122	3	-	-	PUNCT
dpc-1817	122	4	up	up	ADP
dpc-1817	122	5	periods	period	NOUN
dpc-1817	122	6	were	be	AUX
dpc-1817	122	7	adopted	adopt	VERB
dpc-1817	122	8	by	by	ADP
dpc-1817	122	9	physicians	physician	NOUN
dpc-1817	122	10	and	and	CCONJ
dpc-1817	122	11	were	be	AUX
dpc-1817	122	12	found	find	VERB
dpc-1817	122	13	safe	safe	ADJ
dpc-1817	122	14	and	and	CCONJ
dpc-1817	122	15	effective	effective	ADJ
dpc-1817	122	16	in	in	ADP
dpc-1817	122	17	the	the	DET
dpc-1817	122	18	current	current	ADJ
dpc-1817	122	19	study	study	NOUN
dpc-1817	122	20	.	.	PUNCT
dpc-1817	123	1	thus	thus	ADV
dpc-1817	123	2	,	,	PUNCT
dpc-1817	123	3	isotretinoin	isotretinoin	PROPN
dpc-1817	123	4	treatment	treatment	NOUN
dpc-1817	123	5	seems	seem	VERB
dpc-1817	123	6	efficacious	efficacious	ADJ
dpc-1817	123	7	and	and	CCONJ
dpc-1817	123	8	safe	safe	ADJ
dpc-1817	123	9	during	during	ADP
dpc-1817	123	10	pandemic	pandemic	ADJ
dpc-1817	123	11	.	.	PUNCT
dpc-1817	124	1	references	reference	NOUN
dpc-1817	124	2	1	1	NUM
dpc-1817	124	3	.	.	PUNCT
dpc-1817	124	4	kutlu	kutlu	PROPN
dpc-1817	124	5	ö	ö	PROPN
dpc-1817	124	6	,	,	PUNCT
dpc-1817	124	7	güneş	güneş	NOUN
dpc-1817	124	8	r	r	PROPN
dpc-1817	124	9	,	,	PUNCT
dpc-1817	124	10	coerdt	coerdt	ADJ
dpc-1817	124	11	k	k	PROPN
dpc-1817	124	12	,	,	PUNCT
dpc-1817	124	13	metin	metin	PROPN
dpc-1817	124	14	a	a	X
dpc-1817	124	15	,	,	PUNCT
dpc-1817	124	16	khachemoune	khachemoune	NOUN
dpc-1817	124	17	a.	a.	NOUN
dpc-1817	124	18	the	the	DET
dpc-1817	124	19	effect	effect	NOUN
dpc-1817	124	20	of	of	ADP
dpc-1817	124	21	the	the	DET
dpc-1817	124	22	“	"	PUNCT
dpc-1817	124	23	stay	stay	VERB
dpc-1817	124	24	-	-	PUNCT
dpc-1817	124	25	at	at	ADP
dpc-1817	124	26	-	-	PUNCT
dpc-1817	124	27	home	home	NOUN
dpc-1817	124	28	”	"	PUNCT
dpc-1817	124	29	policy	policy	NOUN
dpc-1817	124	30	on	on	ADP
dpc-1817	124	31	requests	request	NOUN
dpc-1817	124	32	for	for	ADP
dpc-1817	124	33	dermatology	dermatology	NOUN
dpc-1817	124	34	outpatient	outpatient	NOUN
dpc-1817	124	35	clinic	clinic	NOUN
dpc-1817	124	36	visits	visit	NOUN
dpc-1817	124	37	after	after	ADP
dpc-1817	124	38	the	the	DET
dpc-1817	124	39	covid-19	covid-19	PROPN
dpc-1817	124	40	outbreak	outbreak	NOUN
dpc-1817	124	41	.	.	PUNCT
dpc-1817	125	1	dermatol	dermatol	NOUN
dpc-1817	125	2	ther	ther	ADV
dpc-1817	125	3	.	.	PUNCT
dpc-1817	126	1	2020;33(4):e13581	2020;33(4):e13581	NUM
dpc-1817	126	2	.	.	X
dpc-1817	126	3	doi	doi	NOUN
dpc-1817	126	4	:	:	PUNCT
dpc-1817	126	5	10.1111	10.1111	NUM
dpc-1817	126	6	/	/	SYM
dpc-1817	126	7	dth.13581	dth.13581	NUM
dpc-1817	126	8	.	.	PUNCT
dpc-1817	127	1	pmid	pmid	NOUN
dpc-1817	127	2	:	:	PUNCT
dpc-1817	127	3	32401401	32401401	NUM
dpc-1817	127	4	.	.	PUNCT
dpc-1817	128	1	pmcid	pmcid	NOUN
dpc-1817	128	2	:	:	PUNCT
dpc-1817	128	3	pmc7272831	pmc7272831	PROPN
dpc-1817	128	4	.	.	PUNCT
dpc-1817	129	1	2	2	X
dpc-1817	129	2	.	.	X
dpc-1817	129	3	sharma	sharma	PROPN
dpc-1817	129	4	a	a	PROPN
dpc-1817	129	5	,	,	PUNCT
dpc-1817	129	6	jindal	jindal	PROPN
dpc-1817	129	7	v	v	PROPN
dpc-1817	129	8	,	,	PUNCT
dpc-1817	129	9	singla	singla	PRON
dpc-1817	129	10	p	p	NOUN
dpc-1817	129	11	,	,	PUNCT
dpc-1817	129	12	goldust	goldust	PROPN
dpc-1817	129	13	m	m	PROPN
dpc-1817	129	14	,	,	PUNCT
dpc-1817	129	15	mhatre	mhatre	NOUN
dpc-1817	129	16	m.	m.	NOUN
dpc-1817	129	17	will	will	AUX
dpc-1817	129	18	teledermatology	teledermatology	NOUN
dpc-1817	129	19	be	be	AUX
dpc-1817	129	20	the	the	DET
dpc-1817	129	21	silver	silver	NOUN
dpc-1817	129	22	lining	lining	NOUN
dpc-1817	129	23	during	during	ADP
dpc-1817	129	24	and	and	CCONJ
dpc-1817	129	25	after	after	ADP
dpc-1817	129	26	covid-19	covid-19	PROPN
dpc-1817	129	27	?	?	PUNCT
dpc-1817	129	28	dermatol	dermatol	NOUN
dpc-1817	129	29	ther	ther	ADV
dpc-1817	129	30	.	.	PUNCT
dpc-1817	130	1	2020;33(4):e13643	2020;33(4):e13643	X
dpc-1817	130	2	.	.	PUNCT
dpc-1817	130	3	doi	doi	NOUN
dpc-1817	130	4	:	:	PUNCT
dpc-1817	130	5	10.1111	10.1111	NUM
dpc-1817	130	6	/	/	SYM
dpc-1817	130	7	dth.13643	dth.13643	PROPN
dpc-1817	130	8	.	.	PUNCT
dpc-1817	131	1	pmid	pmid	NOUN
dpc-1817	131	2	:	:	PUNCT
dpc-1817	131	3	32441373	32441373	NUM
dpc-1817	131	4	.	.	PUNCT
dpc-1817	132	1	pmcid	pmcid	ADJ
dpc-1817	132	2	:	:	PUNCT
dpc-1817	132	3	pmc7267127	pmc7267127	NOUN
dpc-1817	132	4	.	.	PUNCT
dpc-1817	133	1	3	3	X
dpc-1817	133	2	.	.	X
dpc-1817	133	3	alshiyab	alshiyab	PROPN
dpc-1817	133	4	dm	dm	PROPN
dpc-1817	133	5	,	,	PUNCT
dpc-1817	133	6	al	al	PROPN
dpc-1817	133	7	-	-	PUNCT
dpc-1817	133	8	qarqaz	qarqaz	X
dpc-1817	133	9	fa	fa	PROPN
dpc-1817	133	10	,	,	PUNCT
dpc-1817	133	11	muhaidat	muhaidat	PROPN
dpc-1817	133	12	jm	jm	PROPN
dpc-1817	133	13	.	.	PROPN
dpc-1817	133	14	impact	impact	NOUN
dpc-1817	133	15	of	of	ADP
dpc-1817	133	16	covid-19	covid-19	PROPN
dpc-1817	133	17	pandemic	pandemic	ADJ
dpc-1817	133	18	on	on	ADP
dpc-1817	133	19	the	the	DET
dpc-1817	133	20	continuity	continuity	NOUN
dpc-1817	133	21	of	of	ADP
dpc-1817	133	22	care	care	NOUN
dpc-1817	133	23	for	for	ADP
dpc-1817	133	24	dermatologic	dermatologic	ADJ
dpc-1817	133	25	patients	patient	NOUN
dpc-1817	133	26	on	on	ADP
dpc-1817	133	27	systemic	systemic	ADJ
dpc-1817	133	28	therapy	therapy	NOUN
dpc-1817	133	29	during	during	ADP
dpc-1817	133	30	the	the	DET
dpc-1817	133	31	period	period	NOUN
dpc-1817	133	32	of	of	ADP
dpc-1817	133	33	strict	strict	ADJ
dpc-1817	133	34	lockdown	lockdown	NOUN
dpc-1817	133	35	.	.	PUNCT
dpc-1817	134	1	ann	ann	PROPN
dpc-1817	134	2	med	med	PROPN
dpc-1817	134	3	surg	surg	PROPN
dpc-1817	134	4	(	(	PUNCT
dpc-1817	134	5	lond	lond	PROPN
dpc-1817	134	6	)	)	PUNCT
dpc-1817	134	7	.	.	PUNCT
dpc-1817	135	1	2020;60:571	2020;60:571	X
dpc-1817	135	2	-	-	SYM
dpc-1817	135	3	4	4	NUM
dpc-1817	135	4	.	.	PUNCT
dpc-1817	135	5	doi	doi	NOUN
dpc-1817	135	6	:	:	PUNCT
dpc-1817	135	7	10.1016	10.1016	NUM
dpc-1817	135	8	/	/	SYM
dpc-1817	135	9	j.amsu.2020.11.056	j.amsu.2020.11.056	PROPN
dpc-1817	135	10	.	.	PUNCT
dpc-1817	136	1	pmid	pmid	NOUN
dpc-1817	136	2	:	:	PUNCT
dpc-1817	136	3	33251007	33251007	NUM
dpc-1817	136	4	.	.	PUNCT
dpc-1817	137	1	pmcid	pmcid	NOUN
dpc-1817	137	2	:	:	PUNCT
dpc-1817	137	3	pmc7686756	pmc7686756	ADJ
dpc-1817	137	4	.	.	PUNCT
dpc-1817	138	1	4	4	X
dpc-1817	138	2	.	.	X
dpc-1817	138	3	aslan	aslan	PROPN
dpc-1817	138	4	kayiran	kayiran	PROPN
dpc-1817	138	5	m	m	PROPN
dpc-1817	138	6	,	,	PUNCT
dpc-1817	138	7	karadag	karadag	PROPN
dpc-1817	138	8	as	as	ADP
dpc-1817	138	9	,	,	PUNCT
dpc-1817	138	10	jafferany	jafferany	NOUN
dpc-1817	138	11	m.	m.	NOUN
dpc-1817	138	12	psychodermatology	psychodermatology	NOUN
dpc-1817	138	13	of	of	ADP
dpc-1817	138	14	acne	acne	NOUN
dpc-1817	138	15	:	:	PUNCT
dpc-1817	138	16	dermatologist	dermatologist	NOUN
dpc-1817	138	17	’s	’s	PART
dpc-1817	138	18	guide	guide	VERB
dpc-1817	138	19	to	to	ADP
dpc-1817	138	20	inner	inner	ADJ
dpc-1817	138	21	side	side	NOUN
dpc-1817	138	22	of	of	ADP
dpc-1817	138	23	acne	acne	NOUN
dpc-1817	138	24	and	and	CCONJ
dpc-1817	138	25	management	management	NOUN
dpc-1817	138	26	approach	approach	NOUN
dpc-1817	138	27	.	.	PUNCT
dpc-1817	139	1	dermatol	dermatol	NOUN
dpc-1817	139	2	ther	ther	ADV
dpc-1817	139	3	.	.	PUNCT
dpc-1817	140	1	2020;33(6):e14150	2020;33(6):e14150	X
dpc-1817	140	2	.	.	PUNCT
dpc-1817	140	3	doi	doi	NOUN
dpc-1817	140	4	:	:	PUNCT
dpc-1817	140	5	10.1111	10.1111	NUM
dpc-1817	140	6	/	/	SYM
dpc-1817	140	7	dth.14150	dth.14150	NOUN
dpc-1817	140	8	.	.	PUNCT
dpc-1817	141	1	pmid	pmid	NOUN
dpc-1817	141	2	:	:	PUNCT
dpc-1817	141	3	32770727	32770727	NUM
dpc-1817	141	4	.	.	PUNCT
dpc-1817	142	1	5	5	X
dpc-1817	142	2	.	.	X
dpc-1817	142	3	pasion	pasion	NOUN
dpc-1817	142	4	r	r	NOUN
dpc-1817	142	5	,	,	PUNCT
dpc-1817	142	6	paiva	paiva	NOUN
dpc-1817	142	7	to	to	ADP
dpc-1817	142	8	,	,	PUNCT
dpc-1817	142	9	fernandes	fernandes	PROPN
dpc-1817	142	10	c	c	PROPN
dpc-1817	142	11	,	,	PUNCT
dpc-1817	142	12	barbosa	barbosa	PROPN
dpc-1817	142	13	f.	f.	PROPN
dpc-1817	142	14	the	the	DET
dpc-1817	142	15	age	age	NOUN
dpc-1817	142	16	effect	effect	NOUN
dpc-1817	142	17	on	on	ADP
dpc-1817	142	18	protective	protective	ADJ
dpc-1817	142	19	behaviors	behavior	NOUN
dpc-1817	142	20	during	during	ADP
dpc-1817	142	21	the	the	DET
dpc-1817	142	22	covid-19	covid-19	PROPN
dpc-1817	142	23	outbreak	outbreak	NOUN
dpc-1817	142	24	:	:	PUNCT
dpc-1817	142	25	sociodemographic	sociodemographic	ADJ
dpc-1817	142	26	,	,	PUNCT
dpc-1817	142	27	perceptions	perception	NOUN
dpc-1817	142	28	and	and	CCONJ
dpc-1817	142	29	psychological	psychological	ADJ
dpc-1817	142	30	accounts	account	NOUN
dpc-1817	142	31	.	.	PUNCT
dpc-1817	143	1	front	front	ADJ
dpc-1817	143	2	psychol	psychol	PROPN
dpc-1817	143	3	.	.	PUNCT
dpc-1817	144	1	2020	2020	NUM
dpc-1817	144	2	;	;	PUNCT
dpc-1817	144	3	11:561785	11:561785	X
dpc-1817	144	4	.	.	PUNCT
dpc-1817	145	1	doi	doi	NOUN
dpc-1817	145	2	:	:	PUNCT
dpc-1817	145	3	10.3389	10.3389	NUM
dpc-1817	145	4	/	/	SYM
dpc-1817	145	5	fpsyg.2020.561785	fpsyg.2020.561785	PROPN
dpc-1817	145	6	.	.	PUNCT
dpc-1817	146	1	pmid	pmid	NOUN
dpc-1817	146	2	:	:	PUNCT
dpc-1817	146	3	33178069	33178069	NUM
dpc-1817	146	4	.	.	PUNCT
dpc-1817	147	1	pmcid	pmcid	NOUN
dpc-1817	147	2	:	:	PUNCT
dpc-1817	147	3	pmc7595956	pmc7595956	NOUN
dpc-1817	147	4	.	.	PUNCT
dpc-1817	148	1	6	6	X
dpc-1817	148	2	.	.	X
dpc-1817	148	3	searle	searle	PROPN
dpc-1817	148	4	t	t	PROPN
dpc-1817	148	5	,	,	PUNCT
dpc-1817	148	6	ali	ali	PROPN
dpc-1817	148	7	fr	fr	PROPN
dpc-1817	148	8	,	,	PUNCT
dpc-1817	148	9	al	al	PROPN
dpc-1817	148	10	-	-	PUNCT
dpc-1817	148	11	niaimi	niaimi	PROPN
dpc-1817	148	12	f.	f.	PROPN
dpc-1817	148	13	identifying	identifying	NOUN
dpc-1817	148	14	and	and	CCONJ
dpc-1817	148	15	addressing	address	VERB
dpc-1817	148	16	“	"	PUNCT
dpc-1817	148	17	maskne	maskne	NOUN
dpc-1817	148	18	”	"	PUNCT
dpc-1817	148	19	in	in	ADP
dpc-1817	148	20	clinical	clinical	ADJ
dpc-1817	148	21	practice	practice	NOUN
dpc-1817	148	22	.	.	PUNCT
dpc-1817	149	1	dermatol	dermatol	NOUN
dpc-1817	149	2	ther	ther	ADV
dpc-1817	149	3	.	.	PUNCT
dpc-1817	150	1	2021;34(1):e14589	2021;34(1):e14589	X
dpc-1817	150	2	.	.	PUNCT
dpc-1817	151	1	doi	doi	NOUN
dpc-1817	151	2	:	:	PUNCT
dpc-1817	151	3	10.1111	10.1111	NUM
dpc-1817	151	4	/	/	SYM
dpc-1817	151	5	dth.14589	dth.14589	PROPN
dpc-1817	151	6	.	.	PUNCT
dpc-1817	152	1	pmid	pmid	NOUN
dpc-1817	152	2	:	:	PUNCT
dpc-1817	152	3	33244836	33244836	NUM
dpc-1817	152	4	.	.	PUNCT
dpc-1817	153	1	7	7	X
dpc-1817	153	2	.	.	X
dpc-1817	153	3	han	han	PROPN
dpc-1817	153	4	c	c	PROPN
dpc-1817	153	5	,	,	PUNCT
dpc-1817	153	6	shi	shi	PROPN
dpc-1817	153	7	j	j	PROPN
dpc-1817	153	8	,	,	PUNCT
dpc-1817	153	9	chen	chen	PROPN
dpc-1817	153	10	y	y	PROPN
dpc-1817	153	11	,	,	PUNCT
dpc-1817	153	12	zhang	zhang	PROPN
dpc-1817	153	13	z.	z.	PROPN
dpc-1817	153	14	increased	increase	VERB
dpc-1817	153	15	flare	flare	NOUN
dpc-1817	153	16	of	of	ADP
dpc-1817	153	17	acne	acne	NOUN
dpc-1817	153	18	caused	cause	VERB
dpc-1817	153	19	by	by	ADP
dpc-1817	153	20	long	long	ADJ
dpc-1817	153	21	-	-	PUNCT
dpc-1817	153	22	time	time	NOUN
dpc-1817	153	23	mask	mask	NOUN
dpc-1817	153	24	wearing	wear	VERB
dpc-1817	153	25	during	during	ADP
dpc-1817	153	26	covid-19	covid-19	PROPN
dpc-1817	153	27	pandemic	pandemic	ADJ
dpc-1817	153	28	among	among	ADP
dpc-1817	153	29	general	general	ADJ
dpc-1817	153	30	population	population	NOUN
dpc-1817	153	31	.	.	PUNCT
dpc-1817	154	1	dermatol	dermatol	NOUN
dpc-1817	154	2	ther	ther	ADV
dpc-1817	154	3	.	.	PUNCT
dpc-1817	155	1	2020;33(4):e13704	2020;33(4):e13704	X
dpc-1817	155	2	.	.	PUNCT
dpc-1817	155	3	doi	doi	NOUN
dpc-1817	155	4	:	:	PUNCT
dpc-1817	155	5	10.1111	10.1111	NUM
dpc-1817	155	6	/	/	SYM
dpc-1817	155	7	dth.13704	dth.13704	NOUN
dpc-1817	155	8	.	.	PUNCT
dpc-1817	156	1	pmid	pmid	NOUN
dpc-1817	156	2	:	:	PUNCT
dpc-1817	156	3	32472634	32472634	NUM
dpc-1817	156	4	.	.	PUNCT
dpc-1817	157	1	pmcid	pmcid	ADJ
dpc-1817	157	2	:	:	PUNCT
dpc-1817	157	3	pmc7300566.8	pmc7300566.8	X
dpc-1817	157	4	.	.	X
dpc-1817	157	5	8	8	NUM
dpc-1817	157	6	.	.	X
dpc-1817	158	1	damiani	damiani	PROPN
dpc-1817	158	2	g	g	PROPN
dpc-1817	158	3	,	,	PUNCT
dpc-1817	158	4	gironi	gironi	PROPN
dpc-1817	158	5	lc	lc	PROPN
dpc-1817	158	6	,	,	PUNCT
dpc-1817	158	7	grada	grada	PROPN
dpc-1817	158	8	a	a	PROPN
dpc-1817	158	9	,	,	PUNCT
dpc-1817	158	10	et	et	PROPN
dpc-1817	158	11	al	al	PROPN
dpc-1817	158	12	.	.	PUNCT
dpc-1817	159	1	covid-19	covid-19	PROPN
dpc-1817	159	2	related	related	ADJ
dpc-1817	159	3	masks	mask	NOUN
dpc-1817	159	4	increase	increase	VERB
dpc-1817	159	5	severity	severity	NOUN
dpc-1817	159	6	of	of	ADP
dpc-1817	159	7	both	both	DET
dpc-1817	159	8	acne	acne	NOUN
dpc-1817	159	9	(	(	PUNCT
dpc-1817	159	10	maskne	maskne	NOUN
dpc-1817	159	11	)	)	PUNCT
dpc-1817	159	12	and	and	CCONJ
dpc-1817	159	13	rosacea	rosacea	PROPN
dpc-1817	159	14	(	(	PUNCT
dpc-1817	159	15	mask	mask	PROPN
dpc-1817	159	16	rosacea	rosacea	NOUN
dpc-1817	159	17	):	):	PUNCT
dpc-1817	159	18	multi	multi	ADJ
dpc-1817	159	19	-	-	ADJ
dpc-1817	159	20	center	center	ADJ
dpc-1817	159	21	,	,	PUNCT
dpc-1817	159	22	real	real	ADJ
dpc-1817	159	23	-	-	PUNCT
dpc-1817	159	24	life	life	NOUN
dpc-1817	159	25	,	,	PUNCT
dpc-1817	159	26	telemedical	telemedical	ADJ
dpc-1817	159	27	,	,	PUNCT
dpc-1817	159	28	observational	observational	ADJ
dpc-1817	159	29	prospective	prospective	ADJ
dpc-1817	159	30	study	study	NOUN
dpc-1817	159	31	.	.	PUNCT
dpc-1817	160	1	dermatol	dermatol	NOUN
dpc-1817	160	2	ther	ther	ADV
dpc-1817	160	3	.	.	PUNCT
dpc-1817	161	1	2021	2021	NUM
dpc-1817	161	2	:	:	PUNCT
dpc-1817	161	3	e14848	e14848	NOUN
dpc-1817	161	4	.	.	PUNCT
dpc-1817	161	5	doi	doi	NOUN
dpc-1817	161	6	:	:	PUNCT
dpc-1817	161	7	10.1111	10.1111	NUM
dpc-1817	161	8	/	/	SYM
dpc-1817	161	9	dth.14848	dth.14848	PROPN
dpc-1817	161	10	.	.	PUNCT
dpc-1817	162	1	pmid	pmid	NOUN
dpc-1817	162	2	:	:	PUNCT
dpc-1817	162	3	33533563	33533563	NUM
dpc-1817	162	4	.	.	PUNCT
dpc-1817	163	1	pmcid	pmcid	NOUN
dpc-1817	163	2	:	:	PUNCT
dpc-1817	163	3	pmc7995182	pmc7995182	NOUN
dpc-1817	163	4	.	.	PUNCT
dpc-1817	164	1	9	9	X
dpc-1817	164	2	.	.	X
dpc-1817	164	3	abde	abde	ADP
dpc-1817	164	4	lmaksoud	lmaksoud	PROPN
dpc-1817	164	5	a	a	PROPN
dpc-1817	164	6	,	,	PUNCT
dpc-1817	164	7	ves	ves	INTJ
dpc-1817	164	8	t	t	X
dpc-1817	164	9	i	i	PRON
dpc-1817	164	10	ta	ta	PROPN
dpc-1817	164	11	m	m	PROPN
dpc-1817	164	12	,	,	PUNCT
dpc-1817	164	13	e	e	PROPN
dpc-1817	164	14	l	l	PROPN
dpc-1817	164	15	-amawy	-amawy	PROPN
dpc-1817	164	16	hs	hs	PROPN
dpc-1817	164	17	,	,	PUNCT
dpc-1817	164	18	e	e	PROPN
dpc-1817	164	19	t	t	PROPN
dpc-1817	164	20	a	a	DET
dpc-1817	164	21	l	l	NOUN
dpc-1817	164	22	.	.	PUNCT
dpc-1817	165	1	isotretinoin	isotretinoin	PROPN
dpc-1817	165	2	therapy	therapy	NOUN
dpc-1817	165	3	in	in	ADP
dpc-1817	165	4	the	the	DET
dpc-1817	165	5	era	era	NOUN
dpc-1817	165	6	of	of	ADP
dpc-1817	165	7	covid-19	covid-19	PROPN
dpc-1817	165	8	.	.	PUNCT
dpc-1817	165	9	dermatol	dermatol	NOUN
dpc-1817	165	10	ther	ther	ADV
dpc-1817	165	11	.	.	PUNCT
dpc-1817	166	1	2020;33(4):e13482	2020;33(4):e13482	X
dpc-1817	166	2	.	.	X
dpc-1817	166	3	doi	doi	NOUN
dpc-1817	166	4	:	:	PUNCT
dpc-1817	166	5	10.1111	10.1111	NUM
dpc-1817	166	6	/	/	SYM
dpc-1817	166	7	dth.13482	dth.13482	PROPN
dpc-1817	166	8	.	.	PUNCT
dpc-1817	166	9	pmid	pmid	NOUN
dpc-1817	166	10	:	:	PUNCT
dpc-1817	166	11	32358858	32358858	NUM
dpc-1817	166	12	.	.	PUNCT
dpc-1817	167	1	pmcid	pmcid	NOUN
dpc-1817	167	2	:	:	PUNCT
dpc-1817	167	3	pmc7261989	pmc7261989	ADJ
dpc-1817	167	4	.	.	PUNCT
dpc-1817	168	1	10	10	NUM
dpc-1817	168	2	.	.	PUNCT
dpc-1817	169	1	british	british	PROPN
dpc-1817	169	2	association	association	PROPN
dpc-1817	169	3	of	of	ADP
dpc-1817	169	4	dermatologists	dermatologists	PROPN
dpc-1817	169	5	.	.	PUNCT
dpc-1817	170	1	guidance	guidance	NOUN
dpc-1817	170	2	for	for	ADP
dpc-1817	170	3	managing	manage	VERB
dpc-1817	170	4	patients	patient	NOUN
dpc-1817	170	5	on	on	ADP
dpc-1817	170	6	isotretinoin	isotretinoin	PROPN
dpc-1817	170	7	during	during	ADP
dpc-1817	170	8	the	the	DET
dpc-1817	170	9	coronavirus	coronavirus	NOUN
dpc-1817	170	10	pandemic	pandemic	ADJ
dpc-1817	170	11	2020	2020	NUM
dpc-1817	170	12	.	.	PUNCT
dpc-1817	171	1	available	available	ADJ
dpc-1817	171	2	from	from	ADP
dpc-1817	171	3	:	:	PUNCT
dpc-1817	171	4	https://www.bad.org.uk/shared/get-file	https://www.bad.org.uk/shared/get-file	NOUN
dpc-1817	171	5	.	.	PUNCT
dpc-1817	171	6	ashx?itemtype	ashx?itemtype	PROPN
dpc-1817	171	7	=	=	PROPN
dpc-1817	171	8	document&id=6661	document&id=6661	PROPN
dpc-1817	171	9	.	.	PROPN
dpc-1817	171	10	11	11	NUM
dpc-1817	171	11	.	.	PUNCT
dpc-1817	172	1	pathoulas	pathoulas	PROPN
dpc-1817	172	2	jt	jt	PROPN
dpc-1817	172	3	,	,	PUNCT
dpc-1817	172	4	farah	farah	PROPN
dpc-1817	172	5	rs	rs	PROPN
dpc-1817	172	6	,	,	PUNCT
dpc-1817	172	7	fiessinger	fiessinger	ADJ
dpc-1817	172	8	l	l	NOUN
dpc-1817	172	9	,	,	PUNCT
dpc-1817	172	10	mansh	mansh	ADJ
dpc-1817	172	11	m.	m.	NOUN
dpc-1817	172	12	an	an	DET
dpc-1817	172	13	opportunity	opportunity	NOUN
dpc-1817	172	14	for	for	ADP
dpc-1817	172	15	improvement	improvement	NOUN
dpc-1817	172	16	:	:	PUNCT
dpc-1817	172	17	ipledge	ipledge	NOUN
dpc-1817	172	18	policy	policy	NOUN
dpc-1817	172	19	changes	change	NOUN
dpc-1817	172	20	during	during	ADP
dpc-1817	172	21	the	the	DET
dpc-1817	172	22	coronavirus	coronavirus	NOUN
dpc-1817	172	23	pandemic	pandemic	ADJ
dpc-1817	172	24	.	.	PUNCT
dpc-1817	173	1	dermatol	dermatol	NOUN
dpc-1817	173	2	ther	ther	ADV
dpc-1817	173	3	.	.	PUNCT
dpc-1817	174	1	2020;33(6):e14411	2020;33(6):e14411	X
dpc-1817	174	2	.	.	PUNCT
dpc-1817	175	1	doi	doi	NOUN
dpc-1817	175	2	:	:	PUNCT
dpc-1817	175	3	10.1111/	10.1111/	NUM
dpc-1817	175	4	dth.14411	dth.14411	PROPN
dpc-1817	175	5	.	.	PUNCT
dpc-1817	176	1	pmid	pmid	NOUN
dpc-1817	176	2	:	:	PUNCT
dpc-1817	176	3	33052629	33052629	NUM
dpc-1817	176	4	.	.	PUNCT
dpc-1817	177	1	pmcid	pmcid	NOUN
dpc-1817	177	2	:	:	PUNCT
dpc-1817	177	3	pmc7646038	pmc7646038	ADJ
dpc-1817	177	4	.	.	PUNCT
dpc-1817	178	1	12	12	NUM
dpc-1817	178	2	.	.	X
dpc-1817	179	1	ruggiero	ruggiero	PROPN
dpc-1817	179	2	a	a	DET
dpc-1817	179	3	,	,	PUNCT
dpc-1817	179	4	megna	megna	PROPN
dpc-1817	179	5	m	m	PROPN
dpc-1817	179	6	,	,	PUNCT
dpc-1817	179	7	annunziata	annunziata	PROPN
dpc-1817	179	8	mc	mc	PROPN
dpc-1817	179	9	,	,	PUNCT
dpc-1817	179	10	et	et	PROPN
dpc-1817	179	11	al	al	PROPN
dpc-1817	179	12	.	.	PROPN
dpc-1817	179	13	teledermatology	teledermatology	NOUN
dpc-1817	179	14	for	for	ADP
dpc-1817	179	15	acne	acne	NOUN
dpc-1817	179	16	during	during	ADP
dpc-1817	179	17	covid-19	covid-19	PROPN
dpc-1817	179	18	:	:	PUNCT
dpc-1817	179	19	high	high	ADJ
dpc-1817	179	20	patients	patient	NOUN
dpc-1817	179	21	’	'	PUNCT
dpc-1817	179	22	satisfaction	satisfaction	NOUN
dpc-1817	179	23	in	in	ADP
dpc-1817	179	24	spite	spite	NOUN
dpc-1817	179	25	of	of	ADP
dpc-1817	179	26	the	the	DET
dpc-1817	179	27	emergency	emergency	NOUN
dpc-1817	179	28	.	.	PUNCT
dpc-1817	180	1	j	j	PROPN
dpc-1817	180	2	eur	eur	PROPN
dpc-1817	180	3	acad	acad	PROPN
dpc-1817	180	4	dermatol	dermatol	NOUN
dpc-1817	180	5	venereol	venereol	NOUN
dpc-1817	180	6	.	.	PUNCT
dpc-1817	181	1	2020;34(11):e662	2020;34(11):e662	NUM
dpc-1817	181	2	-	-	SYM
dpc-1817	181	3	e663	e663	NUM
dpc-1817	181	4	.	.	PUNCT
dpc-1817	181	5	doi	doi	NOUN
dpc-1817	181	6	:	:	PUNCT
dpc-1817	181	7	10.1111	10.1111	NUM
dpc-1817	181	8	/	/	SYM
dpc-1817	181	9	jdv.16746	jdv.16746	PROPN
dpc-1817	181	10	.	.	PUNCT
dpc-1817	182	1	pmid	pmid	NOUN
dpc-1817	182	2	:	:	PUNCT
dpc-1817	182	3	32534472	32534472	NUM
dpc-1817	182	4	.	.	PUNCT
dpc-1817	183	1	pmcid	pmcid	NOUN
dpc-1817	183	2	:	:	PUNCT
dpc-1817	183	3	pmc7323158	pmc7323158	NOUN
dpc-1817	183	4	.	.	PUNCT
dpc-1817	184	1	13	13	NUM
dpc-1817	184	2	.	.	PUNCT
dpc-1817	185	1	kim	kim	PROPN
dpc-1817	185	2	jk	jk	PROPN
dpc-1817	185	3	,	,	PUNCT
dpc-1817	185	4	crimmins	crimmin	VERB
dpc-1817	185	5	em	em	PRON
dpc-1817	185	6	.	.	PUNCT
dpc-1817	186	1	how	how	SCONJ
dpc-1817	186	2	does	do	AUX
dpc-1817	186	3	age	age	NOUN
dpc-1817	186	4	affect	affect	VERB
dpc-1817	186	5	personal	personal	ADJ
dpc-1817	186	6	and	and	CCONJ
dpc-1817	186	7	social	social	ADJ
dpc-1817	186	8	reactions	reaction	NOUN
dpc-1817	186	9	to	to	ADP
dpc-1817	186	10	covid-19	covid-19	PROPN
dpc-1817	186	11	:	:	PUNCT
dpc-1817	186	12	results	result	NOUN
dpc-1817	186	13	from	from	ADP
dpc-1817	186	14	the	the	DET
dpc-1817	186	15	national	national	PROPN
dpc-1817	186	16	understanding	understanding	PROPN
dpc-1817	186	17	america	america	PROPN
dpc-1817	186	18	study	study	PROPN
dpc-1817	186	19	.	.	PUNCT
dpc-1817	187	1	plos	plos	PROPN
dpc-1817	187	2	one	one	NUM
dpc-1817	187	3	.	.	PUNCT
dpc-1817	188	1	2020;15(11):e0241950	2020;15(11):e0241950	PROPN
dpc-1817	188	2	.	.	PUNCT
dpc-1817	189	1	doi	doi	NOUN
dpc-1817	189	2	:	:	PUNCT
dpc-1817	189	3	10.1371	10.1371	NUM
dpc-1817	189	4	/	/	SYM
dpc-1817	189	5	journal.pone.0241950	journal.pone.0241950	PROPN
dpc-1817	189	6	.	.	PUNCT
dpc-1817	190	1	pmid	pmid	PROPN
dpc-1817	190	2	:	:	PUNCT
dpc-1817	190	3	33170903	33170903	NUM
dpc-1817	190	4	.	.	PUNCT
dpc-1817	191	1	pmcid	pmcid	NOUN
dpc-1817	191	2	:	:	PUNCT
dpc-1817	191	3	pmc7654776	pmc7654776	NOUN
dpc-1817	191	4	.	.	PUNCT
dpc-1817	192	1	14	14	NUM
dpc-1817	192	2	.	.	PUNCT
dpc-1817	193	1	dessinioti	dessinioti	PROPN
dpc-1817	194	1	c	c	X
dpc-1817	194	2	,	,	PUNCT
dpc-1817	194	3	zouboulis	zouboulis	PROPN
dpc-1817	194	4	cc	cc	NOUN
dpc-1817	194	5	,	,	PUNCT
dpc-1817	194	6	bettoli	bettoli	ADP
dpc-1817	194	7	v	v	NOUN
dpc-1817	194	8	,	,	PUNCT
dpc-1817	194	9	rigopoulos	rigopoulos	PROPN
dpc-1817	194	10	d.	d.	PROPN
dpc-1817	194	11	comparison	comparison	NOUN
dpc-1817	194	12	of	of	ADP
dpc-1817	194	13	guidelines	guideline	NOUN
dpc-1817	194	14	and	and	CCONJ
dpc-1817	194	15	consensus	consensus	NOUN
dpc-1817	194	16	articles	article	NOUN
dpc-1817	194	17	on	on	ADP
dpc-1817	194	18	the	the	DET
dpc-1817	194	19	management	management	NOUN
dpc-1817	194	20	of	of	ADP
dpc-1817	194	21	patients	patient	NOUN
dpc-1817	194	22	with	with	ADP
dpc-1817	194	23	acne	acne	NOUN
dpc-1817	194	24	with	with	ADP
dpc-1817	194	25	oral	oral	ADJ
dpc-1817	194	26	isotretinoin	isotretinoin	PROPN
dpc-1817	194	27	.	.	PUNCT
dpc-1817	195	1	j	j	PROPN
dpc-1817	195	2	eur	eur	PROPN
dpc-1817	195	3	acad	acad	PROPN
dpc-1817	195	4	dermatol	dermatol	NOUN
dpc-1817	195	5	venereol	venereol	NOUN
dpc-1817	195	6	.	.	PUNCT
dpc-1817	196	1	2020;34(10):2229	2020;34(10):2229	NUM
dpc-1817	196	2	-	-	SYM
dpc-1817	196	3	2240	2240	NUM
dpc-1817	196	4	.	.	PUNCT
dpc-1817	197	1	doi	doi	NOUN
dpc-1817	197	2	:	:	PUNCT
dpc-1817	197	3	10.1111	10.1111	NUM
dpc-1817	197	4	/	/	SYM
dpc-1817	197	5	jdv.16430	jdv.16430	PROPN
dpc-1817	197	6	.	.	PUNCT
dpc-1817	198	1	pmid	pmid	NOUN
dpc-1817	198	2	:	:	PUNCT
dpc-1817	198	3	32277497	32277497	NUM
dpc-1817	198	4	.	.	PUNCT
dpc-1817	199	1	15	15	NUM
dpc-1817	199	2	.	.	PUNCT
dpc-1817	200	1	lee	lee	PROPN
dpc-1817	200	2	yh	yh	PROPN
dpc-1817	200	3	,	,	PUNCT
dpc-1817	200	4	scharnitz	scharnitz	PROPN
dpc-1817	200	5	tp	tp	PROPN
dpc-1817	200	6	,	,	PUNCT
dpc-1817	200	7	muscat	muscat	PROPN
dpc-1817	200	8	j	j	PROPN
dpc-1817	200	9	,	,	PUNCT
dpc-1817	200	10	chen	chen	PROPN
dpc-1817	200	11	a	a	PROPN
dpc-1817	200	12	,	,	PUNCT
dpc-1817	200	13	gupta	gupta	PROPN
dpc-1817	200	14	-	-	NOUN
dpc-1817	200	15	elera	elera	NOUN
dpc-1817	200	16	g	g	NOUN
dpc-1817	200	17	,	,	PUNCT
dpc-1817	200	18	kirby	kirby	PROPN
dpc-1817	200	19	js	js	PROPN
dpc-1817	200	20	.	.	PUNCT
dpc-1817	201	1	laboratory	laboratory	NOUN
dpc-1817	201	2	monitoring	monitoring	NOUN
dpc-1817	201	3	during	during	ADP
dpc-1817	201	4	isotretinoin	isotretinoin	PROPN
dpc-1817	201	5	therapy	therapy	NOUN
dpc-1817	201	6	for	for	ADP
dpc-1817	201	7	acne	acne	NOUN
dpc-1817	201	8	:	:	PUNCT
dpc-1817	201	9	a	a	DET
dpc-1817	201	10	systematic	systematic	ADJ
dpc-1817	201	11	review	review	NOUN
dpc-1817	201	12	and	and	CCONJ
dpc-1817	201	13	meta	meta	ADJ
dpc-1817	201	14	-	-	PUNCT
dpc-1817	201	15	analysis	analysis	NOUN
dpc-1817	201	16	.	.	PUNCT
dpc-1817	202	1	jama	jama	PROPN
dpc-1817	202	2	dermatol	dermatol	NOUN
dpc-1817	202	3	.	.	PUNCT
dpc-1817	203	1	2016;152(1):35	2016;152(1):35	PROPN
dpc-1817	203	2	-	-	SYM
dpc-1817	203	3	44	44	NUM
dpc-1817	203	4	.	.	PUNCT
dpc-1817	204	1	doi	doi	NOUN
dpc-1817	204	2	:	:	PUNCT
dpc-1817	204	3	10.1001	10.1001	NUM
dpc-1817	204	4	/	/	SYM
dpc-1817	204	5	jamadermatol.2015.3091	jamadermatol.2015.3091	PROPN
dpc-1817	204	6	.	.	PUNCT
dpc-1817	205	1	epmid	epmid	ADP
dpc-1817	205	2	:	:	PUNCT
dpc-1817	205	3	26630323	26630323	NUM
dpc-1817	205	4	.	.	PUNCT
dpc-1817	206	1	16	16	NUM
dpc-1817	206	2	.	.	PUNCT
dpc-1817	207	1	choi	choi	PROPN
dpc-1817	207	2	js	js	PROPN
dpc-1817	207	3	,	,	PUNCT
dpc-1817	207	4	koren	koren	PROPN
dpc-1817	207	5	g	g	PROPN
dpc-1817	207	6	,	,	PUNCT
dpc-1817	207	7	nulman	nulman	ADJ
dpc-1817	207	8	i.	i.	PROPN
dpc-1817	207	9	pregnancy	pregnancy	PROPN
dpc-1817	207	10	and	and	CCONJ
dpc-1817	207	11	isotretinoin	isotretinoin	PROPN
dpc-1817	207	12	therapy	therapy	NOUN
dpc-1817	207	13	.	.	PUNCT
dpc-1817	208	1	cmaj	cmaj	PROPN
dpc-1817	208	2	.	.	PUNCT
dpc-1817	209	1	2013;185(5):411	2013;185(5):411	X
dpc-1817	209	2	-	-	SYM
dpc-1817	209	3	413	413	NUM
dpc-1817	209	4	.	.	PUNCT
dpc-1817	210	1	doi	doi	NOUN
dpc-1817	210	2	:	:	PUNCT
dpc-1817	210	3	10.1503	10.1503	NUM
dpc-1817	210	4	/	/	SYM
dpc-1817	210	5	cmaj.120729	cmaj.120729	NOUN
dpc-1817	210	6	.	.	PUNCT
dpc-1817	211	1	pmid	pmid	NOUN
dpc-1817	211	2	:	:	PUNCT
dpc-1817	211	3	23296582	23296582	NUM
dpc-1817	211	4	.	.	PUNCT
dpc-1817	212	1	pmcid	pmcid	NOUN
dpc-1817	212	2	:	:	PUNCT
dpc-1817	212	3	pmc3602257	pmc3602257	NOUN
dpc-1817	212	4	.	.	PUNCT